{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/dipanjanS/building-effective-agentic-ai-systems-dhs2025/blob/main/Demo_4_Memory_Context_Engineering_for_AI_Agents.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "id": "1101434d",
      "metadata": {
        "id": "1101434d"
      },
      "source": [
        "# Memory Context Engineering for AI Agents\n",
        "\n",
        "This notebook demonstrates how to design and optimize an agentic AI system with memory context engineering for healthcare assistance.  \n",
        "\n",
        "The agent integrates reasoning, external tool usage, and context management to provide reliable, structured, and cost-efficient responses.\n",
        "\n",
        "\n",
        "![](https://i.imgur.com/HRNXG4b.png)\n",
        "\n",
        "Key aspects covered:\n",
        "- **System Design**: Define a health assistant agent that can answer medical queries, research healthcare information, and recommend doctors from a structured database.\n",
        "- **Tool Integration**: Implement two tools, one for searching the web for medical information and another for recommending appropriate doctors.\n",
        "- **Graph Architecture**: Use LangGraph to connect the agent, tools, and memory, enabling structured reasoning and decision-making loops.\n",
        "- **Memory Management**: Employ a checkpointer to persist session context across multiple queries, ensuring continuity in user conversations.\n",
        "- **Context Optimization**: Introduce message trimming and tool output summarization to control context length, reduce costs, and improve efficiency in long-running interactions.\n",
        "- **Practical Testing**: Run the agent on multiple sample queries to demonstrate multi-turn dialogue, contextual awareness, and optimized reasoning.\n",
        "\n",
        "The overall goal is to showcase how memory context engineering techniques can make AI agents more scalable, cost-effective, and reliable in real-world use cases.\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Install Dependencies"
      ],
      "metadata": {
        "id": "-m_zRiJZtZJj"
      },
      "id": "-m_zRiJZtZJj"
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "9bf7b469",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9bf7b469",
        "outputId": "3f31946d-6e19-4f08-f808-dd8777d52890"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m43.7/43.7 kB\u001b[0m \u001b[31m2.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.5/2.5 MB\u001b[0m \u001b[31m33.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m74.4/74.4 kB\u001b[0m \u001b[31m3.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m153.2/153.2 kB\u001b[0m \u001b[31m7.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m43.9/43.9 kB\u001b[0m \u001b[31m1.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m52.0/52.0 kB\u001b[0m \u001b[31m2.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m45.2/45.2 kB\u001b[0m \u001b[31m2.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m50.9/50.9 kB\u001b[0m \u001b[31m2.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m216.5/216.5 kB\u001b[0m \u001b[31m12.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h"
          ]
        }
      ],
      "source": [
        "!pip install langchain==0.3.27 langchain-community==0.3.27 langchain-openai==0.3.30 langgraph==0.6.5 --quiet"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Setup API Keys and Environment\n",
        "\n",
        "Here we enter our API keys for OpenAI and Tavily Search and set them in our environment"
      ],
      "metadata": {
        "id": "crTRTYdTKxGv"
      },
      "id": "crTRTYdTKxGv"
    },
    {
      "cell_type": "code",
      "source": [
        "import os\n",
        "import getpass\n",
        "\n",
        "# OpenAI API Key (for chat & embeddings)\n",
        "if not os.environ.get(\"OPENAI_API_KEY\"):\n",
        "    os.environ[\"OPENAI_API_KEY\"] = getpass.getpass(\"Enter your OpenAI API key (https://platform.openai.com/account/api-keys):\\n\")\n",
        "\n",
        "# Tavily API Key (for web search)\n",
        "if not os.environ.get(\"TAVILY_API_KEY\"):\n",
        "    os.environ[\"TAVILY_API_KEY\"] = getpass.getpass(\"Enter your Tavily API key (https://app.tavily.com/home):\\n\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "dIAVLkpuwR7V",
        "outputId": "6b1bb16d-c8db-4bf5-aedc-076e85088b62"
      },
      "id": "dIAVLkpuwR7V",
      "execution_count": null,
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Enter your OpenAI API key (https://platform.openai.com/account/api-keys):\n",
            "··········\n",
            "Enter your Tavily API key (https://app.tavily.com/home):\n",
            "··········\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Build a Health Assistant Agentic AI System with Memory\n",
        "\n",
        "In this section, we design and implement a health-focused agentic AI system that leverages reasoning, memory, and tool integration.  \n",
        "The goal is to create an AI assistant that can research medical symptoms, provide healthcare guidance, and recommend appropriate doctors.  \n",
        "\n",
        "Key components introduced here:\n",
        "- **System Prompt**: Defines the behavior of the agent, guiding how it responds to different user queries (e.g., when to search vs. when to recommend a doctor).  \n",
        "- **External Tools**: Connect the LLM to outside sources of information like the internet or a doctor database.  \n",
        "- **Memory Integration**: Ensures that past user interactions are retained across multiple turns, allowing the assistant to give context-aware answers.  \n",
        "- **Agent Graph**: Establishes how the agent flows between reasoning, tool usage, and response generation.  \n",
        "\n",
        "This foundation sets up the core structure of the Health Assistant, enabling multi-turn conversations that combine external knowledge with contextual understanding.\n"
      ],
      "metadata": {
        "id": "cdJSOOLJy_wA"
      },
      "id": "cdJSOOLJy_wA"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Build Tools\n",
        "\n",
        "This part covers the creation of specialized tools that the agent can call when reasoning about user queries.  \n",
        "- **Search Web Tool**: Retrieves relevant health information from the internet, ensuring results include detailed content and source links.  \n",
        "- **Recommend Doctor Tool**: Selects appropriate doctors from a small in-memory database using the LLM, returning structured details such as specialization, availability, and contact information.  \n"
      ],
      "metadata": {
        "id": "f5zyTJgGzI1R"
      },
      "id": "f5zyTJgGzI1R"
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "6c011a90",
      "metadata": {
        "id": "6c011a90"
      },
      "outputs": [],
      "source": [
        "from langchain_openai import ChatOpenAI\n",
        "from langchain_community.utilities.tavily_search import TavilySearchAPIWrapper\n",
        "from langchain_core.tools import tool\n",
        "import requests\n",
        "\n",
        "\n",
        "# Tavily Web Search\n",
        "tavily_search = TavilySearchAPIWrapper()\n",
        "\n",
        "@tool\n",
        "def search_web_extract_info(query: str) -> list:\n",
        "    \"\"\"Search the web for a query. Useful for general information or general news.\"\"\"\n",
        "    results = tavily_search.raw_results(query=query, max_results=5, search_depth='advanced',\n",
        "                                        include_answer=False, include_raw_content=True)\n",
        "    docs = results['results']\n",
        "    docs = [doc for doc in docs if doc.get(\"raw_content\") is not None]\n",
        "    docs = ['## Title\\n'+doc['title']+'\\n\\n'+'## Content\\n'+doc['raw_content']+'\\n\\n'+'##Source\\n'+doc['url'] for doc in docs]\n",
        "    return docs"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "6aecfda7",
      "metadata": {
        "id": "6aecfda7"
      },
      "outputs": [],
      "source": [
        "# doctor database\n",
        "doctors_db = [\n",
        "    {\"name\": \"Dr. Janet Dyne\", \"specialization\": \"Endocrinology (Diabetes Care)\", \"available_timings\": \"10:00 AM - 1:00 PM\", \"location\": \"City Health Clinic\", \"contact\": \"janet.dyne@healthclinic.com\"},\n",
        "    {\"name\": \"Dr. Don Blake \", \"specialization\": \"Cardiology (Heart Specialist)\", \"available_timings\": \"2:00 PM - 5:00 PM\", \"location\": \"Metro Cardiac Center\", \"contact\": \"don.blake@metrocardiac.com\"},\n",
        "    {\"name\": \"Dr. Susan D'Souza\", \"specialization\": \"Oncology (Cancer Care)\", \"available_timings\": \"11:00 AM - 2:00 PM\", \"location\": \"Hope Cancer Institute\", \"contact\": \"susan.dsouza@hopecancer.org\"},\n",
        "    {\"name\": \"Dr. Matt Murdock\", \"specialization\": \"Psychiatry (Mental Health)\", \"available_timings\": \"4:00 PM - 7:00 PM\", \"location\": \"Mind Care Center\", \"contact\": \"matt.murdock@mindcare.com\"},\n",
        "    {\"name\": \"Dr. Dinah Lance\", \"specialization\": \"General Physician\", \"available_timings\": \"9:00 AM - 12:00 PM\", \"location\": \"Downtown Medical Center\", \"contact\": \"dinah.lance@downtownmed.com\"}\n",
        "]\n",
        "\n",
        "from langchain_openai import ChatOpenAI\n",
        "from langchain_core.tools import tool\n",
        "\n",
        "small_llm = ChatOpenAI(model=\"gpt-4o-mini\", temperature=0)\n",
        "\n",
        "@tool\n",
        "def recommend_doctor(query: str) -> dict:\n",
        "    \"\"\"Recommend the most suitable doctor based on the user's symptoms.\"\"\"\n",
        "    doctors_list = str(doctors_db)\n",
        "    prompt = f\"\"\"\n",
        "You are an assistant helping recommend a doctor based on patient's health issues.\n",
        "\n",
        "Here is the list of available doctors:\n",
        "\n",
        "{doctors_list}\n",
        "\n",
        "Given the user's query: \"{query}\"\n",
        "\n",
        "Choose the most suitable doctor from the list. Only pick one doctor.\n",
        "Return only the selected doctor's information in JSON format.\n",
        "If not sure, recommend the General Physician.\n",
        "\"\"\"\n",
        "    response = small_llm.invoke(prompt)\n",
        "    return {\"recommended_doctor\": response.content}\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Define Agent Node Functions & Graph\n",
        "\n",
        "Here the notebook defines how the agent workflow is orchestrated with LangGraph.  \n",
        "- **Agent Node**: Uses the system prompt and LLM to decide whether to answer directly or invoke a tool.  \n",
        "- **Tool Node**: Executes the requested tool and passes results back to the LLM.  \n",
        "- **Graph**: Establishes routes between the agent, tools, and end state, while also attaching memory to persist dialogue context across multiple queries.  "
      ],
      "metadata": {
        "id": "QwI-bsw31sA3"
      },
      "id": "QwI-bsw31sA3"
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "dfc8e72e",
      "metadata": {
        "id": "dfc8e72e"
      },
      "outputs": [],
      "source": [
        "tools = [search_web_extract_info, recommend_doctor]\n",
        "\n",
        "llm = ChatOpenAI(model=\"gpt-4o-mini\", temperature=0)\n",
        "llm_with_tools = llm.bind_tools(tools=tools)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_core.messages import SystemMessage\n",
        "\n",
        "AGENT_PROMPT_TXT = \"\"\"You are an agent designed to act as an expert in researching on medical symptoms\n",
        "and also recommend relevant doctors for booking appointments. The current year is 2025.\n",
        "\n",
        "Given an input user query call relevant tools and give the most appropriate response.\n",
        "Follow some of these guidelines to help you make more informed decisions:\n",
        "  - If the user's query specifies recommending a doctor only then recommend an appropriate doctor\n",
        "  - If the user is researching on aspects around healthcare use web search\n",
        "  - Response should include cited source links, Publication Dates if available\n",
        "  - If recommending doctors then show detailed information in a nice structured way and recommend them to book an appointment via email\n",
        "\"\"\"\n",
        "\n",
        "AGENT_SYS_PROMPT = SystemMessage(content=AGENT_PROMPT_TXT)"
      ],
      "metadata": {
        "id": "CebXDsdOdj8u"
      },
      "id": "CebXDsdOdj8u",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "id": "4af2257a",
      "metadata": {
        "id": "4af2257a"
      },
      "outputs": [],
      "source": [
        "from langgraph.graph import StateGraph, START, END\n",
        "from langgraph.prebuilt import ToolNode, tools_condition\n",
        "from langgraph.prebuilt import create_react_agent\n",
        "from langgraph.checkpoint.memory import MemorySaver\n",
        "from typing import Annotated\n",
        "from typing_extensions import TypedDict\n",
        "from langgraph.graph.message import add_messages\n",
        "\n",
        "# create agent state schema\n",
        "class State(TypedDict):\n",
        "    messages: Annotated[list, add_messages]\n",
        "\n",
        "# Create the node function that handles reasoning and planning using the LLM\n",
        "def tool_calling_llm(state: State) -> State:\n",
        "    # get agent state and then get next step (response) from llm\n",
        "    current_state = state[\"messages\"]\n",
        "    state_with_instructions = [AGENT_SYS_PROMPT] + current_state\n",
        "    response = [llm_with_tools.invoke(state_with_instructions)]\n",
        "\n",
        "    token_usage = response[0].usage_metadata\n",
        "    print('-'*25, 'TOKEN USAGE', '-'*25)\n",
        "    print(\"Token count (input context):\", token_usage['input_tokens'])\n",
        "    print(\"Token count (response):\", token_usage['output_tokens'])\n",
        "    print('-'*25, 'TOKEN USAGE', '-'*25)\n",
        "\n",
        "    # Return the updated state containing the new message\n",
        "    return {\"messages\": response}\n",
        "\n",
        "# create node function for tools\n",
        "tool_node = ToolNode(tools=tools)\n",
        "\n",
        "\n",
        "# Build the graph\n",
        "builder = StateGraph(State)\n",
        "\n",
        "# Add nodes\n",
        "builder.add_node(\"tool_calling_llm\", tool_calling_llm)\n",
        "builder.add_node(\"tools\", tool_node)\n",
        "\n",
        "# Add edges\n",
        "builder.add_edge(START, \"tool_calling_llm\")\n",
        "# Conditional edge\n",
        "builder.add_conditional_edges(\n",
        "    \"tool_calling_llm\",\n",
        "    tools_condition, # conditional routing function\n",
        "    [\"tools\", END]\n",
        ")\n",
        "builder.add_edge(\"tools\", \"tool_calling_llm\") # this is the key feedback loop in the agentic system\n",
        "\n",
        "# Compile Agent Graph with memory\n",
        "memory = MemorySaver() # Add in-memory store - can change to in-memory databases also\n",
        "agent = builder.compile(checkpointer=memory)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "agent"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 266
        },
        "id": "sMWlgJAD5TeT",
        "outputId": "c6b96d04-250d-4ad3-b9c0-d1fbe90e7b18"
      },
      "id": "sMWlgJAD5TeT",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<langgraph.graph.state.CompiledStateGraph object at 0x7da4ac166390>"
            ],
            "image/png": "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\n"
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Test Agent on Sample Queries"
      ],
      "metadata": {
        "id": "TIe13vnG04Mn"
      },
      "id": "TIe13vnG04Mn"
    },
    {
      "cell_type": "code",
      "source": [
        "!gdown 1dSyjcjlFoZpYEqv4P9Oi0-kU2gIoolMB"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "WOrDYsHrzwg6",
        "outputId": "c6fcc685-ee1b-4c63-cf78-b0de545aaa76"
      },
      "id": "WOrDYsHrzwg6",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Downloading...\n",
            "From (original): https://drive.google.com/uc?id=1dSyjcjlFoZpYEqv4P9Oi0-kU2gIoolMB\n",
            "From (redirected): https://drive.google.com/uc?id=1dSyjcjlFoZpYEqv4P9Oi0-kU2gIoolMB&confirm=t&uuid=a425770d-1bdc-49b9-9126-a993fd37e466\n",
            "To: /content/agent_utils.py\n",
            "\r  0% 0.00/6.38k [00:00<?, ?B/s]\r100% 6.38k/6.38k [00:00<00:00, 17.6MB/s]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from IPython.display import display, Markdown\n",
        "from agent_utils import format_message\n",
        "\n",
        "# Utility function to call the agent and stream its step-by-step reasoning for a specific user\n",
        "def call_conversational_agent(agent, prompt, user_session_id, verbose=False):\n",
        "    # Stream the agent's execution using the given prompt and session ID for memory tracking\n",
        "    events = agent.stream(\n",
        "        {\"messages\": [{\"role\": \"user\", \"content\": prompt}]},   # User input prompt\n",
        "        {\"configurable\": {\"thread_id\": user_session_id}},      # Thread ID for session-based memory (multi-user support)\n",
        "        stream_mode=\"values\"                                   # Stream messages as the agent processes them\n",
        "    )\n",
        "\n",
        "    print('Running Agent. Please wait...')\n",
        "\n",
        "    # Iterate through each step of the streamed agent output\n",
        "    for event in events:\n",
        "        # If verbose mode is enabled, print each intermediate message\n",
        "        if verbose:\n",
        "            format_message(event[\"messages\"][-1])\n",
        "\n",
        "    # Display the final response from the agent as formatted Markdown\n",
        "    print('\\n\\nAgent Final Response:\\n')\n",
        "    display(Markdown(event[\"messages\"][-1].content))\n",
        "    return event['messages']"
      ],
      "metadata": {
        "id": "3dSQG5ppELWK"
      },
      "id": "3dSQG5ppELWK",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "uid = 'john001'\n",
        "query = \"Tell me latest and best methods for diabetes management\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=True)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "hRY6YRFeEfLh",
        "outputId": "ad16b71f-dc02-4e29-c49d-8c3699c295ab"
      },
      "id": "hRY6YRFeEfLh",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[34m╭─\u001b[0m\u001b[34m──────────────────────────────────────────────────\u001b[0m\u001b[34m 🧑 Human \u001b[0m\u001b[34m───────────────────────────────────────────────────\u001b[0m\u001b[34m─╮\u001b[0m\n",
              "\u001b[34m│\u001b[0m Tell me latest and best methods for diabetes management                                                         \u001b[34m│\u001b[0m\n",
              "\u001b[34m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #000080; text-decoration-color: #000080\">╭─────────────────────────────────────────────────── 🧑 Human ────────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #000080; text-decoration-color: #000080\">│</span> Tell me latest and best methods for diabetes management                                                         <span style=\"color: #000080; text-decoration-color: #000080\">│</span>\n",
              "<span style=\"color: #000080; text-decoration-color: #000080\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 220\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[31m╭─\u001b[0m\u001b[31m───────────────────────────────────────────────\u001b[0m\u001b[31m ⚙️ Tool Request \u001b[0m\u001b[31m────────────────────────────────────────────────\u001b[0m\u001b[31m─╮\u001b[0m\n",
              "\u001b[31m│\u001b[0m                                                                                                                 \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m 🔧 Tool Call: search_web_extract_info                                                                           \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m    Args: {                                                                                                      \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m   \"query\": \"latest methods for diabetes management 2025\"                                                        \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m }                                                                                                               \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m    ID: call_vqZOPx0PErFykPcU2ptx3lP9                                                                            \u001b[31m│\u001b[0m\n",
              "\u001b[31m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #800000; text-decoration-color: #800000\">╭──────────────────────────────────────────────── ⚙️ Tool Request ─────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>                                                                                                                 <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span> 🔧 Tool Call: search_web_extract_info                                                                           <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>    Args: {                                                                                                      <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>   \"query\": \"latest methods for diabetes management 2025\"                                                        <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span> }                                                                                                               <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>    ID: call_vqZOPx0PErFykPcU2ptx3lP9                                                                            <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[33m╭─\u001b[0m\u001b[33m───────────────────────────────────────────────\u001b[0m\u001b[33m 🔧 Tool Output \u001b[0m\u001b[33m────────────────────────────────────────────────\u001b[0m\u001b[33m─╮\u001b[0m\n",
              "\u001b[33m│\u001b[0m [\"## Title\\nChanges to the Standards of Care in Diabetes—2025 - Blog\\n\\n## Content\\nChanges to the Standards of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care in Diabetes—2025 - Blog - NIDDK\\n\\n===============\\n\\n[Skip to main                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m content](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-stand \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ards-care-diabetes2025#main)\\n\\nDue to current HHS and NIH restructuring, the information provided on           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m niddk.nih.gov is not being updated. Please refer to (https://www.nih.gov/).\\n\\n![Image 1: U.S.                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m flag](blob:http://localhost/28ac974dcc54f856173f0c3376bc989e)\\n\\nAn official website of the United States       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m government\\n\\nHere’s how you know\\n\\nHere’s how you know\\n\\n**Official websites use .gov**\\n\\n A **.gov**       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m website belongs to an official government organization in the United States.\\n\\n**Secure .gov websites use      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m HTTPS**\\n\\n A **lock** (  ) or **https://** means you’ve safely connected to the .gov website. Share sensitive  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m information only on official, secure websites.\\n\\n[![Image 2: NIH: National Institute of Diabetes and Digestive \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Kidney Diseases](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#full)![Image 3: NIH:      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m National Institute of Diabetes and Digestive and Kidney                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diseases](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#abbrev)](https://www.niddk.nih.gov/  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\\"NIDDK home page\\\")[![Image 4: 75 years:                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1950-2025](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#full75)![Image 5: 75 years:         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1950-2025](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#abbrev75)](https://www.niddk.nih.go \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m v/about-niddk/75th-anniversary \\\"NIDDK 75th Anniversary\\\")\\n\\nSearch Menu\\n\\nSearch for Information from        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NIDDK\\n\\n*   Entire Site\\n*   Research & Funding\\n*   Health Information\\n*   News\\n*   About                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NIDDK\\n\\nSearch\\n\\n[Home](https://www.niddk.nih.gov/)\\n\\n-  \\n\\n[Research &                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Funding](https://www.niddk.nih.gov/research-funding)Expand Research & Funding \\n\\n[Current Funding              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Opportunities](https://www.niddk.nih.gov/research-funding/current-opportunities)\\n\\n[Research Programs &        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Contacts](https://www.niddk.nih.gov/research-funding/research-programs)\\n\\n[Human Subjects                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Research](https://www.niddk.nih.gov/research-funding/human-subjects-research)\\n\\n[Funding                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Process](https://www.niddk.nih.gov/research-funding/process)\\n\\n[Research Training & Career                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Development](https://www.niddk.nih.gov/research-funding/training-career-development)\\n\\n[Funded Grants & Grant  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m History](https://www.niddk.nih.gov/research-funding/funded-grants-grant-history)\\n\\n[Research                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Resources](https://www.niddk.nih.gov/research-funding/research-resources)\\n\\n[Research at                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NIDDK](https://www.niddk.nih.gov/research-funding/at-niddk)\\n\\n[Technology Advancement &                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Transfer](https://www.niddk.nih.gov/research-funding/technology-advancement-transfer)\\n\\n[Meetings &            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Workshops](https://www.niddk.nih.gov/news/meetings-workshops)\\n\\n-  \\n\\n[Health                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Information](https://www.niddk.nih.gov/health-information)Expand Health Information \\n\\nHealth                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Topics\\n\\n[Diabetes](https://www.niddk.nih.gov/health-information/diabetes)\\n\\n[Digestive                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diseases](https://www.niddk.nih.gov/health-information/digestive-diseases)\\n\\n[Kidney                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease](https://www.niddk.nih.gov/health-information/kidney-disease)\\n\\n[Weight                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Management](https://www.niddk.nih.gov/health-information/weight-management)\\n\\n[Liver                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease](https://www.niddk.nih.gov/health-information/liver-disease)\\n\\n[Urologic                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diseases](https://www.niddk.nih.gov/health-information/urologic-diseases)\\n\\n[Endocrine                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diseases](https://www.niddk.nih.gov/health-information/endocrine-diseases)\\n\\n[Diet &                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Nutrition](https://www.niddk.nih.gov/health-information/diet-nutrition)\\n\\n[Blood                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diseases](https://www.niddk.nih.gov/health-information/blood-diseases)\\n\\n[Diagnostic                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Tests](https://www.niddk.nih.gov/health-information/diagnostic-tests)\\n\\n[La información de la salud en         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m español](https://www.niddk.nih.gov/health-information/informacion-de-la-salud)\\n\\n[Health                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Statistics](https://www.niddk.nih.gov/health-information/health-statistics)\\n\\n[Clinical                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Trials](https://www.niddk.nih.gov/health-information/clinical-trials)\\n\\n[For Health                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Professionals](https://www.niddk.nih.gov/health-information/professionals)\\n\\n[Diabetes Discoveries & Practice  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Blog](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice)\\n\\n[Community   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health & Outreach](https://www.niddk.nih.gov/health-information/community-health-outreach)\\n\\n-                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\n\\n[News](https://www.niddk.nih.gov/news)Expand News \\n\\n[News                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Archive](https://www.niddk.nih.gov/news/archive)\\n\\n[Meetings &                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Workshops](https://www.niddk.nih.gov/news/meetings-workshops)\\n\\n[Media                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Library](https://www.niddk.nih.gov/news/media-library)\\n\\n[Follow                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us](https://www.niddk.nih.gov/news/follow-us)\\n\\n-  \\n\\n[About                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NIDDK](https://www.niddk.nih.gov/about-niddk)Expand About NIDDK \\n\\n[Meet the                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Director](https://www.niddk.nih.gov/about-niddk/meet-director)\\n\\n[Offices &                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Divisions](https://www.niddk.nih.gov/about-niddk/offices-divisions)\\n\\n[Staff                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Directory](https://www.niddk.nih.gov/about-niddk/staff-directory)\\n\\n[Budget & Legislative                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Information](https://www.niddk.nih.gov/about-niddk/budget-legislative-information)\\n\\n[Advisory & Coordinating  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committees](https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees)\\n\\n[Strategic Plans &       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reports](https://www.niddk.nih.gov/about-niddk/strategic-plans-reports)\\n\\n[Research                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Areas](https://www.niddk.nih.gov/about-niddk/research-areas)\\n\\n[FAQs](https://www.niddk.nih.gov/about-niddk/fa \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m qs)\\n\\n[Jobs at NIDDK](https://www.niddk.nih.gov/about-niddk/jobs)\\n\\n[Visit                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us](https://www.niddk.nih.gov/about-niddk/visit-us)\\n\\n[Contact                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us](https://www.niddk.nih.gov/about-niddk/contact-us)\\n\\n[NIDDK 75th                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Anniversary](https://www.niddk.nih.gov/about-niddk/75th-anniversary)\\n\\n1.                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Home](https://www.niddk.nih.gov/)\\n2.   [Health Information](https://www.niddk.nih.gov/health-information)\\n3. \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [For Health Professionals](https://www.niddk.nih.gov/health-information/professionals)\\n4.   [Diabetes          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Discoveries & Practice                                                                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Blog](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice)\\n5.   Changes   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to the Standards of Care in Diabetes—2025\\n\\n[Diabetes Discoveries & Practice                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Blog](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice \\\"Return to the  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m blog home page\\\")\\n\\nChanges to the Standards of Care in                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025\\n=================================================\\n\\nMarch 26, 2025[0                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comments](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-stan \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dards-care-diabetes2025#disqus_thread)\\n\\n*   [Practice                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Transformation](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=Pr \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m actice+Transformation)\\n*   [Social Determinants of                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=Social+Det \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m erminants+of+Health)\\n\\n![Image 6: A doctor and older patient smiling and holding                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hands.](https://www.niddk.nih.gov/-/media/Images/Blog/2025-blog-post-images/DDP_MAR25_2025StandardsOfCare_Sitec \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ore_600x350.jpg)\\nLearn about the 2025 ADA Standards of Care in Diabetes, the latest clinical practice          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m standards for diagnosing and providing care to people with diabetes.\\n\\nThe American Diabetes Association’s     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (ADA) [Standards of Care in Diabetes](https://diabetesjournals.org/care/issue/48/Supplement_1) informs health   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m care professionals about the latest evidence for diagnosing and managing diabetes. The 2025 Standards of Care   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m includes updates to nearly all sections, including revised recommendations for\\n\\n*   diabetes medications\\n*   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m type 1 diabetes testing\\n*   evidence-based eating patterns\\n\\nThe updated Standards of Care also includes new  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m guidance for incorporating diabetes technology and monitoring for diabetes complications.\\n\\nBelow are some     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m notable updates in this year’s Standards of Care.\\n\\n### Choosing diabetes medications that promote heart       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m health\\n\\nThe recent guidance recommends                                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://diabetesjournals.org/care/article/48/Supplement_1/S181/157569/9-Pharmacologic-Approaches-to-Glycemic-T \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m reatment) for people who have type 2 diabetes and chronic kidney disease to lower the risk of heart disease and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m protect the kidneys from more damage. For people with type 2 diabetes, obesity, and heart failure with          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m preserved ejection fraction, consider GLP-1 receptor agonists that help manage glucose and reduce the symptoms  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of heart failure.\\n\\n### Treating adults who have type 2 diabetes or prediabetes and nonalcoholic fatty liver   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m disease (NAFLD)\\n\\nFor adults with                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://diabetesjournals.org/care/article/48/Supplement_1/S59/157568/4-Comprehensive-Medical-Evaluation-and-As \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sessment), also referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), the ADA        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommends considering a GLP-1 receptor agonist or a dual glucose-dependent insulinotropic polypeptide (GIP)    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and GLP-1 receptor agonist as part of the treatment plan. These medications may be prescribed along with        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m lifestyle changes to                                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2024/07/incorporate-w \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m eight-loss-medications-diabetes-care)and help treat nonalcoholic steatohepatitis (NASH), also referred to as    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m metabolic dysfunction-associated steatohepatitis (MASH).\\n\\nFor adults with prediabetes or type 2 diabetes and  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NAFLD with moderate or advanced liver fibrosis, health care professionals are encouraged to consider            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommending a thyroid hormone receptor-β agonist and referring them to a gastroenterologist or                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hepatologist.\\n\\n### Using antibody-based testing to assess type 1 diabetes risk\\n\\nThe ADA now recommends      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classification-of-Diabete \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m s) for people who do not have symptoms of type 1 diabetes but have a higher risk of developing the disease,     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m based on a family history of type 1 diabetes or other known risk. If the                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2024/08/new-horizons- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m testing-diabetes)is positive, health care professionals should perform a repeat antibody test within 3 months   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to confirm the results. A person’s risk of developing type 1 diabetes increases the more antibodies they        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m have.\\n\\n### Advising evidence-based healthy eating patterns\\n\\nThe latest guidance emphasizes advising people  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with diabetes or prediabetes to follow an                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://diabetesjournals.org/care/article/48/Supplement_1/S86/157563/5-Facilitating-Positive-Health-Behaviors- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and-Well). Newly added nutrition recommendations include\\n\\n*   incorporating plant-based protein and fiber as  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m part of an eating pattern that includes a wide variety of healthy foods\\n*   limiting saturated fat intake to   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m lower the risk of developing heart disease\\n*   drinking water instead of drinks with high-calorie or           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m calorie-free sweeteners\\n\\nThis year’s Standards of Care also recommends monitoring for signs of malnutrition,  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m especially in people who have had weight-loss surgery and those who take weight-loss medication.\\n\\n**For more  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m information and resources related to the Standards of Care, visit the [ADA’s Standards of Care resource         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m page](https://professional.diabetes.org/standards-of-care).**\\n\\nSubscribe\\n\\nShare this                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m page\\n\\nPrint[Facebook](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practic \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m e/changes-standards-care-diabetes2025#share-page \\\"Share this page on                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Facebook\\\")[X](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -standards-care-diabetes2025#share-page \\\"Post this page on                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m X\\\")[Email](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-st \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m andards-care-diabetes2025#share-page \\\"Email this page\\\")More                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Options[WhatsApp](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/chan \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ges-standards-care-diabetes2025#share-page \\\"Share this page via                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m WhatsApp\\\")[LinkedIn](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m changes-standards-care-diabetes2025#share-page \\\"Share this page on                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m LinkedIn\\\")[Reddit](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ch \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m anges-standards-care-diabetes2025#share-page \\\"Share this page on                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reddit\\\")[Pinterest](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/c \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hanges-standards-care-diabetes2025#share-page \\\"Share this page on Pinterest\\\")Copy Link\\n\\n[_Newer Post:_ How  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m To Treat Cardiovascular Disease in People with                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2025/04/how- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to-treat-cardiovascular-disease-people-diabetes)[_Older Post:_ How Obesity and Type 2 Diabetes Affect Heart and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Kidney                                                                                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2025/03/how-ob \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m esity-type-2-diabetes-affect-heart-kidney-health)\\n\\nRelated Posts\\n-------------\\n\\n[![Image 7: A health care  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m professional and patient discussing                                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m medication.](https://www.niddk.nih.gov/-/media/Images/Blog/2024-Blog-Post-Images/DDP_Blog_ADA2024_StandardsofCa \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m re_Sitecore_600x350.jpg)](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-pract \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ice/ADA-2024-standards-of-care)\\n### [What’s New in the 2024 ADA Standards of                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care?](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ADA-2024-standa \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m rds-of-care)\\n\\n[![Image 8: Health care professional with                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m patient](https://www.niddk.nih.gov/-/media/Images/Blog/2022-Blog-Post-Images/ADAStandardsUpdate_DPP_Sitecore_60 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0x350.jpg)](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ada-2022-s \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tandards-of-medical-care-in-diabetes-update)\\n### [The ADA’s 2022 Standards of Medical Care in Diabetes         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Update](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ada-2022-stand \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ards-of-medical-care-in-diabetes-update)\\n\\nComments\\n========\\n\\n[Click to load                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m comments](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-stan \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dards-care-diabetes2025#disqus_thread)\\n\\n Loading comments...\\n\\nBlog Tools\\n----------\\n\\n###                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Subscribe\\n\\nSubscribe to get blog updates.\\n\\nSubmit\\n\\n### Share this                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m page\\n\\nPrint[Facebook](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practic \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m e/changes-standards-care-diabetes2025#share-page-rail \\\"Share this page on                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Facebook\\\")[X](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -standards-care-diabetes2025#share-page-rail \\\"Post this page on                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m X\\\")[Email](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-st \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m andards-care-diabetes2025#share-page-rail \\\"Email this page\\\")More                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Options[WhatsApp](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/chan \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ges-standards-care-diabetes2025#share-page-rail \\\"Share this page via                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m WhatsApp\\\")[LinkedIn](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m changes-standards-care-diabetes2025#share-page-rail \\\"Share this page on                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m LinkedIn\\\")[Reddit](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ch \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m anges-standards-care-diabetes2025#share-page-rail \\\"Share this page on                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reddit\\\")[Pinterest](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/c \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hanges-standards-care-diabetes2025#share-page-rail \\\"Share this page on Pinterest\\\")Copy Link\\n\\n###            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Search\\n\\nSearch\\n### About\\n\\n**Diabetes Discoveries and Practice Blog**\\n\\n Dialogue with thought leaders on  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m emerging trends in diabetes care \\n### Tags\\n\\n[Patient                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Communication](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=pat \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ient+communication)62\\n\\n[Research                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Advancements](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=rese \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m arch+advancements)43\\n\\n[Complications of                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=complica \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tions+of+diabetes)38\\n\\n[Medication and                                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Monitoring](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=medica \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tion+and+monitoring)31\\n\\n[Diabetes                                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Prevention](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=diabet \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m es+prevention)24\\n\\n[Obesity and Weight                                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Management](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=obesit \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m y+and+weight+management)24\\n\\n[Practice                                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Transformation](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=pr \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m actice+transformation)23\\n\\n[Patient                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Self-Management](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=p \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m atient+self-management)22\\n\\n[Type 1                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=type+1+d \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m iabetes)18\\n\\n[Diabetic Kidney                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=diabetic+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m kidney+disease)16\\n\\nMore tags\\n\\n[New                                                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Technologies](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=new+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m technologies)16\\n\\n[Social Determinants of                                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=social+det \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m erminants+of+health)16\\n\\n[Nutrition](https://www.niddk.nih.gov/health-information/professionals/diabetes-disco \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m veries-practice?tag=nutrition)15\\n\\n[Shared                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Decision-Making](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=s \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hared+decision-making)14\\n\\n[Community                                                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=community+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m health)6\\n\\nFewer tags\\n\\n### Archive\\n\\n[April                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2025](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 25)1\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2025](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 25)2\\n\\n[Jan.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2025](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2025)1\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2024)1\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2024)1\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024)1\\n\\nMore months\\n\\n[Sept.                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2024)1\\n\\n[Aug.                                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 024)1\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4)1\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4)1\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2024 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )1\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 24)1\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 24)1\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2024)1\\n\\n[Dec.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2023)1\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2023)1\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023)1\\n\\n[Aug.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 023)1\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 3)1\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 3)1\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2023 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )1\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 23)1\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 23)1\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2023)1\\n\\n[Jan.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2023)2\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2022)1\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2022)2\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022)2\\n\\n[Sept.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2022)2\\n\\n[Aug.                                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 022)2\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2)1\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2)2\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2022 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )1\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 22)2\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 22)2\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2022)2\\n\\n[Jan.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2022)2\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2021)2\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2021)1\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021)2\\n\\n[Sept.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2021)2\\n\\n[Aug.                                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 021)1\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1)2\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1)3\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2021 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )1\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 21)2\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 21)2\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2021)2\\n\\n[Jan.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2021)1\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2020)2\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2020)2\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020)2\\n\\n[Sept.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2020)5\\n\\n[Aug.                                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 020)4\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0)3\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0)2\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2020 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )2\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 20)1\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 20)2\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2020)3\\n\\n[Jan.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2020)2\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2019)3\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2019)2\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019)2\\n\\n[Sept.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2019)2\\n\\n[Aug.                                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 019)3\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+201 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9)3\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+201 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9)2\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2019 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )4\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 19)2\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 19)2\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2019)1\\n\\n[Jan.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2019)2\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2018)2\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2018)4\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018)4\\n\\n[Sept.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2018)2\\n\\n[Aug.                                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 018)5\\n\\n[July                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+201 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 8)3\\n\\n[June                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+201 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 8)4\\n\\n[May                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2018 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m )5\\n\\n[April                                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 18)4\\n\\n[March                                                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 18)3\\n\\n[Feb.                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2018)4\\n\\n[Jan.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2018)3\\n\\n[Dec.                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2017)3\\n\\n[Nov.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m +2017)3\\n\\n[Oct.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2017)2\\n\\n[Sept.                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m r+2017)4\\n\\nFewer months\\n\\n### Disclaimer\\n\\nWe welcome comments; all comments must follow our                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://www.niddk.nih.gov/privacy-policy#commentpolicy).\\n\\nBlog posts written by individuals from outside the \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m government may be owned by the writer and graphics may be owned by their creator. In such cases, it is          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m necessary to contact the writer, artist, or publisher to obtain permission for reuse.\\n\\nContact                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us\\n----------\\n\\n**Hours:**8:30 a.m. to 5 p.m. ET, Monday -                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Friday\\n\\n[**Email:**healthinfo@niddk.nih.gov](mailto:healthinfo@niddk.nih.gov)[**Phone:**+1-800-860-8747](tel: \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1-800-860-8747)[**TTY:**+711](tel:711)\\n\\n@NIDDKgov\\n\\n### Chat\\n\\n Live Chat Available\\n\\n 8:30 a.m. - 5 p.m.  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ET\\n\\n Monday - Friday \\n\\n### [Follow                                                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us](https://www.niddk.nih.gov/news/follow-us)\\n\\n[LinkedIn](https://www.linkedin.com/company/national-institute \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -of-diabetes-and-digestive-and-kidney-diseases-niddk \\\"Follow NIDDK on LinkedIn\\\")[X](https://x.com/NIDDKgov    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\\"Follow NIDDK on X\\\")[Facebook](https://www.facebook.com/NIDDKgov \\\"Like NIDDK on                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Facebook\\\")[YouTube](https://www.youtube.com/user/NIDDKgov \\\"Subscribe to NIDDK on                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YouTube\\\")[Instagram](https://www.instagram.com/niddkgov \\\"Follow NIDDK on Instagram\\\")\\n\\nNIH… Turning         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Discovery Into Health ®\\n\\n*   [Privacy Policy](https://www.niddk.nih.gov/privacy-policy)\\n*   [Freedom of      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Information Act](https://www.niddk.nih.gov/freedom-information-act)\\n*                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Accessibility](https://www.niddk.nih.gov/accessibility)\\n*                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Disclaimers](https://www.niddk.nih.gov/disclaimers)\\n*   [Copyright](https://www.niddk.nih.gov/copyright)\\n*   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Vulnerability Disclosure Policy](https://www.hhs.gov/vulnerability-disclosure-policy/index.html)\\n\\n*   [Site  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Map](https://www.niddk.nih.gov/site-map)\\n*   [For Staff                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Only](https://intranet.niddk.nih.gov/SitePages/Home.aspx)\\n*   [Get Email                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Updates](https://public.govdelivery.com/accounts/USNIDDK/subscriber/new)\\n\\n*   [U.S. Department of Health and  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Human Services](https://www.hhs.gov/)\\n*   [National Institutes of                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health](https://www.nih.gov/)\\n\\n\\n##Source\\nhttps://www.niddk.nih.gov/health-information/professionals/diabete \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m s-discoveries-practice/changes-standards-care-diabetes2025\", \"## Title\\nThe American Diabetes Association       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Releases Standards of ...\\n\\n## Content\\n## Navigation\\n\\n## Navigation\\n\\n![ADA                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Logo](https://diabetes.org/sites/default/files/ADA85_logo_full_RGB_0.svg)\\n\\n## Navigation\\n\\n##                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Navigation\\n\\n!(/sites/default/files/2023-08/prediabetes-icon.svg)\\n\\nLearn your risk for type 2 and take steps \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to prevent it\\n\\n![Diabetes Prevention](/sites/default/files/2023-08/diabetes-prevention-icon.svg)\\n\\nLearn the \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ins and outs of diabetes and steps for better                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m care\\n\\n!(/sites/default/files/2024-07/ADA_Icon_Library_scale-full.svg)\\n\\nObesity care is as unique as you     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m are. Discover the different treatment and prevention                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m options.\\n\\n![Education](/sites/default/files/2023-09/Education.svg)\\n\\nLearn what you can do to keep your      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m child with diabetes safe at school\\n\\n![Gestational](/sites/default/files/2023-09/Gestational.svg)\\n\\nWhat you  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m need to know about gestational diabetes\\n\\n![Diabetes                                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Prevention](/sites/default/files/2023-08/diabetes-prevention-icon.svg)\\n\\nMake a plan to be prepared when       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m illness                                                                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m strikes\\n\\n![Calculator](/sites/default/files/2023-09/Calculator.svg)\\n![Paper](/sites/default/files/2023-09/Pa \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m per.svg)\\n\\nSign up to receive timely information on topics to help you and your family live a healthy          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m life\\n\\n![Better Choices for Life logo](/sites/default/files/2023-09/bcfl.svg)\\n\\nBringing ADA's evidence-based \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m guidelines and perspective directly to you in the store so you can make informed choices.\\n\\n![Food             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Bowl](/sites/default/files/2023-09/Food_Bowl.svg)\\n![Milk carrot                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m apple](/sites/default/files/2024-06/meal-patterns-side-nav.svg)\\n![Utensils](/sites/default/files/2023-09/Utens \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ils.svg)\\n!(/sites/default/files/2023-09/NewlyDiagnosed_checklist.svg)\\n\\nTake the 60-second test to find out   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m your                                                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m risk\\n\\n![Book](/sites/default/files/2023-09/two%20tone.svg)\\n![Location](/sites/default/files/2023-09/Location \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m .svg)\\n\\nFind help and resources in your zip code\\n\\n![Money                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hand](/sites/default/files/2023-09/Money_Hand.svg)\\n\\nChoose between a one-time donation or recurring monthly   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m gifts.\\n\\n![Handshake](/sites/default/files/2023-09/handshake.svg)\\n\\nReach out and get involved in programs    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and events near you.\\n\\n![Transportation](/sites/default/files/2023-09/Transportation.svg)\\n\\nWe make vehicle   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m donations easy so you can help fuel our fight,                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hassle-free.\\n\\n![People](/sites/default/files/2023-09/people.svg)\\n![Recipients](/sites/default/files/2023-09/ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Recipients.svg)\\n![Book](/sites/default/files/2023-09/two%20tone.svg)\\n\\n## Navigation\\n\\n## Navigation\\n\\n##   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Breadcrumb\\n\\n# The American Diabetes Association Releases Standards of Care in Diabetes—2025\\n\\n![American     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Association logo reversed out white on red                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m background](/sites/default/files/styles/large/public/2024-06/ada-a_comms_logo-full-crops-clean.jpg?itok=HH6Loyi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m L)\\n\\n*New recommendations on nutrition, weight-loss medications and technology*\\n\\nToday, the American         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Association® released the [*Standards of Care in                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025*](https://diabetesjournals.org/care/issue/48/Supplement_1) (*Standards of Care*) the gold         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m standard in evidence-based guidelines for diagnosing and managing diabetes and prediabetes. Based on the latest \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m scientific research and clinical trials, the *Standards of Care* includes strategies for diagnosing and         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m treating diabetes in both youth and adults, methods to prevent or delay type 2 diabetes and its associated      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m comorbidities like obesity, and care recommendations to enhance health outcomes.\\n\\n“The latest ADA guidelines  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m combine comprehensive, evidence-based recommendations for diabetes care with actionable guidance to enable      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m health care professionals provide the best care possible for those living with diabetes,” said Nuha El Sayed,   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MD, MMSc, the ADA’s senior vice president of health care improvement.\\n\\nNotable updates to the [*Standards of  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care in Diabetes—2025*](https://diabetesjournals.org/care/issue/48/Supplement_1) include*:*\\n\\nThe ADA annually \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m updates its *Standards of Care* through the efforts of its Professional Practice Committee (PPC). Comprising    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m global experts from diverse professional backgrounds, the PPC includes physicians, nurse practitioners,         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m certified diabetes care and education specialists, registered dietitian nutritionists, pharmacists, and         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m methodologists. Its members hold expertise in a range of related fields. The 2025 *Standards of Care* has       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m garnered endorsements from the American College of Cariology (Section 10), the American Geriatrics Society      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (Section 13), the American Society of Bone and Mineral Research (Bone Health, Section 4), and the Obesity       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Society (Section 8).\\n\\nOther noteworthy changes include:\\n\\n“Improving the lives of people affected by         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes is a key part of the ADA’s mission. The *Standards of Care* offers the trusted support needed for      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m people living with diabetes and those caring for them to manage the disease and thrive until we find a cure,”   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m said Charles “Chuck” Henderson, the ADA’s chief executive officer.\\n\\n*The* [*Standards of Care in              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025*](https://diabetesjournals.org/care/issue/48/Supplement_1) is now available online as a           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m supplement to the January 2025 issue of *Diabetes Care®.* In addition, a convenient [Standards of Care          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m app](https://professional.diabetes.org/content-page/standards-care-app-1), available for iOS and Android        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m systems, offers the latest guidelines with interactive tables and algorithms for easy reference. Additional     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m resources, including a comprehensive slide deck and a webcast offering continuing education (CE) credit, are    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m available on the ADA’s professional website [DiabetesPro](https://professional.diabetes.org/)®. A               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m quick-reference pocket chart will soon be available for purchase on ShopDiabetes.org. For primary care          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m providers, the Abridged Standards of Care, developed by the ADA’s Primary Care Advisory Group, is planned for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m release in Spring 2025 in *Clinical Diabetes®*. Through the [“living” Standards of Care                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m process](https://professional.diabetes.org/standards-of-care/living-standards-update), the online version,      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m abridged guidelines, and all related materials will be updated in real time throughout the year to reflect the  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m latest evidence and regulatory changes.\\n\\n# # #\\n\\n**About the American Diabetes Association**   \\nThe         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes and helping people thrive. For 84 years, the ADA has driven discovery and research to prevent, manage, \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m treat, and ultimately cure diabetes. There are 136 million Americans living with diabetes or prediabetes.       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m involved, visit us at (https://diabetes.org/) or call 1-800-DIABETES (800-342-2383). Join the fight with us on  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Facebook ([American Diabetes                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Association](https://www.facebook.com/AmericanDiabetesAssociation?loc=superfooter)), Spanish Facebook           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ([Asociación Americana de la Diabetes](https://www.facebook.com/AsocAmericanaDiabetes)), LinkedIn ([American    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Association](https://www.linkedin.com/company/american-diabetes-association/)), and Instagram          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ((https://www.instagram.com/AmDiabetesAssn/)). To learn more about how we are advocating for everyone affected  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m by diabetes, visit us on X ((https://x.com/AmDiabetesAssn)).\\n\\n## Contact Virginia Cramer for press-related    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m questions.\\n\\n![ADA](https://diabetes.org/sites/default/files/2024-05/JoinTheFight_PopUp_1032x578.jpg)\\n\\n###   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Give Today and Change lives!\\n\\nWith your support, the American Diabetes Association® can continue our          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m lifesaving work to make breakthroughs in research and provide people with the resources they need to fight      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes.\\n\\n![ADA Logo](/sites/default/files/ADA85_logo_full_RGB_0.svg)\\n\\n## Navigation\\n\\n2451 Crystal       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Drive, Suite 900\\n\\nArlington, VA 22202\\n\\nP.O. Box 7023\\n\\nMerrifield, VA 22116-7023\\n\\n[Center for            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Information](/about-us/center-information \\\"Center for Information\\\")\\n\\nMonday to Friday\\n\\n9:00 AM–5:30 PM    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ET\\n\\n## Navigation\\n\\n![National Health council                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m logo](/sites/default/files/styles/sponsor_logo_288_180_no_crop/public/2023-09/National-Health-Council.png.png?i \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tok=WPKlFArr)\\n![Charity navigator                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m logo](/sites/default/files/styles/sponsor_logo_288_180_no_crop/public/2023-09/charity-navigator-g.png.png?itok= \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pJ3CJ7R2)\\n![Accredited charity                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m seal](/sites/default/files/styles/sponsor_logo_288_180_no_crop/public/2023-09/accredited-charity-seal.png.png?i \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tok=v8BJGkOD)\\n\\n## Navigation\\n\\nCopyright 1995–2025. American Diabetes Association®. All rights               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m reserved.\\n\\n##Source\\nhttps://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-stan \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dards-care-diabetes-2025\", \"## Title\\nSummary of Revisions: Standards of Care in Diabetes—2025\\n\\n##            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Content\\nPublished Time: 2024-12-09\\n\\nSummary of Revisions: Standards of Care in Diabetes—2025 | Diabetes Care \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m | American Diabetes Association\\n\\n===============\\n[Skip to Main                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Content](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care-in-Diabetes#skipNav)\\n\\n[![Image 1: American Diabetes Association                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)_O \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pen Menu_](javascript:;)\\n\\n[![Image 2: American Diabetes Association                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)]( \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m https://diabetesjournals.org/)[Close](javascript:;)\\n\\n*   [Professional                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Books](https://diabetesjournals.org/books)\\n*   [Clinical Compendia](https://diabetesjournals.org/compendia)\\n* \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Journals _Open Menu_](javascript:;)\\n    *   [Journals Home](https://diabetesjournals.org/journals)\\n    *     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes](https://diabetesjournals.org/diabetes)\\n    *   [Diabetes Care](https://diabetesjournals.org/care)\\n \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m *   [Clinical Diabetes](https://diabetesjournals.org/clinical)\\n    *   [Diabetes                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Spectrum](https://diabetesjournals.org/spectrum)\\n    *   [Diabetes, Obesity, and Cardiometabolic               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CARE](https://diabetesjournals.org/docm-care)\\n    *   [BMJ Open Diabetes Research & Care Open External         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://drc.bmj.com/)\\n    *   [Journal Article                                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n\\n*   [ADA Standards of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [ADA Meeting                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [Podcasts _Open      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Professional News Open         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m External Link](https://professional.diabetes.org/)\\n\\n[_Search Dropdown Menu_](javascript:;)\\n\\nheader          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m search\\n\\nsearch input Search input auto suggest \\n\\nfilter your search \\n\\n[Search](javascript:;)\\n\\n[Advanced \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Search](https://diabetesjournals.org/advanced-search)\\n\\n[_User Tools Dropdown_](javascript:;)\\n\\n[Sign In      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m _Open Menu_](javascript:;)\\n\\n[![Image 3: Diabetes                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://ada.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/care/care-header-97500660.svg)](https: \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m //diabetesjournals.org/care)\\n\\n[_Toggle Menu_ Menu](javascript:;)\\n*   [Articles & Issues _Open                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [Current Issue](https://diabetesjournals.org/care/issue)\\n    *   [Online Ahead   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of Print](https://diabetesjournals.org/care/online-ahead-of-print)\\n    *   [ADA Standards of                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n    *   [Issue                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Archive](https://diabetesjournals.org/care/issue-covers)\\n    *   [Featured Article                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Collections](https://diabetesjournals.org/journals/pages/diabetes_care_featured_collection)\\n    *   [All       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Article Collections](https://diabetesjournals.org/journals/collections)\\n    *   [Saved                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Searches](https://diabetesjournals.org/my-account/saved-searches)\\n\\n*   [Review                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Articles](https://diabetesjournals.org/collection/2178/Review-Articles)\\n*   [Info & About _Open                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [About the Journal](https://diabetesjournals.org/care/pages/about-the-journal)\\n  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m *   [About the Editors](https://diabetesjournals.org/care/pages/Editorial_Board)\\n    *   [ADA Journal          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n    *   [Reuse, Licensing, and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Public Access](https://diabetesjournals.org/journals/pages/license)\\n    *   [Reprints and                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Permissions](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n    *                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Advertising](https://diabetesjournals.org/journals/pages/advertising)\\n\\n*   [Podcasts _Open                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Submit & Review _Open          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [Instructions for                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Authors](https://diabetesjournals.org/care/pages/instructions-for-authors)\\n    *   [Submit a Manuscript Open   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m External Link](http://mc.manuscriptcentral.com/diabetescare)\\n    *   [Submit Cover                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Artwork](https://diabetesjournals.org/care/pages/submit_a_cover_image)\\n    *   [Guidance for                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n\\n*   [Subscribe _Open                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [Individual                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Subscriptions](https://diabetesjournals.org/journals/pages/individual-subscriptions)\\n    *   [Email            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Alerts](https://diabetesjournals.org/my-account/alerts)\\n    *   [Institutional                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Subscriptions](https://diabetesjournals.org/journals/pages/institutional_subscriptions)\\n    *   [Access        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Institutional Usage                                                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reports](https://diabetesjournals.org/journals/pages/access-institutional-usage-reports)\\n\\n[Skip Nav           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Destination](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -of-Care-in-Diabetes#)\\n\\nClose navigation menu\\n\\nArticle navigation\\n\\n[Volume 48, Issue                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Supplement_1](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n January 2025 \\n\\n[![Image 4:         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Care Cover Image for Volume 48, Issue                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Supplement_1](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/m_diacare \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m _48_supplement_1_cover.png?Expires=1758638706&Signature=vKbCybARdhtGdCVjM18Sbhsog2~CmKfNxjMZW-3pME9xgZbZoRbC-T4 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MpZ1GH6S~KQQBNjQkJzyJ8YHjRubU2IP~AhPcqjfyH~lHsB-REmAAIxTr7DDw0lYkPw958opECfe0h8mtp3F0Sm7a7-aDSAjy67l5d0s~QAzYY3 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 6eJ9Q-mgm9y2SbxMQ0whcwL3SWTHAcTG7UxLuauK0dJZpmkb5hOhwdUmpWDwMGtDzhx1opZvE8Kb6Yn1mi-1Owjjrf3KlF59jMCCquYqhPgRiM6 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m nz5~XuLB3AYlNJM0LOVY8hS-3QC-7QVAdrkYMl5lVkfaGW-CI7-Z0lpn-y5MxElSA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)](https:// \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n*   [Previous                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Article](https://diabetesjournals.org/care/article/48/Supplement_1/S1/157562/Introduction-and-Methodology-Stand \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ards-of-Care-in)\\n*   [Next                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Article](https://diabetesjournals.org/care/article/48/Supplement_1/S14/157553/1-Improving-Care-and-Promoting-He \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m alth-in)\\n\\nArticle Contents\\n\\n*   [General                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Changes](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care-in-Diabetes#5310725) \\n*   [Section                                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Changes](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care-in-Diabetes#5310729) \\n\\nArticle Navigation\\n\\nSummary of Revisions|December 09 2024\\n\\nSummary of         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Revisions: Standards of Care in Diabetes—2025                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m _Free_\\n===============================================================\\n\\n[American Diabetes Association       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Professional Practice Committee](javascript:;)\\n\\n American Diabetes Association Professional Practice          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee \\n\\n Search for other works by this author on: \\n\\n[This                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Site](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professional+ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Practice+Committee+)\\n\\n[PubMed](http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=American%20Diabetes%20Assoc \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m iation%20Professional%20Practice%20Committee)\\n\\n[Google                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Scholar](http://scholar.google.com/scholar?q=author:%22%20%22)\\n\\n[![Image 5: Crossmark: Check for              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Updates](https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg)](javascript:;)\\n\\ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m n_Diabetes Care_                                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2025;48(Supplement_1):S6–S13\\n\\n(https://doi.org/10.2337/dc25-SREV)\\n\\nPubMed:\\n\\n[39651984](https://pubmed.ncb \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m i.nlm.nih.gov/39651984)\\n\\n*                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Split-Screen](https://diabetesjournals.org/care/article-split/48/Supplement_1/S6/157564/Summary-of-Revisions-S \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tandards-of-Care-in-Diabetes)\\n*   [_Views Icon_ Views _Open Menu_](javascript:;)\\n    *   [Article             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m contents](javascript:;)\\n\\n*   [Open the PDF for in another                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S6/791587/dc25srev.pdf)\\n*   [_Share      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Icon_ Share](javascript:;)\\n    *   [Facebook](javascript:;)\\n    *   [X](javascript:;)\\n    *                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [LinkedIn](javascript:;)\\n    *   [Email](javascript:;)\\n\\n*   [_Cite Icon_ Cite](javascript:;) \\n*   [Get      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Permissions](http://s100.copyright.com/AppDispatchServlet?publisherName=Wiley&publication=0149-5992&title=Summa \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ry%20of%20Revisions%3A%20Standards%20of%20Care%20in%20Diabetes%E2%80%942025&publicationDate=2024-12-09&volumeNu \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m m=48&issueNum=Supplement_1&author=American%20Diabetes%20Association%20Professional%20Practice%20Committee%3B%20 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ElSayed%2C%20Nuha%20A.&startPage=S6&endPage=S13&contentId=10.2337%2Fdc25-SREV&oa=&orderBeanReset=True)          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\n\\nCitation\\n\\nAmerican Diabetes Association Professional Practice Committee; Summary of Revisions: Standards  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of Care in Diabetes—2025. _\\\\_Diabetes Care\\\\__ 1 January 2025; 48 (Supplement_1): S6–S13.                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://doi.org/10.2337/dc25-SREV)\\n\\nDownload citation file:\\n\\n*   [Ris                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (Zotero)](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=0)\\n*  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Reference                                                                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Manager](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=0)\\n*   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [EasyBib](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=0)\\n*  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Bookends](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=0)\\n* \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Mendeley](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=0)\\n* \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Papers](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=0)\\n*   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [EndNote](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=1)\\n*  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [RefWorks](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=3)\\n* \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [BibTex](https://diabetesjournals.org/Citation/Download?resourceId=157564&resourceType=3&citationFormat=2)\\n\\nt \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m oolbar search\\n\\n[_Search Dropdown Menu_](javascript:;)\\n\\ntoolbar search\\n\\nsearch input Search input auto     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m suggest \\n\\nfilter your search \\n\\n[Search](javascript:;)\\n\\n[Advanced                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Search](https://diabetesjournals.org/advanced-search)\\n\\nGeneral Changes\\n---------------\\n\\nThe field of       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes care is rapidly changing as new research, technology, and treatments that can improve the health and   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m well-being of people with diabetes continue to emerge. With annual updates since 1989, the American Diabetes    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Association has long been a leader in producing guidelines that capture the most current state of the           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m field.\\n\\nThe 2025 “Standards of Care in Diabetes” has continued to incorporate person-first and inclusive      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m language. Efforts were made to consistently apply terminology that empowers people with diabetes and recognizes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the individual at the center of diabetes care.\\n\\nAlthough levels of evidence for several recommendations have  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m been updated, these changes are not outlined below where the clinical recommendation has remained the same.     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m That is, changes in evidence level from, for example, **E** to **C**, are not noted below. The 2025 Standards   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of Care contains, in addition to many minor changes that clarify recommendations or reflect new evidence, more  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m substantive revisions detailed below.\\n\\nSection Changes\\n---------------\\n\\n### Endorsements\\n\\nFor the second \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m consecutive year, the “Bone Heath” subsection in Section 4, “Comprehensive Medical Evaluation and Assessment of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comorbidities,” received endorsement from the American Society for Bone and Mineral Research and Section 8,     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m “Obesity and Weight Management for the Prevention of Type 2 Diabetes,” received endorsement from The Obesity    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Society. For the seventh consecutive year, Section 10, “Cardiovascular Disease and Risk Management,” received   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m endorsement from the American College of Cardiology. For the first time, Section 13, “Older Adults,” received   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m endorsement from the American Geriatrics Society.\\n\\n### Section 1. Improving Care and Promoting Health in      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Populations\\n\\n((https://doi.org/10.2337/dc25-S001))\\n\\nRecommendation 1.1 was expanded to include people at    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m risk for diabetes in addition to those with diabetes.\\n\\nRecommendation 1.2 was revised to include, in addition \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to the Chronic Care Model, other evidence-based care delivery models and frameworks that have been demonstrated \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to improve diabetes care delivery and health outcomes. These include the Patient-Centered Medical Home model,   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Accountable Care Organizations, and value-based payment models and are discussed in the text.\\n\\nRecommendation \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1.5 was added to emphasize the importance of quality improvement initiatives and interprofessional teams for    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m supporting sustainable and scalable process changes that improve quality of care and health outcomes.           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Implementation concepts were added throughout the section to provide actionable guidance on how to implement    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and sustain interventions that improve care delivery and population health.\\n\\nRecommendation 1.6 was added to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m emphasize the importance of assessing and addressing disparities in diabetes care and health outcomes. The text \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m includes actionable guidance on measuring health disparities and engaging interprofessional teams and community \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m partners to address them.\\n\\nRecommendation 1.7 was revised to emphasize the importance of screening for and    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m addressing multiple social determinants of health that impact diabetes management, health outcomes, and quality \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of life.\\n\\nThe narrative text now includes an expanded discussion of cost and affordability considerations as  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m well as health disparities and social determinants of health.\\n\\n[**Table                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1.1**](https://doi.org/10.2337/dc25-S001) was added to highlight the importance of engaging an                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m interprofessional team approach to person-centered care for people with diabetes across the life span.\\n\\n###   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Section 2. Diagnosis and Classification of Diabetes\\n\\n((https://doi.org/10.2337/dc25-S002))\\n\\n[**Table        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2.3**](https://doi.org/10.2337/dc25-S002) was added to provide considerations related to the use and            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m interpretation of laboratory measurement of glucose and A1C.\\n\\nThe “Classification” subsection has been        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m updated to provide a pragmatic approach to management of individuals who have features of both type 1 and type  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2 diabetes.\\n\\nIn the “Type 1 Diabetes” subsection, Recommendation 2.7 was added to emphasize the importance of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m antibody-based screening for presymptomatic type 1 diabetes in individuals with a family history of type 1      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes or otherwise known elevated genetic risk. The associated text was also updated and expanded to reflect \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m these changes.\\n\\nThe “Gestational Diabetes Mellitus” subsection was completely updated to facilitate           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m understanding and implementation of the current various approaches to screening for and diagnosis of            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m gestational diabetes mellitus (GDM).\\n\\nThe text in various other subsections, including those that discuss     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes and immune checkpoint inhibitors, the role of the gut microbiome in diabetes risk, and monogenic       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes, was updated.\\n\\n### Section 3. Prevention or Delay of Diabetes and Associated                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comorbidities\\n\\n((https://doi.org/10.2337/dc25-S003))\\n\\nIn the “Lifestyle Behavior Change for Type 2 Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Prevention” subsection, text pertaining to sleep health in relation to risk of type 2 diabetes was added. This  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m addition highlights sleep as a central component in the management of prediabetes and type 2 diabetes, placing  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m it on a level playing field with other lifestyle behaviors (e.g., physical activity and eating patterns).\\n\\nIn \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the “Pharmacologic Interventions to Delay Type 2 Diabetes” subsection, the text on the proposed use of vitamin  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m D therapy to prevent type 2 diabetes was extensively updated. The text related to long-term metformin therapy   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and associated vitamin B12 deficiency was also updated.\\n\\nThe language in Recommendation 3.15 was strengthened \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to facilitate discussion with selected individuals aged ≥8 years with stage 2 type 1 diabetes about the role of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m teplizumab-mzwv infusion to delay the onset of symptomatic type 1 diabetes (stage 3).\\n\\n### Section 4.         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comprehensive Medical Evaluation and Assessment of                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comorbidities\\n\\n((https://doi.org/10.2337/dc25-S004))\\n\\nLanguage in [**Fig.                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4.1**](https://doi.org/10.2337/dc25-S004) was updated, and [**Table 4.1**](https://doi.org/10.2337/dc25-S004)   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was modified to include changes made throughout Section 4.\\n\\nRecommendation 4.3 was changed to include         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m assessment for glycemic status and previous treatment at the initial visit and follow-up visits as              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m appropriate.\\n\\n[**Table 4.2**](https://doi.org/10.2337/dc25-S004) was amended to include essential components  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for assessment, planning, and referral as appropriate.\\n\\nChanges were made in the “Immunizations” subsection   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to reflect updates for COVID-19, pneumococcal pneumonia, influenza, and respiratory syncytial virus. [**Table   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4.3**](https://doi.org/10.2337/dc25-S004) was revised to include important vaccination                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m updates.\\n\\nRecommendation 4.6 was modified to specify initial and repeat screening for autoimmune thyroid      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m disease.\\n\\nRecommendation 4.10 was updated to specify avoiding medications with known association with higher  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m fracture risk.\\n\\nRecommendation 4.12 was revised to include the recommended intake of calcium for people with  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes.\\n\\nRecommendation 4.13 was updated to specify when antiresorptive medications and osteoanabolic       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m agents should be considered.\\n\\n[**Table 4.4**](https://doi.org/10.2337/dc25-S004) was updated to specify when  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m bone mineral density testing should be performed.\\n\\nA new subsection, “Dental Care,” was added and includes    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m two new recommendations. Recommendation 4.15 was added to state people with diabetes should be referred for a   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dental exam at least once per year. Recommendation 4.16 was added to state that efforts between medical and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dental teams should be coordinated so that glucose-lowering medications can be appropriately adjusted prior to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and in the post–dental procedure period as needed.\\n\\nRecommendation 4.17 was updated to reflect that an        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m assessment for disability should be performed at the initial visit and an assessment for decline in function    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m should be performed at each subsequent visit.\\n\\nRecommendation 4.18 was modified to include inquiring about    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sexual health in men and to screen with a morning serum total testosterone if symptoms and/or signs of          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypogonadism are present.\\n\\nRecommendation 4.19 was added to specifically state that men with diabetes or      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m prediabetes should be screened for erectile dysfunction, and new text was added on erectile dysfunction.\\n\\nA   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m new subsection, “Female Sexual Dysfunction,” was added and includes two new recommendations. Recommendation     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4.20 states that health care professionals should inquire about sexual health, particularly in women who        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m experience depression and/or anxiety and those with recurrent urinary tract infections. Recommendation 4.21 was \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m added to state that health care professionals should screen for symptoms and/or signs of genitourinary syndrome \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of menopause.\\n\\nThe terminology for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (NASH) was updated to metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dysfunction–associated steatohepatitis (MASH), respectively. This updated nomenclature was incorporated         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m throughout the section.\\n\\nRecommendation 4.22a was revised to specify when to screen for the risk of having or \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m developing cirrhosis related to MASH using the calculated fibrosis-4 index (FIB-4).\\n\\nRecommendation 4.23 was  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m amended to state that adults with type 2 diabetes or prediabetes and a FIB-4 >1.3 should have additional risk   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m stratification performed.\\n\\nRecommendation 4.24 was revised to state that individuals with a higher risk for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m significant liver fibrosis should be referred to a gastroenterologist or hepatologist.\\n\\nRecommendation 4.25   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was revised to include an interprofessional team approach when promoting weight loss, particularly with a       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m structured nutrition plan and physical activity program for cardiometabolic benefits and histological           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m improvement.\\n\\nRecommendation 4.26 was revised to include a dual glucose-dependent insulinotropic polypeptide  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (GIP) and glucagon like peptide 1 (GLP-1) receptor agonist (RA) with potential benefits in MASH as an           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m adjunctive therapy to lifestyle interventions for weight loss in adults with type 2 diabetes, MASLD, and        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m overweight or obesity.\\n\\nRecommendation 4.27a was revised to state that in adults with type 2 diabetes and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m biopsy-proven MASH or those at high risk for liver fibrosis, use of pioglitazone or a GLP-1 RA or a dual GIP    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and GLP-1 RA is preferred for glycemic management due to potential beneficial effects on                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MASH.\\n\\nRecommendation 4.27b was added to state that combination therapy with pioglitazone and a GLP-1 RA can  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m be considered for treatment of hyperglycemia in adults with type 2 diabetes with biopsy-proven MASH or those at \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m high risk of liver fibrosis because of potential beneficial effects of such a combination on                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MASH.\\n\\nRecommendation 4.28 was added to state that treatment with a thyroid hormone receptor-β agonist in     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m adults with type 2 diabetes or prediabetes with MASLD with moderate (F2) or advanced (F3) liver fibrosis may be \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m considered and that the individual should be referred to a gastroenterologist or hepatologist with expertise in \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MASLD management for the initiation and monitoring of this therapy.\\n\\nRecommendation 4.29 was added to         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m emphasize that treatment initiation and monitoring should be individualized and within the context of an        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m interprofessional team for MASLD and MASH management.\\n\\n[**Figure 4.2**](https://doi.org/10.2337/dc25-S004)    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was revised to reflect important updates to the diagnostic algorithm for risk stratification and the prevention \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of cirrhosis in individuals MASLD, and new [**Fig. 4.3**](https://doi.org/10.2337/dc25-S004) includes the MASLD \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m treatment algorithm.\\n\\n### Section 5. Facilitating Positive Health Behaviors and Well-being to Improve Health  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Outcomes\\n\\n((https://doi.org/10.2337/dc25-S005))\\n\\nIn the “Diabetes Self-Management Education and Support”    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m subsection, Recommendation 5.1 was updated to emphasize that all people with diabetes should be advised to      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m participate in diabetes self-management education and support (DSMES) rather than being just encouraged to      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m participate.\\n\\nRecommendation 5.2 was updated to clarify when to provide DSMES.\\n\\nRecommendation 5.3 was      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m revised to be more succinct and action-oriented, placing emphasis on routine assessment of key goals of         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m DSMES.\\n\\nRecommendation 5.4 was added to emphasize the importance of screening for behavioral health concerns  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m at the same time points as evaluating the need for DSMES.\\n\\nLanguage in Recommendation 5.5 was updated to      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m state that DSMES should be culturally appropriate and responsive to individual preferences, needs, and          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m values.\\n\\nRecommendation 5.6 was updated to reflect the now-common practice of remote-delivery of DSMES and    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m reimbursement for remotely delivered modalities.\\n\\nRecommendation 5.9 was updated to reinforce the importance  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of screening for and including social determinants of health in guiding the design and delivery of DSMES.\\n\\nIn \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the “Medical Nutrition Therapy” subsection, Recommendation 5.12 was updated to emphasize the importance of      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m providing treatment based on nutrition, physical activity, and behavioral therapy for individuals with          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m overweight or obesity, aiming for at least 3–7% weight loss.\\n\\nRecommendation 5.14 on eating patterns now has  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m revised verbiage to include processed foods, lean proteins, and nondairy alternatives.\\n\\nRecommendation 5.16   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was updated to include actionable language and clarity regarding the use of dietary supplements for glycemic    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m benefits.\\n\\nRecommendations 5.17 and 5.18 were updated to have revised and actionable language,                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m respectively.\\n\\nRecommendation 5.19 was updated to use actionable language.\\n\\nRecommendation 5.20 was revised \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to recommend limiting sodium as clinically appropriate, which can be done, in part, by limiting consumption of  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m processed foods.\\n\\nRecommendation 5.21 was modified to recommend water over nutritive and nonnutritive         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sweetened beverages, and Recommendation 5.22 was added to state that nonnutritive sweeteners can be used        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m instead of sugar-sweetened products in moderation and for short term to reduce overall calorie and carbohydrate \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m intake.\\n\\nRecommendation 5.23 was added to emphasize the screening for malnutrition, especially for those who  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m have undergone metabolic surgery and for those being treated with weight management pharmacological             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m therapies.\\n\\nRecommendation 5.25 was revised to use actionable language.\\n\\nRecommendation 5.26 was added to   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m address the issue of sodium–glucose cotransporter (SGLT) inhibition being associated with ketoacidosis under    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m certain conditions. It provides guidance on awareness, prevention, risk mitigation, and dietary                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m adjustments.\\n\\nRecommendation 5.29 was added to encourage intake of plant-based proteins and fiber, and        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Recommendation 5.31 was added to encourage limiting foods high in saturated fats to reduce cardiovascular       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m disease risk.\\n\\nTwo new recommendations were added for religious fasting. Recommendation 5.32 states to use    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the Diabetes and Ramadan International Alliance comprehensive prefasting risk assessment for risk               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m stratification of people with diabetes prior to engaging in religious fasting. Recommendation 5.33 was created  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to provide guidance to health care professionals caring for people with diabetes who participate in religious   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m fasting.\\n\\nAdditionally, newly added [**Fig. 5.1**](https://doi.org/10.2337/dc25-S005) illustrates differences \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and similarities between religious and intermittent fasting for people with diabetes. [**Table                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 5.4**](https://doi.org/10.2337/dc25-S005) includes a risk calculation and suggested risk score for people with  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes who seek to fast during Ramadan, and [**Table 5.5**](https://doi.org/10.2337/dc25-S005) includes       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m information about medication changes during fasting.\\n\\nIn the “Physical Activity” subsection, Recommendation   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 5.34 was updated to include a statement about limiting the amount of time spent sedentary, which includes       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recreational screen time.\\n\\nRecommendation 5.38 was modified to state that prolonged sitting should be         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m interrupted at least every 30 min for glycemic benefits.\\n\\nRecommendation 5.39 was added to counsel adults and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m youth receiving weight management pharmacotherapy or metabolic surgery to meet physical activity                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommendations. The accompanying text addresses the concern of sarcopenic obesity with use of incretin         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m therapies and metabolic surgery.\\n\\nIn the “Smoking Cessation: Tobacco, E-cigarettes, and Cannabis” subsection, \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Recommendation 5.42 was added to advise people with type 1 diabetes and those with other forms of diabetes at   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m risk for diabetic ketoacidosis (DKA) to not use recreational cannabis in any form due to the risk of cannabis   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hyperemesis syndrome. The accompanying text describes cannabis hyperemesis syndrome and its diagnostic          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m criteria.\\n\\nRecommendation 5.43 in “Supporting Positive Health Behaviors” was updated to include               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m health-related quality of life as an outcome when using behavioral health strategies to support self-management \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and healthy behaviors.\\n\\nRecommendation 5.45 in “Psychosocial Care” was revised to state the specific          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m psychosocial concerns health care professionals should screen for including diabetes distress, depression,      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m anxiety, fear of hypoglycemia, and disordered eating behaviors.\\n\\nRecommendation 5.48 in “Diabetes Distress”   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was updated to recommend the frequency of at least annual screening for diabetes distress in people with        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes, caregivers, and family members.\\n\\nRecommendation 5.49 in “Anxiety” was updated to recommend          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m screening for anxiety, which is in accordance with the U.S. Preventive Services Task Force recommendation for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m screening for anxiety.\\n\\nRecommendation 5.50 in “Anxiety” was added to include a recommendation for screening  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for fear of hypoglycemia in people with diabetes at risk for hypoglycemia or fear of                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypoglycemia.\\n\\nRecommendation 5.51 in “Depression” was modified to have more actionable language for the      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m importance of depression rescreening.\\n\\nRecommendation 5.54 in “Disordered Eating Behavior” was updated to     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommend screening for disordered or disrupted eating using validated screening measures. The accompanying     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m text describes the disordered or disrupted eating behaviors commonly reported in people with                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes.\\n\\n[**Tables 5.7**](https://doi.org/10.2337/dc25-S005) and                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [**5.8**](https://doi.org/10.2337/dc25-S005) were added to illustrate psychosocial concerns and their           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m association with diabetes-related outcomes in adults with type 1 and type 2 diabetes, respectively.\\n\\n###      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Section 6. Glycemic Goals and Hypoglycemia\\n\\n((https://doi.org/10.2337/dc25-S006))\\n\\nRecommendation 6.12 was  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m added to promote routine screening for fear of hypoglycemia in individuals at risk for hypoglycemia.\\n\\nA new   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m subsection entitled “Hyperglycemic Crises: Diagnosis, Management, and Prevention” was added to cover the        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m epidemiology, diagnostic criteria, and outpatient prevention of DKA and the hyperglycemic hyperosmolar state    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (HHS).\\n\\nNew recommendations on routine assessment of history of DKA and HHS (recommendation 6.20) and         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m providing structured prevention education (Recommendation 6.21) in the outpatient setting were                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m added.\\n\\n[**Tables 6.9**](https://doi.org/10.2337/dc25-S006) and [**6.10**](https://doi.org/10.2337/dc25-S006) \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m were added and include risk factors for hyperglycemic crises as well as clinical presentation of DKA and HHS in \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m people with diabetes, respectively.\\n\\n[**Figure 6.2**](https://doi.org/10.2337/dc25-S006) was revised to       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m provide a specific and actionable approach to selecting individual glycemic goals, accounting for health status \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and other person- and treatment-specific factors favoring more or less stringent goals.\\n\\n### Section 7.       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Technology\\n\\n((https://doi.org/10.2337/dc25-S007))\\n\\nRecommendation 7.8 was modified to emphasize    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m consideration for starting diabetes technology early, even at diagnosis.\\n\\nRecommendation 7.9 was added to     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m emphasize that reports for all continuous glucose monitoring (CGM) devices, connected insulin devices, and      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m continuous subcutaneous insulin infusion and automated insulin delivery (AID) systems should be standardized    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with at a minimum the ambulatory glucose profile and weekly summary. In addition, there should be options for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m raw data or daily and weekly reports available to the health care professionals.\\n\\nRecommendation 7.14 was     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m modified to make the clinician aware of potential interference of medications and other substances on glucose   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m levels measured by blood glucose meters.\\n\\n[**Table 7.2**](https://doi.org/10.2337/dc25-S007) was modified to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m include the various potential substances or medical conditions that may affect glucose levels when measured by  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m blood glucose meters.\\n\\n[**Table 7.3**](https://doi.org/10.2337/dc25-S007) was modified to include the         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m description of over-the-counter CGM devices.\\n\\nRecommendation 7.15 was modified to support the use of          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m real-time CGM (rtCGM) and intermittently scanned CGM (isCGM) for youth and adults with diabetes (type 1 or type \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2) on any type of insulin therapy based on the most recent literature.\\n\\nRecommendation 7.16 was added to      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m consider the use of rtCGM or isCGM in adults with type 2 diabetes on glucose-lowering agents other than insulin \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to achieve and maintain individualized glycemic goals.\\n\\nRecommendation 7.18 was modified to align with        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Section 15, “Management of Diabetes in Pregnancy,” and reflect the update of CGM benefits in type 1 diabetes    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and pregnancy and other types of diabetes in pregnancy.\\n\\nThe text on CGM was expanded to include the updated  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sensors integrated with AID systems and to update the most recent literature evidence supporting the benefits   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of CGM in individuals with type 2 diabetes on glucose-lowering agents other than insulin from clinical trials   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and real-world studies. Furthermore, the CGM section was expanded to include the need to standardize any        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes technology device reports and to provide clinicians not only with single page summaries but also with  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m access to detailed reports and even raw data from devices, especially those reporting insulin dose              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m modifications, such as AID systems.\\n\\nThe text on insulin pumps and AID systems was greatly expanded to        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m discuss the features of the various AID systems and their data from pivotal trials and real-world studies in    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m type 1 and type 2 diabetes.\\n\\nRecommendation 7.29 was modified to include provision of support and diabetes    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m management advice in people with diabetes using open-source closed-loop systems.\\n\\nThe text for open-source    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m closed-loop systems was also expanded to include the most recent published evidence on the safety and           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m effectiveness of these systems in people with type 1 diabetes.\\n\\nRecommendation 7.30 was expanded to include   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the benefits of combining technology with online or virtual coaching to improve glycemic outcomes in            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m individuals with diabetes and prediabetes.\\n\\nRecommendation 7.32 was refined to emphasize the importance of    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m continuing the use of insulin pumps or AID in people with diabetes while hospitalized when clinically           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m appropriate and with confirmatory point-of-care blood glucose measurements for insulin dose adjustments and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypoglycemia assessment and treatment. The use of these devices in the inpatient setting should be contingent   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m on the availability of infrastructure support and institutional diabetes technology protocols.\\n\\n### Section   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 8. Obesity and Weight Management for the Prevention and Treatment of Type 2                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes\\n\\n((https://doi.org/10.2337/dc25-S008))\\n\\nRecommendation 8.2a was updated to clarify that additional \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m measurements of body fat distribution are warranted if BMI is indeterminant.\\n\\nRecommendation 8.2b was revised \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to recommend monitoring of obesity-related anthropometric measurements at least every 3 months during active    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m weight management treatment.\\n\\nDiscussion of weight stigma and bias toward people living in larger bodies was  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m added to the text.\\n\\nRecommendation 8.11 was enhanced to reflect the importance of continued monitoring,       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m support, and interventions for individuals who have achieved weight loss goals to support the maintenance of    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m these goals long term.\\n\\nRecommendation 8.18 was added to recommend screening for malnutrition for people with \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes and obesity who have lost significant weight.\\n\\nRecommendation 8.19 was added to recommend continuing \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m weight management pharmacotherapy, as indicated, beyond reaching weight loss goals to maintain health benefits  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and avoid weight regain and worsening of cardiometabolic abnormalities that often result from sudden            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m discontinuation of weight management pharmacotherapy.\\n\\nRecommendation 8.25 was revised to emphasize use of a  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CGM device to improve safety in individuals with post–metabolic surgery hypoglycemia.\\n\\nUpdated [**Tables      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 8.1**](https://doi.org/10.2337/dc25-S008) and [**8.2**](https://doi.org/10.2337/dc25-S008) provide detailed     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m information on the efficacy, common side effects, safety considerations, and costs of approved weight           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m management pharmacotherapy options.\\n\\nDiscussion of medication cost and access barriers was added to the text, \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m including suggestions to members of the interprofessional diabetes care team on mitigating financial            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m barriers.\\n\\n### Section 9. Pharmacologic Approaches to Glycemic                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Treatment\\n\\n((https://doi.org/10.2337/dc25-S009))\\n\\nThis section was reorganized and expanded with two new    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m subsections: _1_) a subsection titled “Additional Recommendations for All Individuals With Diabetes” that       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m includes new recommendations as well as recommendations previously listed with those for individuals with type  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1 or type 2 diabetes if pertinent to individuals regardless of their type of diabetes, and _2_) a subsection    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m titled “Special Circumstances and Populations.”\\n\\n[**Figure 9.1**](https://doi.org/10.2337/dc25-S009) was      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m revised for clarity, and a general statement was added to [**Table 9.1**](https://doi.org/10.2337/dc25-S009) on \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dose adjustments when using AID systems.\\n\\nThe subsection on insulin administration technique was expanded to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m address inhaled insulin and use of insulin bolus patches.\\n\\nRecommendation 9.8 was revised to emphasize the    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m importance of selecting glucose-lowering medications that provide sufficient effectiveness and achieve and      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m maintain multiple treatment goals simultaneously, including improving cardiovascular, kidney, weight, and other \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m relevant outcomes, reducing hypoglycemia risk, and considering cost, access, risk for adverse reactions, and    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m individual preferences.\\n\\nRecommendations were revised to explicitly advise on choice of pharmacotherapy for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m individuals with type 2 diabetes and established or high risk of atherosclerotic cardiovascular disease (ASCVD) \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (Recommendation 9.10), heart failure (Recommendation 9.11), and chronic kidney disease (CKD) (Recommendation    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9.12) to improve health outcomes for individuals with these conditions irrespective of A1C.\\n\\nRecommendation   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9.12 was added to recommend use of GLP-1 RA with demonstrated benefits in individuals with type 2 diabetes,     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m symptomatic heart failure with preserved ejection fraction, and obesity.\\n\\nRecommendation 9.13 was revised to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommend use of either SGLT2 inhibitor or GLP-1 RA with demonstrated benefits in individuals with type 2       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes and CKD.\\n\\nRecommendations 9.15 and 9.16 were added to recommend treatment of individuals with type 2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes and MASLD or MASH with GLP-1 RA, dual GIP and GLP-1 RA, pioglitazone, or a combination of GLP-1 RA and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pioglitazone based on the staging of liver disease risk and need for weight management.\\n\\n[**Figure            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9.3**](https://doi.org/10.2337/dc25-S009) and the text discussing choice of glucose-lowering therapy in adults  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with type 2 diabetes were extensively revised to facilitate evidence-based selection of glucose-lowering        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m therapies based on individualized treatment goals. Considerations of glucose-lowering medication effects on     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MASLD and MASH were added to [**Fig. 9.3**](https://doi.org/10.2337/dc25-S009).\\n\\n[**Table                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9.2**](https://doi.org/10.2337/dc25-S009) was simplified and revised to better highlight important              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m considerations when choosing medications for lowering glucose in type 2 diabetes.\\n\\nRecommendation 9.20 was    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m clarified to recommend reassessing the need for and/or dose of medications with higher hypoglycemia risk (i.e., \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sulfonylureas, meglitinides, and insulin) when initiating a new glucose-lowering medication to minimize the     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m risk of hypoglycemia and treatment burden.\\n\\nRecommendation 9.21 was added to advise against concurrent use of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m a dipeptidyl peptidase 4 inhibitor with a GLP-1 RA due to lack of additional glucose lowering beyond that of a  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GLP-1 RA alone.\\n\\nRecommendation 9.24 was clarified by specifying that a GLP-1 RA or a dual GIP and GLP-1 RA   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m is preferred to insulin in adults with type 2 diabetes only in the absence of evidence of insulin               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m deficiency.\\n\\nText in the “Basal Insulin” section was revised to provide guidance on switching between         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m different basal insulin formulations.\\n\\n[**Figure 9.4**](https://doi.org/10.2337/dc25-S009) was revised for    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m clarity, and the list of options for prandial insulin was expanded.\\n\\nRecommendation 9.27 was revised to       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m remove consideration of basal insulin doses exceeding 0.5 units/kg/day as evidence of overbasalization.         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Instead, signs of overbasalization including significant bedtime-to-morning or postprandial-to-preprandial      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability should be   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m used.\\n\\n[**Tables 9.3**](https://doi.org/10.2337/dc25-S009) and [**9.4**](https://doi.org/10.2337/dc25-S009)   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m were updated with glucose-lowering medication and insulin costs as of 1 July 2024, and an expanded discussion   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m on medication costs and affordability was added to the text.\\n\\nIn the new subsection “Special Circumstances    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Populations,” Recommendations 9.31a, 9.31b, and 9.31c were added to advise on actions to take when          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m medications are not available (such as medication shortages); Recommendations 9.32a and 9.32b were added to     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m address care considerations for individuals of childbearing potential; and Recommendation 9.33 was added to     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m provide guidance on mitigating risk of ketoacidosis when individuals at risk for ketoacidosis or who follow a   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ketogenic eating pattern are treated with SGLT inhibition. Additional text in this subsection discusses         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m considerations for glucose-lowering pharmacotherapy for individuals with diabetes secondary to chemotherapy and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with other types of diabetes (i.e., pancreatogenic diabetes, cystic fibrosis–related diabetes, posttransplant   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes, maturity-onset diabetes of the young, and neonatal diabetes).\\n\\n### Section 10. Cardiovascular       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease and Risk Management\\n\\n((https://doi.org/10.2337/dc25-S010))\\n\\nRecommendation 10.1 was updated with    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m details on the frequency of recommended blood pressure monitoring.\\n\\n[**Figure                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 10.2**](https://doi.org/10.2337/dc25-S010) was updated to provide clarity on medication classes for the         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m treatment of confirmed hypertension in nonpregnant people with diabetes.\\n\\nRecommendation 10.12 was modified   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to specify appropriate monitoring for increased serum creatinine levels, serum potassium levels, and            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypokalemia when ACE inhibitors, angiotensin receptor blockers (ARBs), or mineralocorticoid receptor            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m antagonists are used.\\n\\nRecommendation 10.13 was added to specify hypertension treatment options that should   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m be avoided during pregnancy and in sexually active individuals of childbearing potential not using reliable     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m contraception.\\n\\nRecommendation 10.26 was added to recommend that in most cases lipid-lowering agents should   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m be discontinued prior to conception and avoided in sexually active individuals of childbearing potential not    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m using reliable contraception, unless the benefits may outweigh the risk.\\n\\n[**Figures                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 10.3**](https://doi.org/10.2337/dc25-S010) and [**10.4**](https://doi.org/10.2337/dc25-S010) were added to      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m illustrate recommendations for primary prevention and secondary prevention of ASCVD, respectively, in people    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with diabetes using cholesterol-lowering therapy.\\n\\nTriglyceride thresholds were updated in Recommendations    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 10.31 and 10.32.\\n\\nThe criteria for coronary artery disease investigations in Recommendation 10.39b were       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m revised to include signs or symptoms of cardiac or associated vascular disease or electrocardiogram             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m abnormalities.\\n\\nRecommendation 10.41 was modified to include screening for peripheral artery disease (PAD)    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with ankle-brachial index testing in asymptomatic people with diabetes aged ≥65 years, microvascular disease in \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m any location, or foot complications or any end-organ damage from diabetes if a PAD diagnosis would change       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m management. PAD screening should also be considered in individuals with diabetes duration ≥10 years and high    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cardiovascular risk.\\n\\nFor individuals with type 2 diabetes, obesity, and symptomatic heart failure with       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m preserved ejection fraction, Recommendation 10.46d was added to recommend treatment with a GLP-1 RA with        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m demonstrated benefit in this population to reduce heart failure–related symptoms, reduce physical limitations,  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and improve exercise function.\\n\\n[**Figure 10.5**](https://doi.org/10.2337/dc25-S010) was added to illustrate  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommendations for screening for asymptomatic and undiagnosed cardiovascular disease, and [**Fig.              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 10.6**](https://doi.org/10.2337/dc25-S010) was added to provide an overview of recommendations for the          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m prevention of the development of symptomatic heart failure in people with diabetes.\\n\\n### Section 11. Chronic  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Kidney Disease and Risk Management\\n\\n((https://doi.org/10.2337/dc25-S011))\\n\\nRecommendation 11.3 was amended  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for clarity about optimizing blood pressure management goals.\\n\\nRecommendation 11.4a was revised to clarify    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m that ACE inhibitors or ARBs should be titrated to the maximally tolerated dose to prevent the progression of    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CKD and reduce cardiovascular events in nonpregnant individuals with diabetes and                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypertension.\\n\\nRecommendation 11.4b was modified to specify appropriate monitoring for increased serum        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m creatinine levels, serum potassium levels, and hypokalemia when ACE inhibitors, ARBs, or mineralocorticoid      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m receptor antagonists are used.\\n\\nRecommendation 11.5b was updated to state that for people with type 2         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes and CKD, a GLP-1 RA with demonstrated benefit in this population should be used to reduce              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cardiovascular risk and kidney disease progression.\\n\\nRecommendation 11.6 was added to state that potentially  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m harmful antihypertensive medications in pregnancy should be avoided in sexually active individuals of           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m childbearing potential not using reliable contraception and to switch to options considered safer prior to      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m conception and during pregnancy.\\n\\nRecommendation 11.7 was updated to specify reducing urinary albumin by ≥30% \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to slow progression of CKD.\\n\\nRecommendation 11.8 was updated to specify protein goals for individuals with    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m stage 3 or higher CKD and those who are treated with dialysis.\\n\\n[**Table                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 11.1**](https://doi.org/10.2337/dc25-S011) was added to include reasons to consider non–diabetes-related kidney \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diseases in a person with CKD and diabetes, and [**Table 11.3**](https://doi.org/10.2337/dc25-S011) was added   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to include suggestions for interventions that lower albuminuria.\\n\\n### Section 12. Retinopathy, Neuropathy,    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Foot Care\\n\\n((https://doi.org/10.2337/dc25-S012))\\n\\nRecommendation 12.5 was updated to specify            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m involvement of an ophthalmologist for more frequent examinations if retinopathy is progressing or sight         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m threatening.\\n\\nRecommendation 12.8 wording was changed to reflect that a dilated eye exam should be performed  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m before and in the first trimester, rather than one or the other.\\n\\nRecommendation 12.19 was modified to        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m include additional screening criteria for symptoms and signs of autonomic neuropathy.\\n\\nRecommendation 12.22   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was updated to recommend against opioid use for neuropathic pain treatment due to the potential for adverse     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m events, and the narrative text was updated to expand on this.\\n\\nA short discussion on the role of weight       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m management and neuropathy was added to the narrative text.\\n\\nRecommendation 12.24 was updated to include the   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Ipswich touch test as an option for neurological assessment.\\n\\nRecommendation 12.29 was expanded to include    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the importance of smoke cessation and referral for counseling for individuals who smoke and have a prior        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m history of lower-extremity complications, loss of protective sensation, structural abnormalities, or            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m PAD.\\n\\nIncreasing role of surgery in diabetic foot management was added to the narrative text of foot care     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m section.\\n\\n### Section 13. Older Adults\\n\\n((https://doi.org/10.2337/dc25-S013))\\n\\nThe 4Ms framework of       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m age-friendly health systems (Mentation, Medications, Mobility, and What Matters Most) as it applies to diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m management in older adults was introduced and illustrated in the new [**Fig.                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 13.1**](https://doi.org/10.2337/dc25-S013).\\n\\nRecommendation 13.8a was modified to include time in range and   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m time below range in addition to A1C treatment goals for older adults who are otherwise healthy with few and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m stable chronic conditions and intact cognitive functional status.\\n\\nRecommendation 13.8b was modified to       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m include time in range and time below range in addition to A1C treatment goals for older adults who have         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m intermediate or complex health who are clinically heterogeneous with variable life expectancy.\\n\\n[**Table      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 13.1**](https://doi.org/10.2337/dc25-S013) was modified to include a column on reasonable CGM goals for each    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m health status category.\\n\\nIn the “Treatment” section, the appropriate selection and use of SGLT2 inhibitors in \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m older adults was expanded.\\n\\n### Section 14. Children and                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Adolescents\\n\\n((https://doi.org/10.2337/dc25-S014))\\n\\nRecommendation 14.4 in the “Type 1 Diabetes” section    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was added to emphasize key nutrition principles.\\n\\nRecommendation 14.10 was altered to emphasize limits on     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sedentary activity.\\n\\nRecommendation 14.21 was changed to state that insulin pumps should be offered to anyone \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with type 1 diabetes who can use the devices safely.\\n\\nRecommendation 14.24 was modified to remove lack of     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m access as a reason for less stringent A1C goals.\\n\\nRecommendation 14.26 was altered to include weight gain as  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m a balancing measure for more stringent A1C goals.\\n\\nRecommendation 14.36 was changed to exclude secondary      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m causes of hypertension.\\n\\nRecommendation 14.41 was updated to include the use of age-approved                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m statins.\\n\\nRecommendation 14.50 was modified to state that screening should be repeated at a minimum of 2-year \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m intervals or more frequently if screening is normal and BMI is increasing.\\n\\nRecommendation 14.57 was revised  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to include the key nutritional principles and provide specific examples of healthy food choices and what foods  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m should be avoided.\\n\\nRecommendation 14.60 was changed to recommend an A1C goal of <6.5% (<48 mmol/mol) for     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m most children and adolescents with type 2 diabetes who have a low risk of hypoglycemia and a higher risk of     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m complications.\\n\\nRecommendation 14.65 was revised to change the terminology from “hyperglycemic hyperosmolar   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m nonketotic syndrome” to “hyperglycemic hyperosmolar state” and include intravenous fluid as the initial step to \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m treat severe hyperglycemia (blood glucose ≥600 mg/dL) once the diagnosis is confirmed.\\n\\nThe narrative was     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m updated to reinforce the benefits and safety of GLP-1 RAs in decreasing A1C, weight, blood pressure, and        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m insulin dose reduction. [**Figure 14.1**](https://doi.org/10.2337/dc25-S014) was updated to reflect the         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m revision in this recommendation.\\n\\nRecommendation 14.73 was modified to reflect that excluding secondary       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypertension is an essential step in hypertension management.\\n\\nRecommendation 14.104 was revised to state     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m that vaping and electronic cigarettes are both discouraged.\\n\\nRecommendation 14.105 in the “Substance Use in   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Pediatric Diabetes” section was added to state that all youth with diabetes should be advised not to use        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cannabis recreationally in any form.\\n\\nRecommendation 14.108 was modified to encourage pediatric diabetes      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m specialists to partner with youth with diabetes and their caregivers to engage in shared                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m decision-making.\\n\\n[**Tables 14.1 _A_**](https://doi.org/10.2337/dc25-S014) and [**14.1                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m _B_**](https://doi.org/10.2337/dc25-S014) were modified to include changes made throughout Section 14.\\n\\n###   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Section 15. Management of Diabetes in Pregnancy\\n\\n((https://doi.org/10.2337/dc25-S015))\\n\\nSection 15 was      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m restructured to discuss the care of pregnant individuals with type 1 diabetes, type 2 diabetes, and GDM in all  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sections and to discuss aspects of management in each relevant subsection (e.g., preconception care and         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pharmacotherapy); consequently, the order of appearance of some of the recommendations                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m changed.\\n\\nRecommendation 15.7 wording was changed to reflect that a dilated eye exam should be performed      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m before and in the first trimester, rather than one or the other.\\n\\n[**Table                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 15.1**](https://doi.org/10.2337/dc25-S015) was updated with a folic acid supplement recommendation of 400–800   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m μg/day and clarification for which checklist items are only for individuals with preexisting diabetes and not   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for individuals with prediabetes or a history of GDM, and specific immunizations were omitted and               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m referenced.\\n\\nIn Recommendation 15.10, the benefits of CGM use in type 1 diabetes and pregnancy were           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m clarified, and an addition of its potential to be beneficial in other types of diabetes in pregnancy was        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m added.\\n\\nRecommendation 15.12 no longer states that CGM metrics should not be used as a substitute for blood   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m glucose monitoring; the recommendation now states that CGM may be used in conjunction with blood glucose        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m monitoring to achieve glycemic goals.\\n\\nGlucose goals for preexisting diabetes, GDM treated with insulin, and  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GDM not treated with insulin are consolidated into a new [**Table                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 15.2**](https://doi.org/10.2337/dc25-S015).\\n\\n“Management of Gestational Diabetes Mellitus” and “Management of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Preexisting Type 1 Diabetes and Type 2 Diabetes Pregnancy” were merged into one subsection, titled “Management  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of Diabetes in Pregnancy,” which includes all aspects of management for all types of diabetes (e.g., nutrition, \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m physical activity, and pharmacotherapy).\\n\\nRecommendation 15.14 provides more clarification on the recommended \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m eating pattern in pregnancy.\\n\\nInsulin recommendations that were previously split into separate                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommendations for preexisting diabetes and GDM were merged.\\n\\nThere are two new recommendations regarding    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m AID use in type 1 diabetes and pregnancy. Recommendation 15.19 states that AID systems are recommended if the   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m system has a pregnancy-specific glucose goal. Recommendation 15.20 states that AID systems may be considered    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for select individuals with an experienced health care team if the system does not have a pregnancy-specific    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m glucose goal or algorithm.\\n\\nRecommendation 15.21 provides more clarification for why metformin and glyburide  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m should not be first-line agents for management of diabetes in pregnancy.\\n\\nThe narrative for subsection        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m “Physical Activity” includes recommended activity levels for pregnancy, as these pertain to individuals with    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m any type of diabetes in pregnancy.\\n\\nThe “Insulin” subsection includes information on different insulin        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m delivery modalities used during labor and delivery or postpartum.\\n\\nThe recommendation to explicitly measure   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m blood pressure during pregnancy is now mentioned in the narrative of the “Preeclampsia and Aspirin” subsection  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m per the recent guidelines of the U.S. Preventive Services Task Force.\\n\\nRecommendation 15.25 was split into    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m two recommendations. Recommendation 15.25a provides more examples of potentially harmful medications in         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pregnancy. Recommendation 15.25b recommends that lipid-lowering medications be avoided in most circumstances in \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pregnancy but that statins may be considered for use in high-risk individuals (such as those with prior ASCVD   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and familial hypercholesterolemia) when benefits outweigh risks. The narrative discusses Recommendation 15.25b  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m in more detail and includes discussion of studies of pravastatin use in pregnancy.\\n\\n### Section 16. Diabetes  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care in the Hospital\\n\\n((https://doi.org/10.2337/dc25-S016))\\n\\nDiabetes care in the hospital stresses         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m identification and treatment of dysglycemia and provides glycemic goals. For the treatment of persistent        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hyperglycemia starting at a threshold of ≥180 mg/dL (≥10.0 mmol/L), Recommendation 16.4a was amended to reflect \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m that insulin should be initiated or intensified for the majority of critically ill individuals, and             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Recommendation 16.4b was added to state that insulin and/or other glucose-lowering therapies should be          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m initiated or intensified for the majority of noncritically ill individuals.\\n\\nRecommendation 16.5a was updated \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to state that a glycemic goal of 140–180 mg/dL (7.8–10.0 mmol/L) is recommended for most critically ill         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m individuals, but more stringent individualized glycemic goals may be appropriate if they can be achieved        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m without significant hypoglycemia. Recommendation 16.5b was updated to recommend a glycemic goal of 100–180      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mg/dL (5.6–10.0 mmol/L) for most noncritically ill individuals if it can be achieved without significant        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypoglycemia.\\n\\nRecommendation 16.7 was amended for clarity on the use of insulin pump or AID continuation and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m their use in people with diabetes who are hospitalized, when clinically appropriate.\\n\\nRecommendation 16.8a    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m was added to state that continuous intravenous insulin infusion is recommended for achieving glycemic goals and \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m avoiding hypoglycemia in critically ill individuals.\\n\\nThe language regarding a hypoglycemia management        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m surveillance protocol for health systems was updated for clarity in Recommendation 16.12.\\n\\nGuidance regarding \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m use of GLP-1 RA and dual GIP and GLP-1 RA medications in the perioperative setting and regarding instructions   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m in preparation for procedures or surgery has been added to the narrative text.\\n\\nRecommendations 16.14 and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 16.15 were added for DKA and HHS management; transition to maintenance subcutaneous insulin administration and  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m discharge planning were added. Additionally, the newly added [**Fig. 16.1**](https://doi.org/10.2337/dc25-S016) \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m includes treatment pathways for DKA and HHS.\\n\\n### Section 17. Diabetes                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Advocacy\\n\\n((https://doi.org/10.2337/dc25-S017))\\n\\nThe subsections “Diabetes Care in the School Setting” and  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m “Diabetes and Driving” were updated with information from recently published advocacy statements. The           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m subsection “Diabetes Management in Detention Facilities” was added with information from a recently published   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m advocacy statement.\\n\\n*A complete list of members of the American Diabetes Association Professional Practice   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee can be found at (https://doi.org/10.2337/dc25-SINT).\\n\\nDuality of interest information for each      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m author is available at [10.2337/dc25-SDIS](https://doi.org/10.2337/dc25-SDIS).\\n\\nSuggested citation: American  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Association Professional Practice Committee. Summary of revisions: Standards of Care in Diabetes—2025. \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Care 2025;48(Suppl. 1):S6–S13\\n\\n© 2024 by the American Diabetes Association\\n\\n2024\\n\\nReaders may    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m use this article as long as the work is properly cited, the use is educational and not for profit, and the work \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m is not altered. More information is available at                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://www.diabetesjournals.org/journals/pages/license).\\n\\n[](https://diabetesjournals.org/care/article/48/S \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m upplement_1/S6/157564/Summary-of-Revisions-Standards-of-Care-in-Diabetes)\\n\\n329,024                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Views\\n\\n[11](https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=silverchair&SrcAuth=WosAPI&KeyUT=WOS: \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 001378283000018&DestLinkType=CitingArticles&DestApp=WOS_CPL)Web of Science\\n\\n[![Image 6: Article has an        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m altmetric score of                                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 25](https://badges.altmetric.com/?size=128&score=25&types=mttttttu)](https://www.altmetric.com/details.php?doma \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m in=diabetesjournals.org&citation_id=171817539)\\n\\n[View Metrics](javascript:;)\\n\\n[×Close                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Modal](javascript:;)\\n\\n### Email alerts\\n\\n[Article Activity Alert](javascript:;)\\n\\n[Online Ahead of Print    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Alert](javascript:;)\\n\\n[Latest Issue Alert](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\nWe Recommend\\n\\n*  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Issues and                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Events](https://rev.trendmd.com/open/hgx1w40eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91cm5 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1DYX \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m JlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiJmNTE1MmU3Z \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m S1lOWU3LTQwNTItOGFiMC0zYzk4ZmNjYTIwMDkiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvZGlhYmV0 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ZXMvYXJ0aWNsZS83MC83LzE2MDIvMTM3ODYwL0lzc3Vlcy1hbmQtRXZlbnRzP3NlYXJjaHJlc3VsdD0xIiwiZGVzdGluYXRpb25QdWJsaWNhdGl \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m vbklkIjoiYzAyM2Y5ZmUtNTJkNS00NWNmLWIyZGUtNGRiMGUxOWE5OGJhIiwiZGVzdGluYXRpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAsInNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m i1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmYtNDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xv \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLCJhZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFN \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTU0LCJjYW1wYWlnblZlcnNpb24iOjIsImNhbXBhaWduVmFyaWFudCI6MywiY29zdCI6MTAwLCJjYW \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1wYWlnbkFkR3JvdXBJZCI6MTU0LCJjYW1wYWlnbkFkSWQiOjE1NCwiY2FtcGFpZ25BZElkZW50aWZpZXIiOiI0YTY0ZjY1Ni1lZjAxLTRkMTgtY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mJkYy02NzBmMjlkZGRhZDIiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiI0MWY5OTY2Zi1hYTRhLTQ1MmItODBlMi1kMDcxNDU4ODIxZmMi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m LCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW9uSWQiOjYwLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0YW1wIjoxNzU1NjE1MDgwODY3LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5cGUiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m VUeXBlIjowfQ3m1klri)American Diabetes Association, Diabetes, 2021 \\n*   [Issues and                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Events](https://rev.trendmd.com/open/4lpk5vseyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91cm5 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1DYX \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m JlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI0Y2MwNTMyZ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m C0zYTdkLTRkMzQtYjViMi1lODBkMzhmMjY3OWEiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXMuZGlhYmV0ZXNqb3VybmFscy5v \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cmcvY29udGVudC83MC81LzEyMDkiLCJkZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiJjMDIzZjlmZS01MmQ1LTQ1Y2YtYjJkZS00ZGIwZTE5YTk \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4YmEiLCJkZXN0aW5hdGlvbkNvbnRlbnRUeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9saWN5VHlwZSI6MCwic2Vzc2lvbklkIjoiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m TY1MTFjYjMtNWEyZi00MDU3LWJkMzMtZTZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUw \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NTI1OTgzNTliNCIsImFkU2xvdEV2ZW50VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNTQsImNhbXBhaWduVmV \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m yc2lvbiI6MiwiY2FtcGFpZ25WYXJpYW50IjozLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNTQsImNhbXBhaWduQWRJZCI6MTU0LC \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m JjYW1wYWlnbkFkSWRlbnRpZmllciI6IjRhNjRmNjU2LWVmMDEtNGQxOC1iYmRjLTY3MGYyOWRkZGFkMiIsImNhbXBhaWduQWRCdWNrZXRSZW1vd \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GVJZCI6IjQxZjk5NjZmLWFhNGEtNDUyYi04MGUyLWQwNzE0NTg4MjFmYyIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25P \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cmdhbml6YXRpb25JZCI6NjAsInRyYWNraW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 3NzAwMCwidHlwZSI6MCwidmVyc2lvbiI6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB96zv9dv4)American Diabetes Association,     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes, 2021 \\n*   [Standards of Care in Diabetes—2023 Abridged for Primary Care                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Providers](https://rev.trendmd.com/open/s182jy6eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI0YjdkNm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Q1NS00ZWQ0LTQxOTMtOGY2MS1lY2M2ODBkZTQzOTMiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvY2xpb \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mljYWwvYXJ0aWNsZS80MS8xLzQvMTQ4MDI5L1N0YW5kYXJkcy1vZi1DYXJlLWluLURpYWJldGVzLTIwMjMtQWJyaWRnZWQtZm9yIiwiZGVzdGlu \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YXRpb25QdWJsaWNhdGlvbklkIjoiZGZjNmI2NmEtZWE4NC00NzE4LWJiOWMtOWY0YTQ1ZWM4YWRlIiwiZGVzdGluYXRpb25Db250ZW50VHlwZXM \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m iOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAsInNlc3Npb25JZCI6ImFhMG \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m VmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmYtNDA1Ny1iZDMzLWU2ZjRkN \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m jZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLCJhZFNsb3RFdmVudFRyYWNr \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m aW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTU0LCJjYW1wYWlnblZlcnNpb24iOjIsImNhbXBhaWduVmFyaWFudCI6Myw \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m iY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTU0LCJjYW1wYWlnbkFkSWQiOjE1NCwiY2FtcGFpZ25BZElkZW50aWZpZXIiOiI0YTY0Zj \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Y1Ni1lZjAxLTRkMTgtYmJkYy02NzBmMjlkZGRhZDIiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJlNDc3MDhmNy00Mzc4LTRmZjAtOTdmN \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m y0zMzY2ZGFiMTBiZTAiLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW9uSWQiOjYwLCJ0cmFja2luZ1Ns \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5cGUiOjAsInZlcnNpb24iOiIwLjU \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQ487qzxq)American Diabetes Association, Clin Diabetes, 2023 \\n*   [Introduction:  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Standards of Care in Diabetes—2024 Abridged for Primary Care                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Professionals](https://rev.trendmd.com/open/ltuxgqreyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVz \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m am91cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m vZi1DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI5YW \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m E3MmFmYy1iOGJiLTQ2YWItYTBlMi03MDkyOWM3MDQ5MzIiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2xpbmljYWwvYXJ0aWNsZS80Mi8yLzE4MS8xNTQ0NjgvSW50cm9kdWN0aW9uLVN0YW5kYXJkcy1vZi1DYXJlLWluLURpYWJldGVzLTIwMjQiLCJk \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiJkZmM2YjY2YS1lYTg0LTQ3MTgtYmI5Yy05ZjRhNDVlYzhhZGUiLCJkZXN0aW5hdGlvbkNvbnRlbnR \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m UeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwic2Vzc2lvbklkIj \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m oiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi00MDU3LWJkMzMtZ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m TZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsImFkU2xvdEV2ZW50 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNTQsImNhbXBhaWduVmVyc2lvbiI6MiwiY2FtcGFpZ25WYXJpYW5 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0IjozLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNTQsImNhbXBhaWduQWRJZCI6MTU0LCJjYW1wYWlnbkFkSWRlbnRpZmllciI6Ij \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m RhNjRmNjU2LWVmMDEtNGQxOC1iYmRjLTY3MGYyOWRkZGFkMiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImU0NzcwOGY3LTQzNzgtNGZmM \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m C05N2Y3LTMzNjZkYWIxMGJlMCIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb25JZCI6NjAsInRyYWNr \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m aW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZSI6MCwidmVyc2lvbiI \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB9p36vumh)American Diabetes Association Primary Care Advisory Group, Clin    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes, 2024 \\n*   [Standards of Medical Care in Diabetes—2022 Abridged for Primary Care                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Providers](https://rev.trendmd.com/open/42osx7deyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI3NTQxY2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m VjMy03MTEzLTQyYjUtODUzYS05MDRlYjI2ZjM4OTciLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvY2xpb \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mljYWwvYXJ0aWNsZS80MC8xLzEwLzEzOTAzNS9TdGFuZGFyZHMtb2YtTWVkaWNhbC1DYXJlLWluLURpYWJldGVzLTIwMjIiLCJkZXN0aW5hdGlv \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m blB1YmxpY2F0aW9uSWQiOiJkZmM2YjY2YS1lYTg0LTQ3MTgtYmI5Yy05ZjRhNDVlYzhhZGUiLCJkZXN0aW5hdGlvbkNvbnRlbnRUeXBlcyI6WzV \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwic2Vzc2lvbklkIjoiYWEwZWYxYj \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m MtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi00MDU3LWJkMzMtZTZmNGQ2NmFiM \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Tk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsImFkU2xvdEV2ZW50VHJhY2tpbmci \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m OnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNTQsImNhbXBhaWduVmVyc2lvbiI6MiwiY2FtcGFpZ25WYXJpYW50IjozLCJjb3N \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNTQsImNhbXBhaWduQWRJZCI6MTU0LCJjYW1wYWlnbkFkSWRlbnRpZmllciI6IjRhNjRmNjU2LW \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m VmMDEtNGQxOC1iYmRjLTY3MGYyOWRkZGFkMiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImU0NzcwOGY3LTQzNzgtNGZmMC05N2Y3LTMzN \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m jZkYWIxMGJlMCIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb25JZCI6NjAsInRyYWNraW5nU2x1Z3Mi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Ont9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZSI6MCwidmVyc2lvbiI6IjAuNTU4LjA \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m iLCJjcmVhdGl2ZVR5cGUiOjB9fo60ufx)American Diabetes Association, Clin Diabetes, 2022 \\n\\n*   [Diabetes can be    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m managed as well in primary care as in                                                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hospital](https://rev.trendmd.com/open/qirdz9feyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91c \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m m5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1D \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiIzYjU3NmY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0YS0yNjJmLTRmZjItYjU1Zi1lNGZhODdmYTA0NTQiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMTcvNz \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m E1NS8wLjgiLCJkZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiI2OTVjNjAyNy05ZTMyLTRjNTEtYjgzOC05MWRmNzgwNWVmZTgiLCJkZXN0aW5hd \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GlvbkNvbnRlbnRUeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m c2Vzc2lvbklkIjoiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi0 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0MDU3LWJkMzMtZTZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsIm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m FkU2xvdEV2ZW50VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNjAsImNhbXBhaWduVmVyc2lvbiI6MTI3NSwiY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2FtcGFpZ25WYXJpYW50IjoyLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNjAsImNhbXBhaWduQWRJZCI6MTYwLCJjYW1wYWlnbkFk \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SWRlbnRpZmllciI6IjllOTkzNjEwLWY5ZjgtNDM1Ny04NWRhLThkYTBhMzQ3NzM5NiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImE0ZTJ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hYmRlLTI1NTgtNDIyMS1hMDIxLTA4MGMyZjdmYjkwNyIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 5JZCI6NjIsInRyYWNraW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SI6MCwidmVyc2lvbiI6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB9babs8ui)British Medical Journal Publishing Group, The    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m BMJ, 1998 \\n*   [American Diabetes Association issues new guidelines for type 1                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes](https://rev.trendmd.com/open/410iis1eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91c \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m m5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1D \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiIyMzBkODc \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0Mi1kYWM1LTRkZDgtYTI1MS01MzMzZjBhMjdjZTUiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zNDgvYm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1qLmc0MTE5IiwiZGVzdGluYXRpb25QdWJsaWNhdGlvbklkIjoiNjk1YzYwMjctOWUzMi00YzUxLWI4MzgtOTFkZjc4MDVlZmU4IiwiZGVzdGluY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m XRpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAs \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m InNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m tNDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLC \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m JhZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTYwLCJjYW1wYWlnblZlcnNpb24iOjEyNzUsI \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mNhbXBhaWduVmFyaWFudCI6MiwiY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTYwLCJjYW1wYWlnbkFkSWQiOjE2MCwiY2FtcGFpZ25B \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ZElkZW50aWZpZXIiOiI5ZTk5MzYxMC1mOWY4LTQzNTctODVkYS04ZGEwYTM0NzczOTYiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJhNGU \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m yYWJkZS0yNTU4LTQyMjEtYTAyMS0wODBjMmY3ZmI5MDciLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 9uSWQiOjYyLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5c \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GUiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQm2d8avx)Michael McCarthy, The BMJ, 2014 \\n*   [Changed \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m criteria for diabetes need further                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m research](https://rev.trendmd.com/open/a1lkbq6eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91c \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m m5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1D \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiJiZGU5ODk \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m zZS1kYzA3LTQ0YjQtOTQxYS0xOTQwMTQ4NTc0OTEiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMTcvNz \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m E1NS8wLjMiLCJkZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiI2OTVjNjAyNy05ZTMyLTRjNTEtYjgzOC05MWRmNzgwNWVmZTgiLCJkZXN0aW5hd \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GlvbkNvbnRlbnRUeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m c2Vzc2lvbklkIjoiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi0 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0MDU3LWJkMzMtZTZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsIm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m FkU2xvdEV2ZW50VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNjAsImNhbXBhaWduVmVyc2lvbiI6MTI3NSwiY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2FtcGFpZ25WYXJpYW50IjoyLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNjAsImNhbXBhaWduQWRJZCI6MTYwLCJjYW1wYWlnbkFk \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SWRlbnRpZmllciI6IjllOTkzNjEwLWY5ZjgtNDM1Ny04NWRhLThkYTBhMzQ3NzM5NiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImE0ZTJ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hYmRlLTI1NTgtNDIyMS1hMDIxLTA4MGMyZjdmYjkwNyIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb2 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 5JZCI6NjIsInRyYWNraW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SI6MCwidmVyc2lvbiI6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB969z2q2s)British Medical Journal Publishing Group, The    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m BMJ, 1998 \\n*   [Effective diabetes care: a need for realistic                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m targets](https://rev.trendmd.com/open/3u6nbk3eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91cm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1DY \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m XJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiJiNGZmMWYw \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NS1jMjY3LTQwYzItYmQ4OC1hYzdmY2YxMjU0ZmEiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMjQvNzM \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1My8xNTc3IiwiZGVzdGluYXRpb25QdWJsaWNhdGlvbklkIjoiNjk1YzYwMjctOWUzMi00YzUxLWI4MzgtOTFkZjc4MDVlZmU4IiwiZGVzdGluYX \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Rpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAsI \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m nNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmYt \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLCJ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTYwLCJjYW1wYWlnblZlcnNpb24iOjEyNzUsIm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NhbXBhaWduVmFyaWFudCI6MiwiY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTYwLCJjYW1wYWlnbkFkSWQiOjE2MCwiY2FtcGFpZ25BZ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ElkZW50aWZpZXIiOiI5ZTk5MzYxMC1mOWY4LTQzNTctODVkYS04ZGEwYTM0NzczOTYiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJhNGUy \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YWJkZS0yNTU4LTQyMjEtYTAyMS0wODBjMmY3ZmI5MDciLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW9 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m uSWQiOjYyLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5cG \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m UiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQubd3vas)Peter Winocour, The BMJ, 2002 \\n*   [Shifting   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of care for diabetes from secondary to primary care, 1990-5: review of general                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m practices](https://rev.trendmd.com/open/fxp0eeieyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI0Njc4OD \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m k3OS02ZGY2LTRhYjktYTQzNC02NDMzYjhmMzM5ODUiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMTYvN \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m zE0My8xNTA1IiwiZGVzdGluYXRpb25QdWJsaWNhdGlvbklkIjoiNjk1YzYwMjctOWUzMi00YzUxLWI4MzgtOTFkZjc4MDVlZmU4IiwiZGVzdGlu \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YXRpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjA \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sInNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m YtNDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiL \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CJhZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTYwLCJjYW1wYWlnblZlcnNpb24iOjEyNzUs \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ImNhbXBhaWduVmFyaWFudCI6MiwiY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTYwLCJjYW1wYWlnbkFkSWQiOjE2MCwiY2FtcGFpZ25 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m BZElkZW50aWZpZXIiOiI5ZTk5MzYxMC1mOWY4LTQzNTctODVkYS04ZGEwYTM0NzczOTYiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJhNG \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m UyYWJkZS0yNTU4LTQyMjEtYTAyMS0wODBjMmY3ZmI5MDciLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0a \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m W9uSWQiOjYyLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cGUiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQotlh5ol)Elizabeth C Goyder, The BMJ, 1998             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\n\\n[Powered by](https://www.trendmd.com/how-it-works-readers)\\n\\n*   [Privacy                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m policy](https://www.trendmd.com/privacy)\\n*   [Google Analytics                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m settings](https://www.trendmd.com/google-analytics)\\n\\n*   Online ISSN 1935-5548\\n*   Print ISSN                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0149-5992\\n\\n### Journals\\n\\n*   [Diabetes](https://diabetesjournals.org/diabetes)\\n*   [Diabetes               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://diabetesjournals.org/care)\\n*   [Diabetes, Obesity, and Cardiometabolic                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CARE](https://diabetesjournals.org/docm-care)\\n*   [Clinical                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://diabetesjournals.org/clinical)\\n*   [Diabetes                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Spectrum](https://diabetesjournals.org/spectrum)\\n*   [Standards of Medical Care in                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [Scientific Sessions                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [BMJ Open Diabetes   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Research & Care](https://drc.bmj.com/)\\n\\n### Books\\n\\n*                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [ShopDiabetes.org](https://shopdiabetes.org/collections/professional-books)\\n*   [ADA Professional              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Books](https://diabetesjournals.org/books)\\n\\n### Clinical Compendia\\n\\n*   [Clinical Compendia                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Home](https://diabetesjournals.org/compendia)\\n\\n### News\\n\\n*   [Latest                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m News](https://www.diabetes.org/newsroom)\\n*   [DiabetesPro                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SmartBrief](https://www2.smartbrief.com/signupSystem/subscribe.action?pageSequence=1&briefName=diabetespro)\\n\\n \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ### Podcasts\\n\\n*   [Diabetes Core                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Update](https://diabetesjournals.org/journals/pages/diabetes-core-update-podcasts)\\n*   [Diabetes Care \\\"On     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Air\\\"](https://sites.libsyn.com/453336/site)\\n*   [DiabetesBio](https://sites.libsyn.com/499063/site)\\n*        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes Day by Day](https://sites.libsyn.com/435096/site)\\n*   [Diabetes Core Update: Special                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n\\n### Other\\n\\n*  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Special Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n*              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [DiabetesPro®](https://professional.diabetes.org/)\\n*   [Diabetes Food                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Hub™](https://www.diabetesfoodhub.org/)\\n*   [Insulin Affordability](https://doi.org/10.2337/dci18-0019)\\n*     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Know Diabetes By Heart™](https://www.knowdiabetesbyheart.org/)\\n\\n### About\\n\\n*   [About the                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ADA](https://www.diabetes.org/about-us)\\n*   [Journal                                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n*   [For                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n*   [Advertising in ADA                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Journals](https://diabetesjournals.org/journals/pages/advertising)\\n*   [Reprints and Permission for            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reuse](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n*   [Copyright Notice/Public      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Access Policy](https://diabetesjournals.org/journals/pages/license)\\n*   [Privacy                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policy](https://diabetes.org/about-us/policies/privacy-policy)\\n\\n### Resources\\n\\n*   [ADA Professional        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Membership](https://professional.diabetes.org/membership)\\n*   [ADA Member                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Directory](http://professional.diabetes.org/directory)\\n*                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes.org](http://www.diabetes.org/)\\n\\n[![Image                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 7](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/logo-umbrella-footer.sv \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m g?versionId=6302)](https://diabetes.org/)\\n\\n*   [X (Twitter)](https://twitter.com/ADA_Pubs)\\n*                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Facebook](https://www.facebook.com/adaPublications)\\n*                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [LinkedIn](https://www.linkedin.com/company/american-diabetes-association/)\\n\\n*   [Contact                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us](https://diabetesjournals.org/contact-us)\\n*   [Cookie                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policy](https://diabetesjournals.org/journals/pages/Policies)\\n*                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Accessibility](https://diabetesjournals.org/pages/Accessibility)\\n*   [Terms &                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Conditions](https://diabetes.org/about-us/policies/terms-of-use)\\n*   [Get Adobe Acrobat                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reader](https://get.adobe.com/reader/)\\n*   © Copyright American Diabetes Association\\n\\n[_Close                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Modal_](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\n##### This Feature Is Available To Subscribers          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Only\\n\\n[Sign                                                                                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m In](https://diabetesjournals.org/sign-in?returnUrl=%2fcare%2farticle%2f48%2fSupplement_1%2fS6%2f157564%2fSummar \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m y-of-Revisions-Standards-of-Care-in-Diabetes) or [Create an                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Account](https://diabetesjournals.org/my-account/register?siteId=1000003&returnUrl=%2fcare%2farticle%2f48%2fSup \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m plement_1%2fS6%2f157564%2fSummary-of-Revisions-Standards-of-Care-in-Diabetes)\\n\\n[_Close                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Modal_](javascript:;)\\n\\n[_Close Modal_](javascript:;)\\n\\n This site uses cookies. By continuing to use our     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m website, you are agreeing to                                                                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://www.diabetesjournals.org/content/privacy-policy-american-diabetes-association-journals)\\n\\n[Accept](ja \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m vascript:;)\\n\\nclose                                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m advertisement\\n\\n\\n##Source\\nhttps://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Rev \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m isions-Standards-of-Care-in-Diabetes\", \"## Title\\n2025 ADA Standards of Medical Care in Diabetes:               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Updates!\\n\\n## Content\\n2025 ADA Standards of Medical Care in Diabetes: Updates! Although the ADA Standards of  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care is a living document throughout the year, annually in Dec/Jan they release a large update. For the         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m purposes of this edition of Pharm Aid, I have highlighted the updates that are pertinent to primary care        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m practice in the table below. Please find the full Standards of Care here:                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m https://professional.diabetes.org/standards-of-care This site includes the full standards in PDF and other      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m useful tools: • Full Standards of Care 2025 • Slide Decks: o Full Standards of Care 2025 (349 slides) o         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Abridged Standards of Care 2024 (107 slides – with easy to follow graphics) • Free Updated APP ----including    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m interactive tools! The KEY highlights are for 2025 are: 1. Continued emphasis on: a. Person-first, inclusive,   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m empowering terminology and consideration for Social Determinants of Health. i. Avoid the term “diabetic” –      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m instead use PERSON with DIABETES (PWD) b. NEW terminology: Cardiorenal metabolic disease or                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m cardiovascular-kidney-metabolic health (CKM) c. Weight-based approach to treatment and use of medications to    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m help with weight loss d. Team-based care e. Broader use of CGM – beyond just persons on insulin 2. Glycemic     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Algorithm continues to aligns with EASD/ADA and AACE: Choose agents with a focus on drug efficacy, Cardiorenal  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m risk reduction, and weight loss. ADDED drugs indicated for MASLD or MASH 3. Endorsements: a. American Society   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for Bone and Mineral Research (Bone Health in Section 4) b. The Obesity Society (Section 8 – Obesity and Weight \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Management) c. American College of Cardiology (Section 10 – CV disease and risk management) d. NEW this year:   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the American Geriatrics Society (Section 13 – Older Adults) 4. TYPE 1 DIABETES updates: a. Antibody based       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m screening for pre-symptomatic T1D in family members of people w/T1 and others at risk: i. Type 1 DM risk: use   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m islet autoantibody tests and criteria for preclinical stages of type 1 to look for potential to delay onset     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m using teplizumab-mzwv (Tzield) in: 1. All 1st degree relatives of PWT1D 2. Newly diagnosed adults 3. Based on   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Consensus guidance b. Autoimmune Disease Screening in Type 1: 1. THYROID: Initial and REPEAT screenings         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommended at regular intervals 2. Celiac: in presence of GI symptoms, or clinical suspicion c. NEW            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommendations for persons at risk of DKA: AVOID CANNABIS due to risk of hyperemesis syndrome 5. Drug Updates: \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m a. Use of GLP1-RA i. How to handle shortages and substitutions ii. Expanded recommendations: Established/High   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Risk for ASCVD, HFpef, CKD 6. Liver Updates: a. Change in Terminology i. Nonalcoholic fatty liver disease       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (NAFLD) updated to: metabolic dysfunction–associated steatotic liver disease (MASLD) ii. Nonalcoholic           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m steatohepatitis (NASH) updated to and metabolic dysfunction–associated steatohepatitis (MASH) b. Drug Therapy   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for MASLD/MASH: i. DM meds with potential benefits: GLP1-RA, GIP/GLP1-RA and pioglitazone (phase 2 trial data)  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1. Use combination pio/GLP in adults with biopsy proven MASH or at higher risk of fibrosis ii. Resmetirom –     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m thyroid hormone receptor beta agonist approved for MASLD with fibrosis- treatment in adults (see Section 4) –   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to be prescribed by specialists only 7. Screening Updates: a. General: i. Assessment for disability at initial  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m visit, with functional decline assessment at each visit ii. PAD screening – using ankle-brachial index testing  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m in asymptomatic persons at risk for PAD, or any person with DM > 10 years duration and high CV risk b.          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Male/Female sexual health i. Men – screen for erectile dysfunction, and monitor serum testosterone if           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m symptomatic of hypogonadism in men ii. Women – sexual health, and symptoms of genitourinary syndrome of         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m menopause c. Psychosocial issues: i. Screen PWD and caregivers for concerns including diabetes distress,        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m depression, anxiety, fear of hypoglycemia, and disordered eating behaviors d. Fasting: i. Utilize the Diabetes  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Ramadan International Alliance comprehensive pre-fasting risk assessment to stratify risk UPDATES by        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SECTION Section 1: Improving Care and Promoting Health in Populations 1. Promotes the use of interprofessional  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m teams and quality improvement initiatives – with actionable guidance on how to improve care delivery, and how   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to screen for, measure and address health disparities, affordability, and social determinants of health. 2.     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Continues to include information on online platforms to support behavior change/well-being Section 2: Diagnosis \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Classification of DM 1. Same 4 categories of Dx: Type 1, Type 2, DM due to other causes, GDM 2. DIAGNOSIS   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m parameters are the same, with more guidance and the addition of random plasma glucose in a symptomatic person:  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 3. NEW TABLE 2.3 – considerations related to the interpretation of lab measurements 4. NEW recommendation for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m approach to the person with features of BOTH Type 1 and Type 2 diabetes. Continues to differentiate forms of    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetes: Type 1, LADA, Type 2, monogenic syndromes (MODY), pancreatic disease (CF, pancreatitis),              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m drug/chemical induced, gestational 5. NEW emphasis on the importance of antibody based screening for            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pre-symptomatic Type 1 in persons with Family History or elevated genetic risk. Reminder: teplizumab-mzwv       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m infusion is available to delay onset of type 1 in persons > 8 yrs. with stage 2 type 1. (Info in Section 3) 6.  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m GDM subsection updated 7. UPDATED: immune checkpoint inhibitors, role of gut microbiome, and monogenic diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 8. Screening thresholds: a. All adults should be screened starting at age 35 b. All overweight/obese adults     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (BMI> 25) with any risk factors (FH, high-risk race, ASCVD, HTN, HLD, PCOS, inactivity) i. If results are       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m normal, screen every 3 years ii. If pre-DM level (A1C 5.7 – 6.4%), re-test yearly c. Youth: screen all who are  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m overweight with 1 or more additional risk factors d. Screen for people on medications with risks for            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hyperglycemia: glucocorticoids, statins, thiazides, HIV meds (baseline and q 3-6 months), 2nd generation        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m anti-psychotics (baseline and 12-16 wks. later) Section 3: Prevention or Delay of Diabetes and Associated       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comorbidities 1. Emphasis on INDIVIDUAL Risk/Benefit Assessment of pre-diabetes 2. NEW: highlights SLEEP as a   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m central component (equal to eating patterns and physical activity) for management 3. Non-Drug: a. All           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m overweight/obesity persons at risk should get INTENSIVE lifestyle behavior change referral b. Care Goals:       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Include 3-7% weight loss/prevention of weight gain with attention to CV risk i. INTENSIVE goals recommended if  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m BMI > 35 kg/m2, A1C > 6%, Hx of GDM c. Recommend local DPP:                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m https://www.cdc.gov/diabetes/prevention/find-a-program.html d. NEW: discussion on the use of VITAMIN D to       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m prevent Type 2 DM (advocated by the US Endocrine Society). Dose is not clear, and more research is needed for a \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommendation. 4. Drug Therapy: (no changes) a. Consider anti-hyperglycemic drug therapy to reduce progression \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to DM in high risk individuals b. Metformin – consider in pts 25-59 years with BMI > 35 kg/m2, fasting PG > 110 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mg/dL , A1C > 6%, women w/GDM c. Recommend PIOGLITAZONE to reduce risk of stroke/MI in people w/stroke hx and   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pre-DM, although need to balance w/the risk of weight gain, edema, and fractures (lower dose) Section 4:        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Comprehensive Medical Evaluation and Assessment of Comorbidities 1. Immunization Updates: a. Table 4.3 includes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m consideration for: COVID-19, Hepatitis B, Influenza, Pneumococcal, RSV, Tdap, Zoster 2. BONE HEALTH updates: a. \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m When to do Bone Mineral Density (BMD) testing i. Initial: All older adults (>65 yo), and younger persons with   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m multiple risk factors every 2 to 3 years b. In those at risk: i. Avoid meds with association to higher fracture \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m risk (pioglitazone, sulfonylureas) ii. Avoid meds with hypoglycemia or fall risk c. Recommended Calcium intake  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1000-1200mg/day with Vitamin D d. When to start antiresorptive and osteoanabolic agents: i. Older adults at     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m high risk of fracture: Risk Assessment Tool score (>3% for hip, > 20% for osteoporotic), BMD T-score < 2, hx of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m fracture (hip/pelvis, vertebral, forearm) 3. NEW subsection: DENTAL CARE a. Dental Exam at least once per year  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4. Updates to assessment for: a. Disability and decline (every visit) b. Sexual health, erectile dysfunction    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and potential hypogonadism in men 5. NEW Subsection: FEMALE SEXUAL DYSFUNCTION a. Ask about sexual health (esp  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m w/hx of depression, anxiety, UTIs) b. Screen for s/sx of genitourinary syndrome of menopause 6. NEW Updates to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m LIVER: a. Terminology changed: i. Nonalcoholic fatty liver disease (NAFLD) is now: metabolic                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dysfunction–associated steatotic liver disease (MASLD) ii. Nonalcoholic steatohepatitis (NASH) was updated to   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and metabolic dysfunction– associated steatohepatitis (MASH) • SCREENING recommendations: LFTs should be        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m monitored and if ALT elevated, assess risk and/or refer to liver specialist • RISK stratification: Use          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Fibrosis-4 Index to assess, or FIB-4 (FIB-4> 1.3), then refer to GI or hepatologist. See Figure 4.2 –           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diagnostic algorithm • NEW: MASLD Treatment Algorithm (Fig 4.3): MANAGE with weight loss, meds with evidence    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (GLP1-RA, dual GLP/GIP, Pioglitazone) • NEW: treatment with a thyroid hormone receptor beta agonist             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (resmetirom) in adults with prediabetes, type 2 and MASLD with moderate or advanced liver fibrosis. Med to be   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dosed and monitored by specialty Section 5: Facilitating Positive Health Behaviors and Well-being to Improve    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health Outcomes 1. NEW - Screen people with diabetes, caregivers, and family for diabetes distress at the same  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m critical times as screening for DSMES needs: UPDATED in 2024: DSMES should be provided to ALL persons with DM   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m at least 5 critical times: at diagnosis, annually, when not meeting targets/complication factors arise, during  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m transitions of life and care 2. Re-enforced the use of technology for Diabetes Self-Management Education and    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Support (DSMES)– mobile apps, simulation tools, digital coaching are effective methods AND recommended a focus  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m on Social Determinants of Health for design and delivery of education programs. 3. Dietary Recommendations: a.  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Emphasis on the quality of food sources (nutrient-dense, high-fiber, non-processed, healthy fats) regardless of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m carbohydrate amount eaten. b. See TABLE 5.3 – Nutrition Behaviors to ENCOURAGE c. Impact of high protein/high   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m fat mixed meals and insulin dosing adjustments noted d. Continue screening for food insecurity e. Non-nutritive \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m sweetener section expanded: conditional recommendations – still recommended over sugar-sweetened products, but  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m in moderation for SHORT TERM f. WATER is preferred over nutritive and non-nutritive sweetened beverages (DIET)  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m g. UPDATED information on religious fasting and chrono nutrition 4. NEW: FASTING guidance: -- Risk              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Stratification is recommended BEFORE religious fasting – see the NEW guidance for this that comes from Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Ramadan International Alliance a. Fig 5.1 – differences between religious and intermittent fasting b. Table \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 5.4 – Risk calculation and scoring c. Table 5.5 – Med changes during fasting 5. Weight loss: a. Goal: 3-7%      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m based on nutrition, physical activity, and behavior therapy i. up to 15%: to support possible REMISSION of DM   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m b. NEW recommendation: Counsel patients who are losing weight to include muscle-strengthening exercise in order \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to avoid sarcopenia. 6. Smoking Cessation: NEW – recommendation to AVOID cannabis due to risk of cannabis       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hyperemesis syndrome and potential DKA 7. Psychosocial Care – REVISED to recommend routine/at least annual      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m screening for diabetes distress, depression, anxiety, fear of hypoglycemia, and disordered eating behavior – in \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m PWD and caregivers a. Table 5.7 – Association of PS concerns and DM -related outcomes Section 6: Glycemic Goals \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and Hypoglycemia 1. NEW subsection: epidemiology, diagnostic criteria & outpatient prevention of DKA and HHS a. \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NEW Tables: risk factors and clinical presentation of DKA and HHS 2. NEW graphic to help clarify                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Individualization of A1C Goals: a. This helps to support when DEINTENSIFYING medications is appropriate when    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the harms of treatment (hypoglycemia) may be greater than the benefits and goals should be adjusted. (Decreased \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m life expectancy, co-morbidities) Section 7: Diabetes Technology 1. CGM should be offered for ALL PWD (at        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diagnosis) that can understand how to use it a. Higher recommendation for persons on multiple daily injections  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m or pumps, or medications that can cause hypoglycemia. b. Benefits in PWT2 and non-intensive therapy are also    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m highlighted 2. MODIFIED: a. Table 7.2 and 7.4 – ALL potential substances/medical conditions that can affect     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m glucose levels b. Includes NEW OTC CGM devices in this section c. Sections on insulin pumps and AID systems     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with clinical trial data d. Recommendation to combine technology with online or virtual coaching e. Emphasis to \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m use Pumps and AIDs in hospitalized patients that already use them Section 8: Obesity and Weight Management for  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the Prevention and Treatment of Type 2 DM 1. >90% of PWT2D are obese 2. REVISIONS include recommendations to:   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m a. Avoid therapeutic inertia and address weight stigma and bias b. Monitor anthropometric measurements at least \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m every 3 months during active weight loss 3. AFTER achieving weight loss goals: a. CONTINUE monitoring and       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m support to MAINTAIN weight loss b. CONTINUE weight loss pharmacotherapy to reduce cv risks c. Screen for        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Malnutrition d. Utilize CGM post-metabolic surgery to improve safety from hypoglycemia risks 4. UPDATED Drug    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Therapy a. TABLES updated: efficacy, adr’s, safety, costs of approved options b. Efficacy: Tirzepatide          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (Mounjaro®, Zepbound®) > Semaglutide (Ozempic®, Wegovy®) > Liraglutide (Victoza®, Saxenda®) > Dulaglutide       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (Trulicity®) > Exenatide (Bydureon®) c. 2025 New agent (not yet in guidelines) to watch: Triple Agonist:        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Retatrutide Section 9: Pharmacologic Approaches to Glycemic Treatment 1. RE-organized and EXPANDED 2. NEW       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SUB-SECTION: Special Circumstances and Populations: a. Continue to routinely assess ALL PWD for financial       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m obstacles and cost reduction b. NEW: Guidance on how to handle med shortages c. Recommendations for med choice  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m for persons of childbearing potential (use of contraception, glycemic goals, how to prepare for pregnancy) i.   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Decreased efficacy of oral contraception when using GLP1-RA or GIP drugs d. Guidance to mitigate DKA in persons \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m on SGLT-2 inhibitors and ketogenic diet: knowing risks and signs, and having tools to measure ketones e.        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Considerations for PWD secondary to chemotherapy, or with other types of DM i. Specific chemo agents can        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m increase insulin resistance: in those cases, metformin is the treatment of choice, followed by pioglitazone or  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SGLT2-i 3. NEW: INSULIN administration section expanded to include INHALED insulin and BOLUS patches 4.         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ALGORITHM updates: a. Includes healthy behaviors, education, avoidance of therapeutic inertia, and SDOH b.      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Prioritize agents to meet MULTIPLE TX GOALS: Efficacy, improve cv, kidney, liver, weight, reduce hypoglycemia   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m with consideration for COST, ACCESS, Risk of ADRs, and PWD preference c. NEW: assess the need or dose of drugs  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m that have a higher hypo risk (SFU, meglitinides, insulin), and DECREASE when adding new meds d. NEW: GLP-1RA    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m recommended for PWD and symptomatic HF with preserved EF, and obesity – irrespective of A1C (although the       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m algorithm still only has SGLT2-inhibitors on it for HF) e. AVOID using DPP4-inhibitors with GLP1-RA (lack of    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m benefit) f. ADDED: recommendations for PWD and MASLD or MASH g. Where does Metformin fit? – As an add on to any \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of the drugs used for co-morbidities, and as a starting agent for persons without any of the co-morbidities:    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ASCVD (Or high risk) Independent of A1c Heart Failure CKD eGFR 20 – 60 ml/min/1.73m2 And/or albuminuria (ACR>   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 30) On Max tolerated ACEi or ARB NEW: MASLD or MASH GLP1-RAs: Dula/Lira/Sema- -or- SGLT2-i Cana/Dapa/Empa- -Or  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m combo- SGLT2-i Cana/Dapa/ Empa/Ertu GLP1-RA (sema) if symptomatic and pEF & obesity NEW: EITHER GLP1-RA Sema >  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Lira > Dulaglutide -or- SGLT2-I: cana/dapa/empa- w/eGFR > 20 -Or combo- GLP1-RA or GIP/GLP1-RA (esp if obese)   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Pioglitazone (NOT if obese) -Or combo of GLP/pio- CKD: i. SGLT2-inhibitor is recommended to prevent CKD         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m progression, although glycemic benefit is reduced at eGFR < 45 ml/min. ii. If eGFR < 30 ml/min – GLP-1RA is     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m preferred 5. INSULIN UPDATES: a. GLP1-RA or GLP/GIP – PREFERRED to insulin when there is NO evidence of insulin \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m deficiency b. INSULIN recommended for A1C > 10% or symptomatic (polyuria/polydipsia, weight loss,               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m hypertriglyceridemia, ketosis) c. If insulin IS used, combination with GLP or GLP/GIP is recommended d. NEW –   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m guidance on switching between basal insulins: e. Usually unit:unit, although in persons on tight management or  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m high risk of hypo, cut dose 10-20% when switching. f. NEW: When assessing for over-basalization, basal dose >   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 0.5 U/kg/day has been REMOVED! Instead, assess by significant HS to AM -or- pre to post prandial differences (> \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 50 mg/dL), hypoglycemia occurrence, and high glycemic variability g. REMINDER: i. When initiating insulin,      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CONTINUE Metformin, SGLT2-I, GLP1-RA ii. STOP sulfonylureas, meglitinides and Dpp-4i --- they have NO           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m additional beneficial effects on cv/kidney/weight/liver… and increase risk of hypoglycemia and wt gain Section  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 10: Cardiovascular Disease and Risk Management Endorsed by ACC and AHA 1. TO reduce complications, include all  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 4: a. Glycemic Management b. BP Management c. Lipid Management d. Use Agents with CV and Kidney benefit         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (GLP1-RA and SGLT2-inhibitors) NEW Screening Recommendations: 2. HTN Recommendations: Diagnosis remains: a.     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Elevated BP: > 130 mmHg systolic OR > 80 mmHg diastolic -OR- a single BP > 180/110 mmHg b. BP GOAL: < 130/80    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m mmHg if can be done safely i. Initiate lifestyle interventions if BP > 120/80 mmHg ii. Start an agent if BP >   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 130/80 mmHg iii. Start 2 agents if BP > 150/90 mmHg c. CLARITY on med classes: ACE-I/ARB, Thiazide or CCB i.    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ACE-I or ARB: FIRST LINE if CAD, or UACR > 30 mg/g 1. MONITOR SCr, Potassium 2. AVOID if childbearing potential \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m without contraception: ACE-I, ARB, MRAs, neprilysin inhibitors ii. DIURETICS: monitor Scr/potassium 7-14 days   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m after initiation iii. MRA (spironolactone/eplerenone) – use for resistant HTN (if already on 3 recommended      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m classes, and secondary causes ruled out) iv. Beta-blockers – only if prior MI, active angina, or HFrEF d. In    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Pregnancy: Initiate therapy if BP > 140/90 mmHg i. Drugs considered effective and safe: methyldopa, labetalol,  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m nifedipine ER ii. BP < 90/60 mmHg – DE-intensify therapy 3. STATIN recommendations: a. NEW – avoid in           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m childbearing potential persons not using reliable contraception b. NEW – figures 10.3 and 10.4: Intolerance to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m statin therapy: 4. HYPERTRIGLYCERIDEMIA: a. NEW – Thresholds updated: i. FASTING > 150 mg/dL -or- NON-FASTING > \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 175 mg/dL ii. Fasting > 500 mg/dL: evaluate for secondary causes and consider fibrates or fish oil to reduce    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pancreatitis risk iii. If ASCVD, addition of icosapent ethyl can be considered if TG 150 – 499 mg/dL 5. HEART   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m FAILURE (HF): a. NEW – Figure 10.6 – Recommendations for prevention of symptomatic HF: b. EDUCATE on DKA s/sx,  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m management (hold the med when ill) for any persons on SGLT2i and ketogenic diets Section 11: Chronic Kidney     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease and Risk Management ALIGNS with KDIGO consensus report: https://kdigo.org/guidelines/diabetes-ckd/ •    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Categorize patients with DKD by measuring BOTH eGFR and ALBUMINURIA a. Need 2 of 3 urine albumin-to-creatinine  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ratio (UACR) collected and abnormal b. Albuminuria as a target: in pts with CKD and > 300mg/day urine albumin   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m i. GOAL: to reduce albuminuria by > 30% & to slow progression of CKD. Treatment • ACE-I or ARB: IF they have    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m albuminuria (UACR > 30 mg/g) • NO NEED for ACEI or ARB in people with NORMAL BP, normal UACR and normal eGFR •  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NEW: If on ACE-I or ARB: titrate to MAX tolerated dose • If already on MAX tolerated ACEI or ARB, ADD           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m finerenone(NSMRA) if eGFR > 25 - to improve CV outcomes and reduce progression of CKD. • NEW: if on ACE-I or    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ARB or NSMRA: Monitor SCr & Potassium TREATMENT of GLYCEMIA in a Person with CKD: • SGLT2i is recommended for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m patients with an eGFR < 60 ml/min and UACR > 200 mg/g (or any level) --- do not initiate if eGFR< 20 ml/min •   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NEW: GLP-1 RA with demonstrated benefit (semaglutide at this time) should be used REFER to NEPHROLOGY: •        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Continuous increase in urinary albumin or decrease in eGFR • eGFR < 30 ml/min Section 12: Retinopathy,          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Neuropathy, and Foot Care 1. Eyes: Initial dilated and comprehensive exam at diagnosis and again every 1 to 2   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m years if no evidence of retinopathy and glycemia is within goal range. 2. NEUROPATHY: Additional screening      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m criteria for AUTONOMIC Neuropathy recommended: a. Ask about symptoms: orthostatic dizziness, syncope, early     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m satiety, ED, changes in sweating patterns, dry cracked skin in extremities, resting tachycardia b. Assess for   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m PAD via food screening, educate and REFER for work up 3. NEUROPATHY TREATMENT to include: a. Glycemic, lipid,   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m BP and weight control b. Meds: gabapentinoids, SNRIs, TCA, sodium channel blockers c. NEW: AVOID Opioids 4.     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NEW: Foot Care – increasing role of surgery a. Annual distal symmetric polyneuropathy assessment: monofilament, \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m vibration, and vascular assessment. If ANY sensory loss, recommend feet inspection at EVERY VISIT b.            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Re-enforced: The importance of smoking cessation for PAD prevention! Section 13: Older Adults UPDATE: 4Ms       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m framework: Mentation, Medications, Mobility, and what Matters Most REMINDERS: Older adults who are otherwise    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m healthy with few coexisting chronic conditions can have adult glycemic goals of A1C < 7-7.5% and TIR ~ 70%.     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Individualize using the 4 M’s 1. Deintensification goals – reduce risk of hypoglycemia (increase A1C target to  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m < 7.5% or < 8%) a. AVOID hypo-glycemia causing medications; switch to those with lower risks b. Include agents  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to reduce cardiorenal risk, regardless of glycemia. 2. Simplification goals – decrease polypharmacy, regimen,   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m burden of disease – see Figure 13.1 for algorithm Section 14: Children and Adolescents Many small updates to    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m this section. Re-enforced the importance of treatment (due to rapid progression of complications in youth) and  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m psychosocial care: clarify diabetes distress and lower engagement in self-management behavior. Of note: • BP:   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Lifestyle modification, weight management o If needed, ACE-I or ARB, with reliable contraception if indicated • \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Lipids: Lifestyle o Age-approved statins (rosuvastatin >6 years old) with LDL goal < 100 mg/dL o WITH reliable  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m contraception if indicated • Key nutritional principles include specific examples of healthy food choices and   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m what to avoid • NEW: A1C goal < 6.5% - for most children and adolescents • NEW: Benefits and Safety of GLP-1    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m RAs reinforced • NEW: avoid vaping, avoid cannabis NEW: Treatment choices: 2. If additional medication is       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m needed: (> 10 years old) • Consider these meds before intensifying insulin: • GLP1-RAs approved for use in      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m adolescents: (in addition to metformin) o > 12 years old: Liraglutide (Victoza), exenatide (Bydureon) and       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Semaglutide (Wygovy) o > 10 years old: Dulaglutide (Trulicity) • SGLT2-inhibitor: empagliflozin (Jardiance®)    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Section 15: Management of Diabetes in Pregnancy (PG) NEW: RESTRUCTURED: the care of Pregnant women with all     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m types: T1, T2 and GDM. Instead of separate sections, they are merged NEW: Table 15.1 updates: Added Folic Acid  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 400-800 mcg/day, update on immunizations • Updates: expanded use of CGM, and considerations for AID • Glycemic  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Goals: ALL pregnant persons should monitor fasting, pre-prandial and postprandial glucose o Goals: ▪ Fasting <  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 95 mg/dL (70-95 mg/dL) ▪ 1 h Postprandial < 140 mg/dL (110 – 140 mg/dL) ▪ 2 h postprandial < 120 mg/dL (100 –   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 120 mg/dL) o CGM goals: ▪ Target Range: 63-140 mg/dL ▪ Time below range goal < 4%, (<1% below 54 mg/dL) ▪ Time  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m above range goal < 25 % o A1C is lower due to increased RBC turnover, so goal of < 6% is ideal Blood Pressure   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Targets remain: • Goal: 110-135/85 mmHg • Treat if > 140/90 mmHg • Updates to use of Aspirin therapy for        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m preeclampsia to match US Preventative Services Task Force • Further Explanation on why hyperglycemia in PG      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m should NOT be treated with metformin and glyburide as first line agents; LIFESTYLE and INSULIN are recommended. \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m If on metformin for PCOS, it should be stopped after the 1st trimester • Updated: o Harmful meds in pregnancy   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m to stop: ACE-I, ARBs, MRAs o Consider statin continuation in high-risk persons when benefit > risk Section 16:  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Care in the Hospital Treatment should start at a threshold of > 180 mg/dL • Individualize Targets: if  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m can be reached WITHOUT significant hypoglycemia • Critically ill target range of 140-180 mg/dL o Recommend      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m continuous IV insulin infusion • Noncritically ill patients: Target ranges 100 – 180 mg/dL • Preferred regimen  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m is basal, prandial, with correction insulin doses NEW: • While in hospital: continue insulin pump or AID when   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m clinically appropriate • Guidance on use of GLP agents in the perioperative setting included in the narrative   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m NEW for DKA/HHS: • Transition to subcutaneous insulin administration outlined • Fig 16.1 – new treatment        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pathways for DKA and HHS Section 17: Diabetes Advocacy Updated advocacy statement on Diabetes care in the       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m school setting and Diabetes and Driving New subsection on Diabetes Management in Detention Facilities American  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Association Professional Practice Committee. Standards of care in diabetes—2025. Diabetes Care 1       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m January                                                                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 2025;48(Supplement_1):S1-S352.\\n\\n##Source\\nhttps://www.wafp.org/assets/files/2025_ADA_Updates_All_Sections_95. \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pdf\", \"## Title\\nVolume 48 Issue Supplement_1 | Diabetes Care\\n\\n## Content\\nVolume 48 Issue Supplement_1 |     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes Care | American Diabetes Association\\n\\n===============\\n[Skip to Main                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Content](https://diabetesjournals.org/care/issue/48/Supplement_1#skipNav)\\n\\n[![Image 1: American Diabetes      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Association                                                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)_O \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m pen Menu_](javascript:;)\\n\\n[![Image 2: American Diabetes Association                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)]( \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m https://diabetesjournals.org/)[Close](javascript:;)\\n\\n*   [Professional                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Books](https://diabetesjournals.org/books)\\n*   [Clinical Compendia](https://diabetesjournals.org/compendia)\\n* \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Journals _Open Menu_](javascript:;)\\n    *   [Journals Home](https://diabetesjournals.org/journals)\\n    *     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes](https://diabetesjournals.org/diabetes)\\n    *   [Diabetes Care](https://diabetesjournals.org/care)\\n \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m *   [Clinical Diabetes](https://diabetesjournals.org/clinical)\\n    *   [Diabetes                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Spectrum](https://diabetesjournals.org/spectrum)\\n    *   [Diabetes, Obesity, and Cardiometabolic               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m CARE](https://diabetesjournals.org/docm-care)\\n    *   [BMJ Open Diabetes Research & Care Open External         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://drc.bmj.com/)\\n    *   [Journal Article                                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n\\n*   [ADA Standards of \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [ADA Meeting                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [Podcasts _Open      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Professional News Open         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m External Link](https://professional.diabetes.org/)\\n\\n[_Search Dropdown Menu_](javascript:;)\\n\\nheader          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m search\\n\\nsearch input Search input auto suggest \\n\\nfilter your search \\n\\n[Search](javascript:;)\\n\\n[Advanced \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Search](https://diabetesjournals.org/advanced-search)\\n\\n[_User Tools Dropdown_](javascript:;)\\n\\n[Sign In      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m _Open Menu_](javascript:;)\\n\\n[![Image 3: Diabetes                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://ada.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/care/care-header-97500660.svg)](https: \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m //diabetesjournals.org/care)\\n\\n[_Toggle Menu_ Menu](javascript:;)\\n*   [Articles & Issues _Open                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [Current Issue](https://diabetesjournals.org/care/issue)\\n    *   [Online Ahead   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of Print](https://diabetesjournals.org/care/online-ahead-of-print)\\n    *   [ADA Standards of                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n    *   [Issue                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Archive](https://diabetesjournals.org/care/issue-covers)\\n    *   [Featured Article                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Collections](https://diabetesjournals.org/journals/pages/diabetes_care_featured_collection)\\n    *   [All       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Article Collections](https://diabetesjournals.org/journals/collections)\\n    *   [Saved                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Searches](https://diabetesjournals.org/my-account/saved-searches)\\n\\n*   [Review                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Articles](https://diabetesjournals.org/collection/2178/Review-Articles)\\n*   [Info & About _Open                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [About the Journal](https://diabetesjournals.org/care/pages/about-the-journal)\\n  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m *   [About the Editors](https://diabetesjournals.org/care/pages/Editorial_Board)\\n    *   [ADA Journal          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n    *   [Reuse, Licensing, and     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Public Access](https://diabetesjournals.org/journals/pages/license)\\n    *   [Reprints and                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Permissions](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n    *                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Advertising](https://diabetesjournals.org/journals/pages/advertising)\\n\\n*   [Podcasts _Open                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Submit & Review _Open          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [Instructions for                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Authors](https://diabetesjournals.org/care/pages/instructions-for-authors)\\n    *   [Submit a Manuscript Open   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m External Link](http://mc.manuscriptcentral.com/diabetescare)\\n    *   [Submit Cover                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Artwork](https://diabetesjournals.org/care/pages/submit_a_cover_image)\\n    *   [Guidance for                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n\\n*   [Subscribe _Open                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Menu_](javascript:;)\\n    *   [Individual                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Subscriptions](https://diabetesjournals.org/journals/pages/individual-subscriptions)\\n    *   [Email            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Alerts](https://diabetesjournals.org/my-account/alerts)\\n    *   [Institutional                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Subscriptions](https://diabetesjournals.org/journals/pages/institutional_subscriptions)\\n    *   [Access        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Institutional Usage                                                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reports](https://diabetesjournals.org/journals/pages/access-institutional-usage-reports)\\n\\n[Skip Nav           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Destination](https://diabetesjournals.org/care/issue/48/Supplement_1#)\\n\\nIssues\\n======\\n\\nSelect Year         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\n\\nIssue \\n\\n[Volume 48, Issue Supplement_1](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m January 2025\\n\\n[![Image 4: Diabetes Care Cover Image for Volume 48, Issue                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Supplement_1](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/m_diacare \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m _48_supplement_1_cover.png?Expires=1758638061&Signature=tsRky5lPZ-16NyGxHsqrxBouoDXlxnN57vQ-9YyZNi77R3DMLbvfdNg \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 8f0sclCHxw~HNtctPdRGY1r88tBEyawz8yd4nRP5r52xOY01egzMTeeByJ0HbxJikbS4PxjvLLysBUKSQFzxTwLcazql9PGXm-~SrYClxiaQs7s \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m L5k-z0qLrz~DvbfnB0RrttRNHPuFiCcmB4I0ePC8vnr-lDtdCY6~F0ztPpQ1pea6~YLfzgVmPuzz~7nIhqFwIaGFdoOIneuUay9pZRFQ8fEdysH \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ~lVY6LaUOag95KKeu6XH4Lo9awqTqOPekqoKPVpdbAQxB1TnmLjx2EGc2FyDxiHmA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)](https:// \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n[All                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Issues](https://diabetesjournals.org/care/issue/browse-by-year)\\n\\n*   [Cover Image](javascript:;)#### Cover    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Image\\n\\n![Image 5: Issue cover                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m image](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/diacare_48_suppl \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ement_1_coverfig.png?Expires=1758638061&Signature=ZEMis5fuLT55dKIErWQfVh~10x1nVMu0GEjCW9TwKy8o501Q52EZ5t-U6Dair \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m gWqCztu4DH9clg2QY2HeGnsJNqYRl0JiKbilWaOZKYNaz~dQUde8yBzyrfRrJ9XH6CmWONAbAPTwYSq32vp3SB~jaD4R~K5t1x81tF3xS5tc6XS \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m xwTfKTPfgKfnboLsLgj9paZvd9JQxg1hxXkxqUCYNfXe1h7d06yOr0RjNFNse-OZyX5oe0hDCsx-0f7DmXsBY-GV9ZmXRSaTGyI47FwLLhNBHKm \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m qU6Qz6SHL9vUO5UJa5hVMAyXzkF2vw8n36942jc~wSLSPX5GDLHm9z5eRFg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)   \\n*   _PDF    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Icon_[_PDF Link_ Table of                                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Contents](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/toc.pdf?Expir \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m es=1758638061&Signature=0i7yam0Q8gx22R39sKdA2yGqUWJCDiEYKWn0iN-Xg0brqJy54tItri8Yv1Jcq6mcQ6CC3GR0~Av6KePk8pc7M5X \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ehiH3xp4HrnGWaF8qphJK7RPkXjt61vwDvPM2tZ6ukGeNciR0BnsgpIS6mxXmdRZoskhYwRYfggg6Lc7v4Ec99yxw5eWerTRnuCOYtFVGvaVbGy \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SNCSWPdNybYQ-wYifj33IBHK3oAxfaE0iD9cUpqG-gFWmvid6~36EuVaH3zk5jQCPATXzezxxNhmBcMJsJLDTlZgQCaCEXKJJIrs4YNNigaY8Wg \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Q38zxD4X5RAsn-~nSHS0LiCL6yFGFEvNw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\\n*   _PDF Icon_[_PDF Link_ Standards of   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care                                                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (PDF)](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/standards-of-car \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m e-2025.pdf?Expires=1758638061&Signature=mtVgD6fn5mJYnPE~FA7KpDwv-TbRBuTNGlqz6v-U78Nel6WzdhVVxvOnh0wGojU40r7HXjU \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m oQljMzrCCq-Rb1TGQrGrpyJUs84fQ-cD4869dIVYoqe4GIvxa1B8-Qb4WneiuxC3aaxcpy95yji489lJxMnk6teE1KekMHKJr3B2WKQth-fgN0x \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m x5Zzi0Q0v48cIly4mAlMyjwnWm5EcCrdyebll6QpgaClnI1duens~bQv-dDs0R6-z70xOxnSgtMEpGiZuLU0pnsx0iTPwUJLJmnqn5vxBu7DWB- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m EBOlF~uI7VdczQVYMK8FU1LgPtRIlTG6Ybh-hWP-PcVNyK1sw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\\n*   _PDF Icon_[_PDF      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Link_ Editorial                                                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Board](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/ed_board.pdf?Exp \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ires=1758638061&Signature=AzekLMO5lGilJb9sstZ5d-SsSAsav2OYfceKBJ-BMOjhAwQxdHGxLyhhVBNX4n9XdHKglff3wY~4V5kVE6miA \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m A-IiavfhLu5so-Y72TlCd-~aP6FqV~ln8Mw1fCoodRorCLXWq4R9pwHKYuyB99lPptJRnd2D0TKU5uOKz~3iusalWdprFzisbFoYQzxXrTxHcUA \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m uqn1~6SEHDoLKlSUi5JSuKWHKrYeDnin0kLTB0jaAx8SMzlGo9hkxn5ZZp2XBFBpnVER1QFShO-ybBGfwCVNVxBJ-AQ1G3-88X1-ikR31EWVdJ~ \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Z~cleQppXNJbBG8-XCFqb-Tg964DYw6O17Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\\n\\nISSN 0149-5992\\n\\nEISSN              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 1935-5548\\n\\nClose navigation menu\\n\\nIn this Issue\\n\\n*   [Introduction and                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Methodology](https://diabetesjournals.org/care/issue/48/Supplement_1#24260-157562) \\n*   [Summary of            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Revisions](https://diabetesjournals.org/care/issue/48/Supplement_1#24261-157564) \\n*   [Standards of Care in    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/issue/48/Supplement_1#24262-157553) \\n*                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Disclosures](https://diabetesjournals.org/care/issue/48/Supplement_1#24263-157567) \\n*                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Index](https://diabetesjournals.org/care/issue/48/Supplement_1#24264-157560) \\n\\nIssue Navigation\\n\\nSearch    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m within issue: \\n\\n[Search within issue](javascript:;)\\n\\n#### Introduction and Methodology\\n\\n#####             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Introduction and Methodology: Standards of Care in                                                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S1/157562/Introduction-and-Methodology \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -Standards-of-Care-in)\\n\\n[American Diabetes Association Professional Practice                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S1/157562/Introduction-and-Methodology-Standards-of-Care-in)\\n\\n[Open the PDF for in another              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S1/791585/dc25sint.pdf)\\n\\nDiabetes Care  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S1-S5. doi:(https://doi.org/10.2337/dc25-SINT)\\n\\n#### Summary of Revisions\\n\\n#####     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Summary of Revisions: Standards of Care in                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standar \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ds-of-Care-in-Diabetes)\\n\\n[American Diabetes Association Professional Practice                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S6/157564/Summary-of-Revisions-Standards-of-Care-in-Diabetes)\\n\\n[Open the PDF for in another             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S6/791587/dc25srev.pdf)\\n\\nDiabetes Care  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S6-S13. doi:(https://doi.org/10.2337/dc25-SREV)\\n\\n#### Standards of Care in             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025\\n\\n##### [1. Improving Care and Promoting Health in Populations: Standards of Care in             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S14/157553/1-Improving-Care-and-Promot \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ing-Health-in)\\n\\n[American Diabetes Association Professional Practice                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S14/157553/1-Improving-Care-and-Promoting-Health-in)\\n\\n[Open the PDF for in another                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S14/791468/dc25s001.pdf)\\n\\nDiabetes Care \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S14-S26. doi:(https://doi.org/10.2337/dc25-S001)\\n\\n##### [2. Diagnosis and              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Classification of Diabetes: Standards of Care in                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classificat \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ion-of-Diabetes)\\n\\n[American Diabetes Association Professional Practice                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S27/157566/2-Diagnosis-and-Classification-of-Diabetes)\\n\\n[Open the PDF for in another                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S27/791502/dc25s002.pdf)\\n\\nDiabetes Care \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S27-S49. doi:(https://doi.org/10.2337/dc25-S002)\\n\\n##### [3. Prevention or Delay of     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes and Associated Comorbidities: Standards of Care in                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S50/157550/3-Prevention-or-Delay-of-Di \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m abetes-and-Associated)\\n\\n[American Diabetes Association Professional Practice                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S50/157550/3-Prevention-or-Delay-of-Diabetes-and-Associated)\\n\\n[Open the PDF for in another              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S50/791483/dc25s003.pdf)\\n\\nDiabetes Care \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S50-S58. doi:(https://doi.org/10.2337/dc25-S003)\\n\\n##### [4. Comprehensive Medical      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Evaluation and Assessment of Comorbidities: Standards of Care in                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S59/157568/4-Comprehensive-Medical-Eva \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m luation-and-Assessment)\\n\\n[American Diabetes Association Professional Practice                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S59/157568/4-Comprehensive-Medical-Evaluation-and-Assessment)\\n\\n[Open the PDF for in another             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S59/791510/dc25s004.pdf)\\n\\nDiabetes Care \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S59-S85. doi:(https://doi.org/10.2337/dc25-S004)\\n\\n##### [5. Facilitating Positive      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S86/157563/5-Facilitating-Positive-Hea \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m lth-Behaviors-and-Well)\\n\\n[American Diabetes Association Professional Practice                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S86/157563/5-Facilitating-Positive-Health-Behaviors-and-Well)\\n\\n[Open the PDF for in another             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S86/791496/dc25s005.pdf)\\n\\nDiabetes Care \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m December 2024, Vol.48, S86-S127. doi:(https://doi.org/10.2337/dc25-S005)\\n\\n##### [6. Glycemic Goals and        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Hypoglycemia: Standards of Care in                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S128/157561/6-Glycemic-Goals-and-Hypog \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m lycemia-Standards-of)\\n\\n[American Diabetes Association Professional Practice                                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S128/157561/6-Glycemic-Goals-and-Hypoglycemia-Standards-of)\\n\\n[Open the PDF for in another               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S128/791506/dc25s006.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S128-S145. doi:(https://doi.org/10.2337/dc25-S006)\\n\\n##### [7. Diabetes            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Technology: Standards of Care in                                                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S146/157557/7-Diabetes-Technology-Stan \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m dards-of-Care-in)\\n\\n[American Diabetes Association Professional Practice                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S146/157557/7-Diabetes-Technology-Standards-of-Care-in)\\n\\n[Open the PDF for in another                   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S146/791474/dc25s007.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S146-S166. doi:(https://doi.org/10.2337/dc25-S007)\\n\\n##### [8. Obesity and Weight  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes–2025](https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Manag \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ement-for-the-Prevention)\\n\\n[American Diabetes Association Professional Practice                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention)\\n\\n[Open the PDF for in another           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S167/791462/dc25s008.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S167-S180. doi:(https://doi.org/10.2337/dc25-S008)\\n\\n##### [9. Pharmacologic       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Approaches to Glycemic Treatment: Standards of Care in                                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S181/157569/9-Pharmacologic-Approaches \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -to-Glycemic-Treatment)\\n\\n[American Diabetes Association Professional Practice                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S181/157569/9-Pharmacologic-Approaches-to-Glycemic-Treatment)\\n\\n[Open the PDF for in another             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S181/791515/dc25s009.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S181-S206. doi:(https://doi.org/10.2337/dc25-S009)\\n\\n##### [10. Cardiovascular     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease and Risk Management: Standards of Care in                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S207/157549/10-Cardiovascular-Disease- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and-Risk-Management)\\n\\n[American Diabetes Association Professional Practice                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S207/157549/10-Cardiovascular-Disease-and-Risk-Management)\\n\\n[Open the PDF for in another                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S207/791453/dc25s010.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S207-S238. doi:(https://doi.org/10.2337/dc25-S010)\\n\\n##### [11. Chronic Kidney     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Disease and Risk Management: Standards of Care in                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S239/157554/11-Chronic-Kidney-Disease- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and-Risk-Management)\\n\\n[American Diabetes Association Professional Practice                                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S239/157554/11-Chronic-Kidney-Disease-and-Risk-Management)\\n\\n[Open the PDF for in another                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S239/791464/dc25s011.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S239-S251. doi:(https://doi.org/10.2337/dc25-S011)\\n\\n##### [12. Retinopathy,       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Neuropathy, and Foot Care: Standards of Care in                                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S252/157552/12-Retinopathy-Neuropathy- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m and-Foot-Care-Standards)\\n\\n[American Diabetes Association Professional Practice                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S252/157552/12-Retinopathy-Neuropathy-and-Foot-Care-Standards)\\n\\n[Open the PDF for in another            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S252/791472/dc25s012.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S252-S265. doi:(https://doi.org/10.2337/dc25-S012)\\n\\n##### [13. Older Adults:      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Standards of Care in                                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S266/157556/13-Older-Adults-Standards- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of-Care-in-Diabetes-2025)\\n\\n[American Diabetes Association Professional Practice                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S266/157556/13-Older-Adults-Standards-of-Care-in-Diabetes-2025)\\n\\n[Open the PDF for in another           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S266/791479/dc25s013.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S266-S282. doi:(https://doi.org/10.2337/dc25-S013)\\n\\n##### [14. Children and       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Adolescents: Standards of Care in                                                                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S283/157559/14-Children-and-Adolescent \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m s-Standards-of-Care-in)\\n\\n[American Diabetes Association Professional Practice                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S283/157559/14-Children-and-Adolescents-Standards-of-Care-in)\\n\\n[Open the PDF for in another             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S283/791491/dc25s014.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S283-S305. doi:(https://doi.org/10.2337/dc25-S014)\\n\\n##### [15. Management of      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes in Pregnancy: Standards of Care in                                                                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S306/157565/15-Management-of-Diabetes- \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m in-Pregnancy-Standards)\\n\\n[American Diabetes Association Professional Practice                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S306/157565/15-Management-of-Diabetes-in-Pregnancy-Standards)\\n\\n[Open the PDF for in another             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S306/791470/dc25s015.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S306-S320. doi:(https://doi.org/10.2337/dc25-S015)\\n\\n##### [16. Diabetes Care in   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m the Hospital: Standards of Care in                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S321/157551/16-Diabetes-Care-in-the-Ho \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m spital-Standards-of-Care)\\n\\n[American Diabetes Association Professional Practice                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S321/157551/16-Diabetes-Care-in-the-Hospital-Standards-of-Care)\\n\\n[Open the PDF for in another           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S321/791476/dc25s016.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S321-S334. doi:(https://doi.org/10.2337/dc25-S016)\\n\\n##### [17. Diabetes Advocacy: \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Standards of Care in                                                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S335/157558/17-Diabetes-Advocacy-Stand \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ards-of-Care-in-Diabetes)\\n\\n[American Diabetes Association Professional Practice                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S335/157558/17-Diabetes-Advocacy-Standards-of-Care-in-Diabetes)\\n\\n[Open the PDF for in another           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S335/791489/dc25s017.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S335-S336. doi:(https://doi.org/10.2337/dc25-S017)\\n\\n#### Disclosures\\n\\n#####     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Disclosures: Standards of Care in                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S337/157567/Disclosures-Standards-of-C \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m are-in-Diabetes-2025)\\n\\n[View article titled,                                                                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S337/157567/Disclosures-Standards-of-Care-in-Diabetes-2025)\\n\\n[Open the PDF for in another               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S337-S343. doi:(https://doi.org/10.2337/dc25-SDIS)\\n\\n#### Index\\n\\n#####           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Index](https://diabetesjournals.org/care/article/48/Supplement_1/S344/157560/Index)\\n\\n[Extract](javascript:;) \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m \\n\\n[View article titled,                                                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ent_1/S344/157560/Index)\\n\\n[Open the PDF for in another                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S344/791494/dc25in01.pdf)\\n\\nDiabetes     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Care December 2024, Vol.48, S344-S352. doi:(https://doi.org/10.2337/dc25-in01)\\n\\n### Email alerts\\n\\n[Online   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Ahead of Print Alert](javascript:;)\\n\\n[Latest Issue Alert](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\n### \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m RSS Feeds\\n\\n[Current Issue RSS Feed](https://diabetesjournals.org/rss/site_1000003/1000004.xml)\\n\\n[RSS Feed - \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Advance Access](https://diabetesjournals.org/rss/site_1000003/advanceAccess_1000004.xml)\\n\\n*   [Most           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Read](javascript:;)\\n*   [Most Cited](javascript:;)\\n\\n[2. Diagnosis and Classification of Diabetes: Standards  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m of Care in                                                                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classificat \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ion-of-Diabetes)\\n\\n[9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S181/157569/9-Pharmacologic-Approaches \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -to-Glycemic-Treatment)\\n\\n[Hyperglycemic Crises in Adults With Diabetes: A Consensus                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Report](https://diabetesjournals.org/care/article/47/8/1257/156808/Hyperglycemic-Crises-in-Adults-With-Diabetes \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m -A)\\n\\n[Summary of Revisions: Standards of Care in                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standar \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ds-of-Care-in-Diabetes)\\n\\n[Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Glucose                                                                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Monitoring](https://diabetesjournals.org/care/article/41/11/2275/36593/Glucose-Management-Indicator-GMI-A-New-T \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m erm-for)\\n\\n*   Online ISSN 1935-5548\\n*   Print ISSN 0149-5992\\n\\n### Journals\\n\\n*                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes](https://diabetesjournals.org/diabetes)\\n*   [Diabetes Care](https://diabetesjournals.org/care)\\n*    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes, Obesity, and Cardiometabolic CARE](https://diabetesjournals.org/docm-care)\\n*   [Clinical            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://diabetesjournals.org/clinical)\\n*   [Diabetes                                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Spectrum](https://diabetesjournals.org/spectrum)\\n*   [Standards of Medical Care in                             \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Diabetes](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [Scientific Sessions                    \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [BMJ Open Diabetes   \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Research & Care](https://drc.bmj.com/)\\n\\n### Books\\n\\n*                                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [ShopDiabetes.org](https://shopdiabetes.org/collections/professional-books)\\n*   [ADA Professional              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Books](https://diabetesjournals.org/books)\\n\\n### Clinical Compendia\\n\\n*   [Clinical Compendia                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Home](https://diabetesjournals.org/compendia)\\n\\n### News\\n\\n*   [Latest                                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m News](https://www.diabetes.org/newsroom)\\n*   [DiabetesPro                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m SmartBrief](https://www2.smartbrief.com/signupSystem/subscribe.action?pageSequence=1&briefName=diabetespro)\\n\\n \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ### Podcasts\\n\\n*   [Diabetes Core                                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Update](https://diabetesjournals.org/journals/pages/diabetes-core-update-podcasts)\\n*   [Diabetes Care \\\"On     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Air\\\"](https://sites.libsyn.com/453336/site)\\n*   [DiabetesBio](https://sites.libsyn.com/499063/site)\\n*        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes Day by Day](https://sites.libsyn.com/435096/site)\\n*   [Diabetes Core Update: Special                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n\\n### Other\\n\\n*  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Special Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n*              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [DiabetesPro®](https://professional.diabetes.org/)\\n*   [Diabetes Food                                          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Hub™](https://www.diabetesfoodhub.org/)\\n*   [Insulin Affordability](https://doi.org/10.2337/dci18-0019)\\n*     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Know Diabetes By Heart™](https://www.knowdiabetesbyheart.org/)\\n\\n### About\\n\\n*   [About the                  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ADA](https://www.diabetes.org/about-us)\\n*   [Journal                                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n*   [For                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n*   [Advertising in ADA                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Journals](https://diabetesjournals.org/journals/pages/advertising)\\n*   [Reprints and Permission for            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reuse](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n*   [Copyright Notice/Public      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Access Policy](https://diabetesjournals.org/journals/pages/license)\\n*   [Privacy                               \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policy](https://diabetes.org/about-us/policies/privacy-policy)\\n\\n### Resources\\n\\n*   [ADA Professional        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Membership](https://professional.diabetes.org/membership)\\n*   [ADA Member                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Directory](http://professional.diabetes.org/directory)\\n*                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Diabetes.org](http://www.diabetes.org/)\\n\\n[![Image                                                            \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m 6](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/logo-umbrella-footer.sv \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m g?versionId=6302)](https://diabetes.org/)\\n\\n*   [X (Twitter)](https://twitter.com/ADA_Pubs)\\n*                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Facebook](https://www.facebook.com/adaPublications)\\n*                                                         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [LinkedIn](https://www.linkedin.com/company/american-diabetes-association/)\\n\\n*   [Contact                     \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Us](https://diabetesjournals.org/contact-us)\\n*   [Cookie                                                       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Policy](https://diabetesjournals.org/journals/pages/Policies)\\n*                                                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Accessibility](https://diabetesjournals.org/pages/Accessibility)\\n*   [Terms &                                 \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Conditions](https://diabetes.org/about-us/policies/terms-of-use)\\n*   [Get Adobe Acrobat                        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Reader](https://get.adobe.com/reader/)\\n*   © Copyright American Diabetes Association\\n\\n[_Close                \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Modal_](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\n##### This Feature Is Available To Subscribers          \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Only\\n\\n[Sign In](https://diabetesjournals.org/sign-in?returnUrl=%2fcare%2fissue%2f48%2fSupplement_1) or        \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m [Create an                                                                                                      \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Account](https://diabetesjournals.org/my-account/register?siteId=1000003&returnUrl=%2fcare%2fissue%2f48%2fSuppl \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m ement_1)\\n\\n[_Close Modal_](javascript:;)\\n\\n[_Close Modal_](javascript:;)\\n\\n This site uses cookies. By       \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m continuing to use our website, you are agreeing to                                                              \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (https://www.diabetesjournals.org/content/privacy-policy-american-diabetes-association-journals)\\n\\n[Accept](ja \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m vascript:;)\\n\\nclose advertisement\\n\\n\\n##Source\\nhttps://diabetesjournals.org/care/issue/48/Supplement_1\"]     \u001b[33m│\u001b[0m\n",
              "\u001b[33m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #808000; text-decoration-color: #808000\">╭──────────────────────────────────────────────── 🔧 Tool Output ─────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [\"## Title\\nChanges to the Standards of Care in Diabetes—2025 - Blog\\n\\n## Content\\nChanges to the Standards of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care in Diabetes—2025 - Blog - NIDDK\\n\\n===============\\n\\n[Skip to main                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> content](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-stand <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ards-care-diabetes2025#main)\\n\\nDue to current HHS and NIH restructuring, the information provided on           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> niddk.nih.gov is not being updated. Please refer to (https://www.nih.gov/).\\n\\n![Image 1: U.S.                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> flag](blob:http://localhost/28ac974dcc54f856173f0c3376bc989e)\\n\\nAn official website of the United States       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> government\\n\\nHere’s how you know\\n\\nHere’s how you know\\n\\n**Official websites use .gov**\\n\\n A **.gov**       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> website belongs to an official government organization in the United States.\\n\\n**Secure .gov websites use      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> HTTPS**\\n\\n A **lock** (  ) or **https://** means you’ve safely connected to the .gov website. Share sensitive  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> information only on official, secure websites.\\n\\n[![Image 2: NIH: National Institute of Diabetes and Digestive <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Kidney Diseases](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#full)![Image 3: NIH:      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> National Institute of Diabetes and Digestive and Kidney                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diseases](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#abbrev)](https://www.niddk.nih.gov/  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\\"NIDDK home page\\\")[![Image 4: 75 years:                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1950-2025](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#full75)![Image 5: 75 years:         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1950-2025](https://www.niddk.nih.gov/_ux/niddk/9.40.0/images/site-logos.svg#abbrev75)](https://www.niddk.nih.go <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> v/about-niddk/75th-anniversary \\\"NIDDK 75th Anniversary\\\")\\n\\nSearch Menu\\n\\nSearch for Information from        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NIDDK\\n\\n*   Entire Site\\n*   Research &amp; Funding\\n*   Health Information\\n*   News\\n*   About                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NIDDK\\n\\nSearch\\n\\n[Home](https://www.niddk.nih.gov/)\\n\\n-  \\n\\n[Research &amp;                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Funding](https://www.niddk.nih.gov/research-funding)Expand Research &amp; Funding \\n\\n[Current Funding              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Opportunities](https://www.niddk.nih.gov/research-funding/current-opportunities)\\n\\n[Research Programs &amp;        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Contacts](https://www.niddk.nih.gov/research-funding/research-programs)\\n\\n[Human Subjects                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Research](https://www.niddk.nih.gov/research-funding/human-subjects-research)\\n\\n[Funding                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Process](https://www.niddk.nih.gov/research-funding/process)\\n\\n[Research Training &amp; Career                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Development](https://www.niddk.nih.gov/research-funding/training-career-development)\\n\\n[Funded Grants &amp; Grant  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> History](https://www.niddk.nih.gov/research-funding/funded-grants-grant-history)\\n\\n[Research                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Resources](https://www.niddk.nih.gov/research-funding/research-resources)\\n\\n[Research at                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NIDDK](https://www.niddk.nih.gov/research-funding/at-niddk)\\n\\n[Technology Advancement &amp;                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Transfer](https://www.niddk.nih.gov/research-funding/technology-advancement-transfer)\\n\\n[Meetings &amp;            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Workshops](https://www.niddk.nih.gov/news/meetings-workshops)\\n\\n-  \\n\\n[Health                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Information](https://www.niddk.nih.gov/health-information)Expand Health Information \\n\\nHealth                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Topics\\n\\n[Diabetes](https://www.niddk.nih.gov/health-information/diabetes)\\n\\n[Digestive                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diseases](https://www.niddk.nih.gov/health-information/digestive-diseases)\\n\\n[Kidney                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease](https://www.niddk.nih.gov/health-information/kidney-disease)\\n\\n[Weight                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Management](https://www.niddk.nih.gov/health-information/weight-management)\\n\\n[Liver                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease](https://www.niddk.nih.gov/health-information/liver-disease)\\n\\n[Urologic                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diseases](https://www.niddk.nih.gov/health-information/urologic-diseases)\\n\\n[Endocrine                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diseases](https://www.niddk.nih.gov/health-information/endocrine-diseases)\\n\\n[Diet &amp;                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Nutrition](https://www.niddk.nih.gov/health-information/diet-nutrition)\\n\\n[Blood                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diseases](https://www.niddk.nih.gov/health-information/blood-diseases)\\n\\n[Diagnostic                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Tests](https://www.niddk.nih.gov/health-information/diagnostic-tests)\\n\\n[La información de la salud en         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> español](https://www.niddk.nih.gov/health-information/informacion-de-la-salud)\\n\\n[Health                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Statistics](https://www.niddk.nih.gov/health-information/health-statistics)\\n\\n[Clinical                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Trials](https://www.niddk.nih.gov/health-information/clinical-trials)\\n\\n[For Health                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Professionals](https://www.niddk.nih.gov/health-information/professionals)\\n\\n[Diabetes Discoveries &amp; Practice  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Blog](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice)\\n\\n[Community   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health &amp; Outreach](https://www.niddk.nih.gov/health-information/community-health-outreach)\\n\\n-                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\n\\n[News](https://www.niddk.nih.gov/news)Expand News \\n\\n[News                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Archive](https://www.niddk.nih.gov/news/archive)\\n\\n[Meetings &amp;                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Workshops](https://www.niddk.nih.gov/news/meetings-workshops)\\n\\n[Media                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Library](https://www.niddk.nih.gov/news/media-library)\\n\\n[Follow                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us](https://www.niddk.nih.gov/news/follow-us)\\n\\n-  \\n\\n[About                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NIDDK](https://www.niddk.nih.gov/about-niddk)Expand About NIDDK \\n\\n[Meet the                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Director](https://www.niddk.nih.gov/about-niddk/meet-director)\\n\\n[Offices &amp;                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Divisions](https://www.niddk.nih.gov/about-niddk/offices-divisions)\\n\\n[Staff                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Directory](https://www.niddk.nih.gov/about-niddk/staff-directory)\\n\\n[Budget &amp; Legislative                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Information](https://www.niddk.nih.gov/about-niddk/budget-legislative-information)\\n\\n[Advisory &amp; Coordinating  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committees](https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees)\\n\\n[Strategic Plans &amp;       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reports](https://www.niddk.nih.gov/about-niddk/strategic-plans-reports)\\n\\n[Research                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Areas](https://www.niddk.nih.gov/about-niddk/research-areas)\\n\\n[FAQs](https://www.niddk.nih.gov/about-niddk/fa <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> qs)\\n\\n[Jobs at NIDDK](https://www.niddk.nih.gov/about-niddk/jobs)\\n\\n[Visit                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us](https://www.niddk.nih.gov/about-niddk/visit-us)\\n\\n[Contact                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us](https://www.niddk.nih.gov/about-niddk/contact-us)\\n\\n[NIDDK 75th                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Anniversary](https://www.niddk.nih.gov/about-niddk/75th-anniversary)\\n\\n1.                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Home](https://www.niddk.nih.gov/)\\n2.   [Health Information](https://www.niddk.nih.gov/health-information)\\n3. <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [For Health Professionals](https://www.niddk.nih.gov/health-information/professionals)\\n4.   [Diabetes          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Discoveries &amp; Practice                                                                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Blog](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice)\\n5.   Changes   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to the Standards of Care in Diabetes—2025\\n\\n[Diabetes Discoveries &amp; Practice                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Blog](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice \\\"Return to the  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> blog home page\\\")\\n\\nChanges to the Standards of Care in                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025\\n=================================================\\n\\nMarch 26, 2025[0                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comments](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-stan <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dards-care-diabetes2025#disqus_thread)\\n\\n*   [Practice                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Transformation](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=Pr <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> actice+Transformation)\\n*   [Social Determinants of                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=Social+Det <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> erminants+of+Health)\\n\\n![Image 6: A doctor and older patient smiling and holding                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hands.](https://www.niddk.nih.gov/-/media/Images/Blog/2025-blog-post-images/DDP_MAR25_2025StandardsOfCare_Sitec <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ore_600x350.jpg)\\nLearn about the 2025 ADA Standards of Care in Diabetes, the latest clinical practice          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> standards for diagnosing and providing care to people with diabetes.\\n\\nThe American Diabetes Association’s     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (ADA) [Standards of Care in Diabetes](https://diabetesjournals.org/care/issue/48/Supplement_1) informs health   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> care professionals about the latest evidence for diagnosing and managing diabetes. The 2025 Standards of Care   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> includes updates to nearly all sections, including revised recommendations for\\n\\n*   diabetes medications\\n*   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> type 1 diabetes testing\\n*   evidence-based eating patterns\\n\\nThe updated Standards of Care also includes new  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> guidance for incorporating diabetes technology and monitoring for diabetes complications.\\n\\nBelow are some     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> notable updates in this year’s Standards of Care.\\n\\n### Choosing diabetes medications that promote heart       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> health\\n\\nThe recent guidance recommends                                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://diabetesjournals.org/care/article/48/Supplement_1/S181/157569/9-Pharmacologic-Approaches-to-Glycemic-T <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> reatment) for people who have type 2 diabetes and chronic kidney disease to lower the risk of heart disease and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> protect the kidneys from more damage. For people with type 2 diabetes, obesity, and heart failure with          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> preserved ejection fraction, consider GLP-1 receptor agonists that help manage glucose and reduce the symptoms  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of heart failure.\\n\\n### Treating adults who have type 2 diabetes or prediabetes and nonalcoholic fatty liver   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> disease (NAFLD)\\n\\nFor adults with                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://diabetesjournals.org/care/article/48/Supplement_1/S59/157568/4-Comprehensive-Medical-Evaluation-and-As <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sessment), also referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), the ADA        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommends considering a GLP-1 receptor agonist or a dual glucose-dependent insulinotropic polypeptide (GIP)    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and GLP-1 receptor agonist as part of the treatment plan. These medications may be prescribed along with        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> lifestyle changes to                                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2024/07/incorporate-w <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> eight-loss-medications-diabetes-care)and help treat nonalcoholic steatohepatitis (NASH), also referred to as    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> metabolic dysfunction-associated steatohepatitis (MASH).\\n\\nFor adults with prediabetes or type 2 diabetes and  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NAFLD with moderate or advanced liver fibrosis, health care professionals are encouraged to consider            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommending a thyroid hormone receptor-β agonist and referring them to a gastroenterologist or                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hepatologist.\\n\\n### Using antibody-based testing to assess type 1 diabetes risk\\n\\nThe ADA now recommends      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classification-of-Diabete <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> s) for people who do not have symptoms of type 1 diabetes but have a higher risk of developing the disease,     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> based on a family history of type 1 diabetes or other known risk. If the                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2024/08/new-horizons- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> testing-diabetes)is positive, health care professionals should perform a repeat antibody test within 3 months   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to confirm the results. A person’s risk of developing type 1 diabetes increases the more antibodies they        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> have.\\n\\n### Advising evidence-based healthy eating patterns\\n\\nThe latest guidance emphasizes advising people  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with diabetes or prediabetes to follow an                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://diabetesjournals.org/care/article/48/Supplement_1/S86/157563/5-Facilitating-Positive-Health-Behaviors- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and-Well). Newly added nutrition recommendations include\\n\\n*   incorporating plant-based protein and fiber as  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> part of an eating pattern that includes a wide variety of healthy foods\\n*   limiting saturated fat intake to   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> lower the risk of developing heart disease\\n*   drinking water instead of drinks with high-calorie or           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> calorie-free sweeteners\\n\\nThis year’s Standards of Care also recommends monitoring for signs of malnutrition,  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> especially in people who have had weight-loss surgery and those who take weight-loss medication.\\n\\n**For more  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> information and resources related to the Standards of Care, visit the [ADA’s Standards of Care resource         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> page](https://professional.diabetes.org/standards-of-care).**\\n\\nSubscribe\\n\\nShare this                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> page\\n\\nPrint[Facebook](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practic <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> e/changes-standards-care-diabetes2025#share-page \\\"Share this page on                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Facebook\\\")[X](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -standards-care-diabetes2025#share-page \\\"Post this page on                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> X\\\")[Email](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-st <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> andards-care-diabetes2025#share-page \\\"Email this page\\\")More                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Options[WhatsApp](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/chan <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ges-standards-care-diabetes2025#share-page \\\"Share this page via                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> WhatsApp\\\")[LinkedIn](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> changes-standards-care-diabetes2025#share-page \\\"Share this page on                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> LinkedIn\\\")[Reddit](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ch <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> anges-standards-care-diabetes2025#share-page \\\"Share this page on                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reddit\\\")[Pinterest](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/c <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hanges-standards-care-diabetes2025#share-page \\\"Share this page on Pinterest\\\")Copy Link\\n\\n[_Newer Post:_ How  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> To Treat Cardiovascular Disease in People with                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2025/04/how- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to-treat-cardiovascular-disease-people-diabetes)[_Older Post:_ How Obesity and Type 2 Diabetes Affect Heart and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Kidney                                                                                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/2025/03/how-ob <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> esity-type-2-diabetes-affect-heart-kidney-health)\\n\\nRelated Posts\\n-------------\\n\\n[![Image 7: A health care  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> professional and patient discussing                                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> medication.](https://www.niddk.nih.gov/-/media/Images/Blog/2024-Blog-Post-Images/DDP_Blog_ADA2024_StandardsofCa <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> re_Sitecore_600x350.jpg)](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-pract <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ice/ADA-2024-standards-of-care)\\n### [What’s New in the 2024 ADA Standards of                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care?](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ADA-2024-standa <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> rds-of-care)\\n\\n[![Image 8: Health care professional with                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> patient](https://www.niddk.nih.gov/-/media/Images/Blog/2022-Blog-Post-Images/ADAStandardsUpdate_DPP_Sitecore_60 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0x350.jpg)](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ada-2022-s <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tandards-of-medical-care-in-diabetes-update)\\n### [The ADA’s 2022 Standards of Medical Care in Diabetes         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Update](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ada-2022-stand <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ards-of-medical-care-in-diabetes-update)\\n\\nComments\\n========\\n\\n[Click to load                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> comments](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-stan <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dards-care-diabetes2025#disqus_thread)\\n\\n Loading comments...\\n\\nBlog Tools\\n----------\\n\\n###                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Subscribe\\n\\nSubscribe to get blog updates.\\n\\nSubmit\\n\\n### Share this                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> page\\n\\nPrint[Facebook](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practic <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> e/changes-standards-care-diabetes2025#share-page-rail \\\"Share this page on                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Facebook\\\")[X](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -standards-care-diabetes2025#share-page-rail \\\"Post this page on                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> X\\\")[Email](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/changes-st <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> andards-care-diabetes2025#share-page-rail \\\"Email this page\\\")More                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Options[WhatsApp](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/chan <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ges-standards-care-diabetes2025#share-page-rail \\\"Share this page via                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> WhatsApp\\\")[LinkedIn](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> changes-standards-care-diabetes2025#share-page-rail \\\"Share this page on                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> LinkedIn\\\")[Reddit](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/ch <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> anges-standards-care-diabetes2025#share-page-rail \\\"Share this page on                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reddit\\\")[Pinterest](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/c <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hanges-standards-care-diabetes2025#share-page-rail \\\"Share this page on Pinterest\\\")Copy Link\\n\\n###            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Search\\n\\nSearch\\n### About\\n\\n**Diabetes Discoveries and Practice Blog**\\n\\n Dialogue with thought leaders on  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> emerging trends in diabetes care \\n### Tags\\n\\n[Patient                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Communication](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=pat <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ient+communication)62\\n\\n[Research                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Advancements](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=rese <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> arch+advancements)43\\n\\n[Complications of                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=complica <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tions+of+diabetes)38\\n\\n[Medication and                                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Monitoring](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=medica <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tion+and+monitoring)31\\n\\n[Diabetes                                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Prevention](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=diabet <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> es+prevention)24\\n\\n[Obesity and Weight                                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Management](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=obesit <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> y+and+weight+management)24\\n\\n[Practice                                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Transformation](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=pr <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> actice+transformation)23\\n\\n[Patient                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Self-Management](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=p <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> atient+self-management)22\\n\\n[Type 1                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=type+1+d <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> iabetes)18\\n\\n[Diabetic Kidney                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=diabetic+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> kidney+disease)16\\n\\nMore tags\\n\\n[New                                                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Technologies](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=new+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> technologies)16\\n\\n[Social Determinants of                                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=social+det <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> erminants+of+health)16\\n\\n[Nutrition](https://www.niddk.nih.gov/health-information/professionals/diabetes-disco <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> veries-practice?tag=nutrition)15\\n\\n[Shared                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Decision-Making](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=s <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hared+decision-making)14\\n\\n[Community                                                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?tag=community+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> health)6\\n\\nFewer tags\\n\\n### Archive\\n\\n[April                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2025](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 25)1\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2025](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 25)2\\n\\n[Jan.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2025](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2025)1\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2024)1\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2024)1\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024)1\\n\\nMore months\\n\\n[Sept.                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2024)1\\n\\n[Aug.                                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 024)1\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4)1\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4)1\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2024 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )1\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 24)1\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 24)1\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2024](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2024)1\\n\\n[Dec.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2023)1\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2023)1\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023)1\\n\\n[Aug.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 023)1\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 3)1\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 3)1\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2023 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )1\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 23)1\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 23)1\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2023)1\\n\\n[Jan.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2023)2\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2022)1\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2022)2\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022)2\\n\\n[Sept.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2022)2\\n\\n[Aug.                                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 022)2\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2)1\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2)2\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2022 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )1\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 22)2\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 22)2\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2022)2\\n\\n[Jan.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2022)2\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2021)2\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2021)1\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021)2\\n\\n[Sept.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2021)2\\n\\n[Aug.                                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 021)1\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1)2\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1)3\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2021 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )1\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 21)2\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 21)2\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2021)2\\n\\n[Jan.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2021)1\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2020)2\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2020)2\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020)2\\n\\n[Sept.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2020)5\\n\\n[Aug.                                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 020)4\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0)3\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+202 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0)2\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2020 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )2\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 20)1\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 20)2\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2020)3\\n\\n[Jan.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2020)2\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2019)3\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2019)2\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019)2\\n\\n[Sept.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2019)2\\n\\n[Aug.                                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 019)3\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+201 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9)3\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+201 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9)2\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2019 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )4\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 19)2\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 19)2\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2019)1\\n\\n[Jan.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2019)2\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2018)2\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2018)4\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018)4\\n\\n[Sept.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2018)2\\n\\n[Aug.                                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=august+2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 018)5\\n\\n[July                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=july+201 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 8)3\\n\\n[June                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=june+201 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 8)4\\n\\n[May                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=may+2018 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> )5\\n\\n[April                                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=april+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 18)4\\n\\n[March                                                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=march+20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 18)3\\n\\n[Feb.                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=february <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2018)4\\n\\n[Jan.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=january+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2018)3\\n\\n[Dec.                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=december <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2017)3\\n\\n[Nov.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=november <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> +2017)3\\n\\n[Oct.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=october+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2017)2\\n\\n[Sept.                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2017](https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice?archive=septembe <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> r+2017)4\\n\\nFewer months\\n\\n### Disclaimer\\n\\nWe welcome comments; all comments must follow our                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://www.niddk.nih.gov/privacy-policy#commentpolicy).\\n\\nBlog posts written by individuals from outside the <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> government may be owned by the writer and graphics may be owned by their creator. In such cases, it is          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> necessary to contact the writer, artist, or publisher to obtain permission for reuse.\\n\\nContact                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us\\n----------\\n\\n**Hours:**8:30 a.m. to 5 p.m. ET, Monday -                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Friday\\n\\n[**Email:**healthinfo@niddk.nih.gov](mailto:healthinfo@niddk.nih.gov)[**Phone:**+1-800-860-8747](tel: <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1-800-860-8747)[**TTY:**+711](tel:711)\\n\\n@NIDDKgov\\n\\n### Chat\\n\\n Live Chat Available\\n\\n 8:30 a.m. - 5 p.m.  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ET\\n\\n Monday - Friday \\n\\n### [Follow                                                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us](https://www.niddk.nih.gov/news/follow-us)\\n\\n[LinkedIn](https://www.linkedin.com/company/national-institute <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -of-diabetes-and-digestive-and-kidney-diseases-niddk \\\"Follow NIDDK on LinkedIn\\\")[X](https://x.com/NIDDKgov    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\\"Follow NIDDK on X\\\")[Facebook](https://www.facebook.com/NIDDKgov \\\"Like NIDDK on                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Facebook\\\")[YouTube](https://www.youtube.com/user/NIDDKgov \\\"Subscribe to NIDDK on                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YouTube\\\")[Instagram](https://www.instagram.com/niddkgov \\\"Follow NIDDK on Instagram\\\")\\n\\nNIH… Turning         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Discovery Into Health ®\\n\\n*   [Privacy Policy](https://www.niddk.nih.gov/privacy-policy)\\n*   [Freedom of      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Information Act](https://www.niddk.nih.gov/freedom-information-act)\\n*                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Accessibility](https://www.niddk.nih.gov/accessibility)\\n*                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Disclaimers](https://www.niddk.nih.gov/disclaimers)\\n*   [Copyright](https://www.niddk.nih.gov/copyright)\\n*   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Vulnerability Disclosure Policy](https://www.hhs.gov/vulnerability-disclosure-policy/index.html)\\n\\n*   [Site  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Map](https://www.niddk.nih.gov/site-map)\\n*   [For Staff                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Only](https://intranet.niddk.nih.gov/SitePages/Home.aspx)\\n*   [Get Email                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Updates](https://public.govdelivery.com/accounts/USNIDDK/subscriber/new)\\n\\n*   [U.S. Department of Health and  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Human Services](https://www.hhs.gov/)\\n*   [National Institutes of                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health](https://www.nih.gov/)\\n\\n\\n##Source\\nhttps://www.niddk.nih.gov/health-information/professionals/diabete <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> s-discoveries-practice/changes-standards-care-diabetes2025\", \"## Title\\nThe American Diabetes Association       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Releases Standards of ...\\n\\n## Content\\n## Navigation\\n\\n## Navigation\\n\\n![ADA                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Logo](https://diabetes.org/sites/default/files/ADA85_logo_full_RGB_0.svg)\\n\\n## Navigation\\n\\n##                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Navigation\\n\\n!(/sites/default/files/2023-08/prediabetes-icon.svg)\\n\\nLearn your risk for type 2 and take steps <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to prevent it\\n\\n![Diabetes Prevention](/sites/default/files/2023-08/diabetes-prevention-icon.svg)\\n\\nLearn the <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ins and outs of diabetes and steps for better                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> care\\n\\n!(/sites/default/files/2024-07/ADA_Icon_Library_scale-full.svg)\\n\\nObesity care is as unique as you     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> are. Discover the different treatment and prevention                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> options.\\n\\n![Education](/sites/default/files/2023-09/Education.svg)\\n\\nLearn what you can do to keep your      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> child with diabetes safe at school\\n\\n![Gestational](/sites/default/files/2023-09/Gestational.svg)\\n\\nWhat you  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> need to know about gestational diabetes\\n\\n![Diabetes                                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Prevention](/sites/default/files/2023-08/diabetes-prevention-icon.svg)\\n\\nMake a plan to be prepared when       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> illness                                                                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> strikes\\n\\n![Calculator](/sites/default/files/2023-09/Calculator.svg)\\n![Paper](/sites/default/files/2023-09/Pa <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> per.svg)\\n\\nSign up to receive timely information on topics to help you and your family live a healthy          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> life\\n\\n![Better Choices for Life logo](/sites/default/files/2023-09/bcfl.svg)\\n\\nBringing ADA's evidence-based <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> guidelines and perspective directly to you in the store so you can make informed choices.\\n\\n![Food             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Bowl](/sites/default/files/2023-09/Food_Bowl.svg)\\n![Milk carrot                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> apple](/sites/default/files/2024-06/meal-patterns-side-nav.svg)\\n![Utensils](/sites/default/files/2023-09/Utens <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ils.svg)\\n!(/sites/default/files/2023-09/NewlyDiagnosed_checklist.svg)\\n\\nTake the 60-second test to find out   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> your                                                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> risk\\n\\n![Book](/sites/default/files/2023-09/two%20tone.svg)\\n![Location](/sites/default/files/2023-09/Location <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> .svg)\\n\\nFind help and resources in your zip code\\n\\n![Money                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hand](/sites/default/files/2023-09/Money_Hand.svg)\\n\\nChoose between a one-time donation or recurring monthly   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> gifts.\\n\\n![Handshake](/sites/default/files/2023-09/handshake.svg)\\n\\nReach out and get involved in programs    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and events near you.\\n\\n![Transportation](/sites/default/files/2023-09/Transportation.svg)\\n\\nWe make vehicle   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> donations easy so you can help fuel our fight,                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hassle-free.\\n\\n![People](/sites/default/files/2023-09/people.svg)\\n![Recipients](/sites/default/files/2023-09/ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Recipients.svg)\\n![Book](/sites/default/files/2023-09/two%20tone.svg)\\n\\n## Navigation\\n\\n## Navigation\\n\\n##   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Breadcrumb\\n\\n# The American Diabetes Association Releases Standards of Care in Diabetes—2025\\n\\n![American     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Association logo reversed out white on red                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> background](/sites/default/files/styles/large/public/2024-06/ada-a_comms_logo-full-crops-clean.jpg?itok=HH6Loyi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> L)\\n\\n*New recommendations on nutrition, weight-loss medications and technology*\\n\\nToday, the American         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Association® released the [*Standards of Care in                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025*](https://diabetesjournals.org/care/issue/48/Supplement_1) (*Standards of Care*) the gold         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> standard in evidence-based guidelines for diagnosing and managing diabetes and prediabetes. Based on the latest <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> scientific research and clinical trials, the *Standards of Care* includes strategies for diagnosing and         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> treating diabetes in both youth and adults, methods to prevent or delay type 2 diabetes and its associated      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> comorbidities like obesity, and care recommendations to enhance health outcomes.\\n\\n“The latest ADA guidelines  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> combine comprehensive, evidence-based recommendations for diabetes care with actionable guidance to enable      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> health care professionals provide the best care possible for those living with diabetes,” said Nuha El Sayed,   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MD, MMSc, the ADA’s senior vice president of health care improvement.\\n\\nNotable updates to the [*Standards of  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care in Diabetes—2025*](https://diabetesjournals.org/care/issue/48/Supplement_1) include*:*\\n\\nThe ADA annually <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> updates its *Standards of Care* through the efforts of its Professional Practice Committee (PPC). Comprising    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> global experts from diverse professional backgrounds, the PPC includes physicians, nurse practitioners,         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> certified diabetes care and education specialists, registered dietitian nutritionists, pharmacists, and         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> methodologists. Its members hold expertise in a range of related fields. The 2025 *Standards of Care* has       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> garnered endorsements from the American College of Cariology (Section 10), the American Geriatrics Society      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (Section 13), the American Society of Bone and Mineral Research (Bone Health, Section 4), and the Obesity       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Society (Section 8).\\n\\nOther noteworthy changes include:\\n\\n“Improving the lives of people affected by         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes is a key part of the ADA’s mission. The *Standards of Care* offers the trusted support needed for      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> people living with diabetes and those caring for them to manage the disease and thrive until we find a cure,”   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> said Charles “Chuck” Henderson, the ADA’s chief executive officer.\\n\\n*The* [*Standards of Care in              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025*](https://diabetesjournals.org/care/issue/48/Supplement_1) is now available online as a           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> supplement to the January 2025 issue of *Diabetes Care®.* In addition, a convenient [Standards of Care          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> app](https://professional.diabetes.org/content-page/standards-care-app-1), available for iOS and Android        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> systems, offers the latest guidelines with interactive tables and algorithms for easy reference. Additional     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> resources, including a comprehensive slide deck and a webcast offering continuing education (CE) credit, are    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> available on the ADA’s professional website [DiabetesPro](https://professional.diabetes.org/)®. A               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> quick-reference pocket chart will soon be available for purchase on ShopDiabetes.org. For primary care          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> providers, the Abridged Standards of Care, developed by the ADA’s Primary Care Advisory Group, is planned for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> release in Spring 2025 in *Clinical Diabetes®*. Through the [“living” Standards of Care                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> process](https://professional.diabetes.org/standards-of-care/living-standards-update), the online version,      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> abridged guidelines, and all related materials will be updated in real time throughout the year to reflect the  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> latest evidence and regulatory changes.\\n\\n# # #\\n\\n**About the American Diabetes Association**   \\nThe         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes and helping people thrive. For 84 years, the ADA has driven discovery and research to prevent, manage, <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> treat, and ultimately cure diabetes. There are 136 million Americans living with diabetes or prediabetes.       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> involved, visit us at (https://diabetes.org/) or call 1-800-DIABETES (800-342-2383). Join the fight with us on  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Facebook ([American Diabetes                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Association](https://www.facebook.com/AmericanDiabetesAssociation?loc=superfooter)), Spanish Facebook           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ([Asociación Americana de la Diabetes](https://www.facebook.com/AsocAmericanaDiabetes)), LinkedIn ([American    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Association](https://www.linkedin.com/company/american-diabetes-association/)), and Instagram          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ((https://www.instagram.com/AmDiabetesAssn/)). To learn more about how we are advocating for everyone affected  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> by diabetes, visit us on X ((https://x.com/AmDiabetesAssn)).\\n\\n## Contact Virginia Cramer for press-related    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> questions.\\n\\n![ADA](https://diabetes.org/sites/default/files/2024-05/JoinTheFight_PopUp_1032x578.jpg)\\n\\n###   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Give Today and Change lives!\\n\\nWith your support, the American Diabetes Association® can continue our          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> lifesaving work to make breakthroughs in research and provide people with the resources they need to fight      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes.\\n\\n![ADA Logo](/sites/default/files/ADA85_logo_full_RGB_0.svg)\\n\\n## Navigation\\n\\n2451 Crystal       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Drive, Suite 900\\n\\nArlington, VA 22202\\n\\nP.O. Box 7023\\n\\nMerrifield, VA 22116-7023\\n\\n[Center for            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Information](/about-us/center-information \\\"Center for Information\\\")\\n\\nMonday to Friday\\n\\n9:00 AM–5:30 PM    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ET\\n\\n## Navigation\\n\\n![National Health council                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> logo](/sites/default/files/styles/sponsor_logo_288_180_no_crop/public/2023-09/National-Health-Council.png.png?i <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tok=WPKlFArr)\\n![Charity navigator                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> logo](/sites/default/files/styles/sponsor_logo_288_180_no_crop/public/2023-09/charity-navigator-g.png.png?itok= <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pJ3CJ7R2)\\n![Accredited charity                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> seal](/sites/default/files/styles/sponsor_logo_288_180_no_crop/public/2023-09/accredited-charity-seal.png.png?i <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tok=v8BJGkOD)\\n\\n## Navigation\\n\\nCopyright 1995–2025. American Diabetes Association®. All rights               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> reserved.\\n\\n##Source\\nhttps://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-stan <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dards-care-diabetes-2025\", \"## Title\\nSummary of Revisions: Standards of Care in Diabetes—2025\\n\\n##            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Content\\nPublished Time: 2024-12-09\\n\\nSummary of Revisions: Standards of Care in Diabetes—2025 | Diabetes Care <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> | American Diabetes Association\\n\\n===============\\n[Skip to Main                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Content](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care-in-Diabetes#skipNav)\\n\\n[![Image 1: American Diabetes Association                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)_O <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pen Menu_](javascript:;)\\n\\n[![Image 2: American Diabetes Association                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)]( <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> https://diabetesjournals.org/)[Close](javascript:;)\\n\\n*   [Professional                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Books](https://diabetesjournals.org/books)\\n*   [Clinical Compendia](https://diabetesjournals.org/compendia)\\n* <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Journals _Open Menu_](javascript:;)\\n    *   [Journals Home](https://diabetesjournals.org/journals)\\n    *     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes](https://diabetesjournals.org/diabetes)\\n    *   [Diabetes Care](https://diabetesjournals.org/care)\\n <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> *   [Clinical Diabetes](https://diabetesjournals.org/clinical)\\n    *   [Diabetes                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Spectrum](https://diabetesjournals.org/spectrum)\\n    *   [Diabetes, Obesity, and Cardiometabolic               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CARE](https://diabetesjournals.org/docm-care)\\n    *   [BMJ Open Diabetes Research &amp; Care Open External         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://drc.bmj.com/)\\n    *   [Journal Article                                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n\\n*   [ADA Standards of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [ADA Meeting                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [Podcasts _Open      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Professional News Open         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> External Link](https://professional.diabetes.org/)\\n\\n[_Search Dropdown Menu_](javascript:;)\\n\\nheader          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> search\\n\\nsearch input Search input auto suggest \\n\\nfilter your search \\n\\n[Search](javascript:;)\\n\\n[Advanced <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Search](https://diabetesjournals.org/advanced-search)\\n\\n[_User Tools Dropdown_](javascript:;)\\n\\n[Sign In      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> _Open Menu_](javascript:;)\\n\\n[![Image 3: Diabetes                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://ada.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/care/care-header-97500660.svg)](https: <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> //diabetesjournals.org/care)\\n\\n[_Toggle Menu_ Menu](javascript:;)\\n*   [Articles &amp; Issues _Open                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [Current Issue](https://diabetesjournals.org/care/issue)\\n    *   [Online Ahead   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of Print](https://diabetesjournals.org/care/online-ahead-of-print)\\n    *   [ADA Standards of                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n    *   [Issue                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Archive](https://diabetesjournals.org/care/issue-covers)\\n    *   [Featured Article                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Collections](https://diabetesjournals.org/journals/pages/diabetes_care_featured_collection)\\n    *   [All       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Article Collections](https://diabetesjournals.org/journals/collections)\\n    *   [Saved                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Searches](https://diabetesjournals.org/my-account/saved-searches)\\n\\n*   [Review                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Articles](https://diabetesjournals.org/collection/2178/Review-Articles)\\n*   [Info &amp; About _Open                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [About the Journal](https://diabetesjournals.org/care/pages/about-the-journal)\\n  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> *   [About the Editors](https://diabetesjournals.org/care/pages/Editorial_Board)\\n    *   [ADA Journal          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n    *   [Reuse, Licensing, and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Public Access](https://diabetesjournals.org/journals/pages/license)\\n    *   [Reprints and                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Permissions](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n    *                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Advertising](https://diabetesjournals.org/journals/pages/advertising)\\n\\n*   [Podcasts _Open                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Submit &amp; Review _Open          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [Instructions for                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Authors](https://diabetesjournals.org/care/pages/instructions-for-authors)\\n    *   [Submit a Manuscript Open   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> External Link](http://mc.manuscriptcentral.com/diabetescare)\\n    *   [Submit Cover                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Artwork](https://diabetesjournals.org/care/pages/submit_a_cover_image)\\n    *   [Guidance for                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n\\n*   [Subscribe _Open                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [Individual                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Subscriptions](https://diabetesjournals.org/journals/pages/individual-subscriptions)\\n    *   [Email            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Alerts](https://diabetesjournals.org/my-account/alerts)\\n    *   [Institutional                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Subscriptions](https://diabetesjournals.org/journals/pages/institutional_subscriptions)\\n    *   [Access        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Institutional Usage                                                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reports](https://diabetesjournals.org/journals/pages/access-institutional-usage-reports)\\n\\n[Skip Nav           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Destination](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -of-Care-in-Diabetes#)\\n\\nClose navigation menu\\n\\nArticle navigation\\n\\n[Volume 48, Issue                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Supplement_1](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n January 2025 \\n\\n[![Image 4:         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Care Cover Image for Volume 48, Issue                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Supplement_1](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/m_diacare <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> _48_supplement_1_cover.png?Expires=1758638706&amp;Signature=vKbCybARdhtGdCVjM18Sbhsog2~CmKfNxjMZW-3pME9xgZbZoRbC-T4 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MpZ1GH6S~KQQBNjQkJzyJ8YHjRubU2IP~AhPcqjfyH~lHsB-REmAAIxTr7DDw0lYkPw958opECfe0h8mtp3F0Sm7a7-aDSAjy67l5d0s~QAzYY3 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 6eJ9Q-mgm9y2SbxMQ0whcwL3SWTHAcTG7UxLuauK0dJZpmkb5hOhwdUmpWDwMGtDzhx1opZvE8Kb6Yn1mi-1Owjjrf3KlF59jMCCquYqhPgRiM6 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> nz5~XuLB3AYlNJM0LOVY8hS-3QC-7QVAdrkYMl5lVkfaGW-CI7-Z0lpn-y5MxElSA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)](https:// <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n*   [Previous                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Article](https://diabetesjournals.org/care/article/48/Supplement_1/S1/157562/Introduction-and-Methodology-Stand <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ards-of-Care-in)\\n*   [Next                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Article](https://diabetesjournals.org/care/article/48/Supplement_1/S14/157553/1-Improving-Care-and-Promoting-He <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> alth-in)\\n\\nArticle Contents\\n\\n*   [General                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Changes](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care-in-Diabetes#5310725) \\n*   [Section                                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Changes](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care-in-Diabetes#5310729) \\n\\nArticle Navigation\\n\\nSummary of Revisions|December 09 2024\\n\\nSummary of         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Revisions: Standards of Care in Diabetes—2025                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> _Free_\\n===============================================================\\n\\n[American Diabetes Association       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Professional Practice Committee](javascript:;)\\n\\n American Diabetes Association Professional Practice          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee \\n\\n Search for other works by this author on: \\n\\n[This                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Site](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professional+ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Practice+Committee+)\\n\\n[PubMed](http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=American%20Diabetes%20Assoc <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> iation%20Professional%20Practice%20Committee)\\n\\n[Google                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Scholar](http://scholar.google.com/scholar?q=author:%22%20%22)\\n\\n[![Image 5: Crossmark: Check for              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Updates](https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg)](javascript:;)\\n\\ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> n_Diabetes Care_                                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2025;48(Supplement_1):S6–S13\\n\\n(https://doi.org/10.2337/dc25-SREV)\\n\\nPubMed:\\n\\n[39651984](https://pubmed.ncb <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> i.nlm.nih.gov/39651984)\\n\\n*                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Split-Screen](https://diabetesjournals.org/care/article-split/48/Supplement_1/S6/157564/Summary-of-Revisions-S <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tandards-of-Care-in-Diabetes)\\n*   [_Views Icon_ Views _Open Menu_](javascript:;)\\n    *   [Article             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> contents](javascript:;)\\n\\n*   [Open the PDF for in another                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S6/791587/dc25srev.pdf)\\n*   [_Share      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Icon_ Share](javascript:;)\\n    *   [Facebook](javascript:;)\\n    *   [X](javascript:;)\\n    *                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [LinkedIn](javascript:;)\\n    *   [Email](javascript:;)\\n\\n*   [_Cite Icon_ Cite](javascript:;) \\n*   [Get      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Permissions](http://s100.copyright.com/AppDispatchServlet?publisherName=Wiley&amp;publication=0149-5992&amp;title=Summa <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ry%20of%20Revisions%3A%20Standards%20of%20Care%20in%20Diabetes%E2%80%942025&amp;publicationDate=2024-12-09&amp;volumeNu <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> m=48&amp;issueNum=Supplement_1&amp;author=American%20Diabetes%20Association%20Professional%20Practice%20Committee%3B%20 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ElSayed%2C%20Nuha%20A.&amp;startPage=S6&amp;endPage=S13&amp;contentId=10.2337%2Fdc25-SREV&amp;oa=&amp;orderBeanReset=True)          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\n\\nCitation\\n\\nAmerican Diabetes Association Professional Practice Committee; Summary of Revisions: Standards  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of Care in Diabetes—2025. _\\\\_Diabetes Care\\\\__ 1 January 2025; 48 (Supplement_1): S6–S13.                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://doi.org/10.2337/dc25-SREV)\\n\\nDownload citation file:\\n\\n*   [Ris                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (Zotero)](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=0)\\n*  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Reference                                                                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Manager](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=0)\\n*   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [EasyBib](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=0)\\n*  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Bookends](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=0)\\n* <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Mendeley](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=0)\\n* <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Papers](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=0)\\n*   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [EndNote](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=1)\\n*  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [RefWorks](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=3)\\n* <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [BibTex](https://diabetesjournals.org/Citation/Download?resourceId=157564&amp;resourceType=3&amp;citationFormat=2)\\n\\nt <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> oolbar search\\n\\n[_Search Dropdown Menu_](javascript:;)\\n\\ntoolbar search\\n\\nsearch input Search input auto     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> suggest \\n\\nfilter your search \\n\\n[Search](javascript:;)\\n\\n[Advanced                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Search](https://diabetesjournals.org/advanced-search)\\n\\nGeneral Changes\\n---------------\\n\\nThe field of       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes care is rapidly changing as new research, technology, and treatments that can improve the health and   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> well-being of people with diabetes continue to emerge. With annual updates since 1989, the American Diabetes    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Association has long been a leader in producing guidelines that capture the most current state of the           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> field.\\n\\nThe 2025 “Standards of Care in Diabetes” has continued to incorporate person-first and inclusive      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> language. Efforts were made to consistently apply terminology that empowers people with diabetes and recognizes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the individual at the center of diabetes care.\\n\\nAlthough levels of evidence for several recommendations have  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> been updated, these changes are not outlined below where the clinical recommendation has remained the same.     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> That is, changes in evidence level from, for example, **E** to **C**, are not noted below. The 2025 Standards   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of Care contains, in addition to many minor changes that clarify recommendations or reflect new evidence, more  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> substantive revisions detailed below.\\n\\nSection Changes\\n---------------\\n\\n### Endorsements\\n\\nFor the second <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> consecutive year, the “Bone Heath” subsection in Section 4, “Comprehensive Medical Evaluation and Assessment of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comorbidities,” received endorsement from the American Society for Bone and Mineral Research and Section 8,     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> “Obesity and Weight Management for the Prevention of Type 2 Diabetes,” received endorsement from The Obesity    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Society. For the seventh consecutive year, Section 10, “Cardiovascular Disease and Risk Management,” received   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> endorsement from the American College of Cardiology. For the first time, Section 13, “Older Adults,” received   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> endorsement from the American Geriatrics Society.\\n\\n### Section 1. Improving Care and Promoting Health in      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Populations\\n\\n((https://doi.org/10.2337/dc25-S001))\\n\\nRecommendation 1.1 was expanded to include people at    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> risk for diabetes in addition to those with diabetes.\\n\\nRecommendation 1.2 was revised to include, in addition <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to the Chronic Care Model, other evidence-based care delivery models and frameworks that have been demonstrated <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to improve diabetes care delivery and health outcomes. These include the Patient-Centered Medical Home model,   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Accountable Care Organizations, and value-based payment models and are discussed in the text.\\n\\nRecommendation <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1.5 was added to emphasize the importance of quality improvement initiatives and interprofessional teams for    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> supporting sustainable and scalable process changes that improve quality of care and health outcomes.           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Implementation concepts were added throughout the section to provide actionable guidance on how to implement    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and sustain interventions that improve care delivery and population health.\\n\\nRecommendation 1.6 was added to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> emphasize the importance of assessing and addressing disparities in diabetes care and health outcomes. The text <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> includes actionable guidance on measuring health disparities and engaging interprofessional teams and community <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> partners to address them.\\n\\nRecommendation 1.7 was revised to emphasize the importance of screening for and    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> addressing multiple social determinants of health that impact diabetes management, health outcomes, and quality <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of life.\\n\\nThe narrative text now includes an expanded discussion of cost and affordability considerations as  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> well as health disparities and social determinants of health.\\n\\n[**Table                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1.1**](https://doi.org/10.2337/dc25-S001) was added to highlight the importance of engaging an                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> interprofessional team approach to person-centered care for people with diabetes across the life span.\\n\\n###   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Section 2. Diagnosis and Classification of Diabetes\\n\\n((https://doi.org/10.2337/dc25-S002))\\n\\n[**Table        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2.3**](https://doi.org/10.2337/dc25-S002) was added to provide considerations related to the use and            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> interpretation of laboratory measurement of glucose and A1C.\\n\\nThe “Classification” subsection has been        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> updated to provide a pragmatic approach to management of individuals who have features of both type 1 and type  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2 diabetes.\\n\\nIn the “Type 1 Diabetes” subsection, Recommendation 2.7 was added to emphasize the importance of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> antibody-based screening for presymptomatic type 1 diabetes in individuals with a family history of type 1      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes or otherwise known elevated genetic risk. The associated text was also updated and expanded to reflect <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> these changes.\\n\\nThe “Gestational Diabetes Mellitus” subsection was completely updated to facilitate           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> understanding and implementation of the current various approaches to screening for and diagnosis of            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> gestational diabetes mellitus (GDM).\\n\\nThe text in various other subsections, including those that discuss     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes and immune checkpoint inhibitors, the role of the gut microbiome in diabetes risk, and monogenic       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes, was updated.\\n\\n### Section 3. Prevention or Delay of Diabetes and Associated                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comorbidities\\n\\n((https://doi.org/10.2337/dc25-S003))\\n\\nIn the “Lifestyle Behavior Change for Type 2 Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Prevention” subsection, text pertaining to sleep health in relation to risk of type 2 diabetes was added. This  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> addition highlights sleep as a central component in the management of prediabetes and type 2 diabetes, placing  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> it on a level playing field with other lifestyle behaviors (e.g., physical activity and eating patterns).\\n\\nIn <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the “Pharmacologic Interventions to Delay Type 2 Diabetes” subsection, the text on the proposed use of vitamin  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> D therapy to prevent type 2 diabetes was extensively updated. The text related to long-term metformin therapy   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and associated vitamin B12 deficiency was also updated.\\n\\nThe language in Recommendation 3.15 was strengthened <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to facilitate discussion with selected individuals aged ≥8 years with stage 2 type 1 diabetes about the role of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> teplizumab-mzwv infusion to delay the onset of symptomatic type 1 diabetes (stage 3).\\n\\n### Section 4.         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comprehensive Medical Evaluation and Assessment of                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comorbidities\\n\\n((https://doi.org/10.2337/dc25-S004))\\n\\nLanguage in [**Fig.                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4.1**](https://doi.org/10.2337/dc25-S004) was updated, and [**Table 4.1**](https://doi.org/10.2337/dc25-S004)   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was modified to include changes made throughout Section 4.\\n\\nRecommendation 4.3 was changed to include         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> assessment for glycemic status and previous treatment at the initial visit and follow-up visits as              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> appropriate.\\n\\n[**Table 4.2**](https://doi.org/10.2337/dc25-S004) was amended to include essential components  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for assessment, planning, and referral as appropriate.\\n\\nChanges were made in the “Immunizations” subsection   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to reflect updates for COVID-19, pneumococcal pneumonia, influenza, and respiratory syncytial virus. [**Table   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4.3**](https://doi.org/10.2337/dc25-S004) was revised to include important vaccination                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> updates.\\n\\nRecommendation 4.6 was modified to specify initial and repeat screening for autoimmune thyroid      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> disease.\\n\\nRecommendation 4.10 was updated to specify avoiding medications with known association with higher  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> fracture risk.\\n\\nRecommendation 4.12 was revised to include the recommended intake of calcium for people with  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes.\\n\\nRecommendation 4.13 was updated to specify when antiresorptive medications and osteoanabolic       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> agents should be considered.\\n\\n[**Table 4.4**](https://doi.org/10.2337/dc25-S004) was updated to specify when  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> bone mineral density testing should be performed.\\n\\nA new subsection, “Dental Care,” was added and includes    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> two new recommendations. Recommendation 4.15 was added to state people with diabetes should be referred for a   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dental exam at least once per year. Recommendation 4.16 was added to state that efforts between medical and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dental teams should be coordinated so that glucose-lowering medications can be appropriately adjusted prior to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and in the post–dental procedure period as needed.\\n\\nRecommendation 4.17 was updated to reflect that an        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> assessment for disability should be performed at the initial visit and an assessment for decline in function    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> should be performed at each subsequent visit.\\n\\nRecommendation 4.18 was modified to include inquiring about    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sexual health in men and to screen with a morning serum total testosterone if symptoms and/or signs of          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypogonadism are present.\\n\\nRecommendation 4.19 was added to specifically state that men with diabetes or      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> prediabetes should be screened for erectile dysfunction, and new text was added on erectile dysfunction.\\n\\nA   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> new subsection, “Female Sexual Dysfunction,” was added and includes two new recommendations. Recommendation     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4.20 states that health care professionals should inquire about sexual health, particularly in women who        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> experience depression and/or anxiety and those with recurrent urinary tract infections. Recommendation 4.21 was <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> added to state that health care professionals should screen for symptoms and/or signs of genitourinary syndrome <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of menopause.\\n\\nThe terminology for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (NASH) was updated to metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dysfunction–associated steatohepatitis (MASH), respectively. This updated nomenclature was incorporated         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> throughout the section.\\n\\nRecommendation 4.22a was revised to specify when to screen for the risk of having or <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> developing cirrhosis related to MASH using the calculated fibrosis-4 index (FIB-4).\\n\\nRecommendation 4.23 was  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> amended to state that adults with type 2 diabetes or prediabetes and a FIB-4 &gt;1.3 should have additional risk   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> stratification performed.\\n\\nRecommendation 4.24 was revised to state that individuals with a higher risk for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> significant liver fibrosis should be referred to a gastroenterologist or hepatologist.\\n\\nRecommendation 4.25   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was revised to include an interprofessional team approach when promoting weight loss, particularly with a       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> structured nutrition plan and physical activity program for cardiometabolic benefits and histological           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> improvement.\\n\\nRecommendation 4.26 was revised to include a dual glucose-dependent insulinotropic polypeptide  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (GIP) and glucagon like peptide 1 (GLP-1) receptor agonist (RA) with potential benefits in MASH as an           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> adjunctive therapy to lifestyle interventions for weight loss in adults with type 2 diabetes, MASLD, and        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> overweight or obesity.\\n\\nRecommendation 4.27a was revised to state that in adults with type 2 diabetes and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> biopsy-proven MASH or those at high risk for liver fibrosis, use of pioglitazone or a GLP-1 RA or a dual GIP    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and GLP-1 RA is preferred for glycemic management due to potential beneficial effects on                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MASH.\\n\\nRecommendation 4.27b was added to state that combination therapy with pioglitazone and a GLP-1 RA can  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> be considered for treatment of hyperglycemia in adults with type 2 diabetes with biopsy-proven MASH or those at <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> high risk of liver fibrosis because of potential beneficial effects of such a combination on                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MASH.\\n\\nRecommendation 4.28 was added to state that treatment with a thyroid hormone receptor-β agonist in     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> adults with type 2 diabetes or prediabetes with MASLD with moderate (F2) or advanced (F3) liver fibrosis may be <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> considered and that the individual should be referred to a gastroenterologist or hepatologist with expertise in <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MASLD management for the initiation and monitoring of this therapy.\\n\\nRecommendation 4.29 was added to         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> emphasize that treatment initiation and monitoring should be individualized and within the context of an        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> interprofessional team for MASLD and MASH management.\\n\\n[**Figure 4.2**](https://doi.org/10.2337/dc25-S004)    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was revised to reflect important updates to the diagnostic algorithm for risk stratification and the prevention <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of cirrhosis in individuals MASLD, and new [**Fig. 4.3**](https://doi.org/10.2337/dc25-S004) includes the MASLD <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> treatment algorithm.\\n\\n### Section 5. Facilitating Positive Health Behaviors and Well-being to Improve Health  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Outcomes\\n\\n((https://doi.org/10.2337/dc25-S005))\\n\\nIn the “Diabetes Self-Management Education and Support”    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> subsection, Recommendation 5.1 was updated to emphasize that all people with diabetes should be advised to      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> participate in diabetes self-management education and support (DSMES) rather than being just encouraged to      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> participate.\\n\\nRecommendation 5.2 was updated to clarify when to provide DSMES.\\n\\nRecommendation 5.3 was      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> revised to be more succinct and action-oriented, placing emphasis on routine assessment of key goals of         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> DSMES.\\n\\nRecommendation 5.4 was added to emphasize the importance of screening for behavioral health concerns  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> at the same time points as evaluating the need for DSMES.\\n\\nLanguage in Recommendation 5.5 was updated to      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> state that DSMES should be culturally appropriate and responsive to individual preferences, needs, and          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> values.\\n\\nRecommendation 5.6 was updated to reflect the now-common practice of remote-delivery of DSMES and    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> reimbursement for remotely delivered modalities.\\n\\nRecommendation 5.9 was updated to reinforce the importance  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of screening for and including social determinants of health in guiding the design and delivery of DSMES.\\n\\nIn <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the “Medical Nutrition Therapy” subsection, Recommendation 5.12 was updated to emphasize the importance of      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> providing treatment based on nutrition, physical activity, and behavioral therapy for individuals with          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> overweight or obesity, aiming for at least 3–7% weight loss.\\n\\nRecommendation 5.14 on eating patterns now has  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> revised verbiage to include processed foods, lean proteins, and nondairy alternatives.\\n\\nRecommendation 5.16   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was updated to include actionable language and clarity regarding the use of dietary supplements for glycemic    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> benefits.\\n\\nRecommendations 5.17 and 5.18 were updated to have revised and actionable language,                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> respectively.\\n\\nRecommendation 5.19 was updated to use actionable language.\\n\\nRecommendation 5.20 was revised <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to recommend limiting sodium as clinically appropriate, which can be done, in part, by limiting consumption of  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> processed foods.\\n\\nRecommendation 5.21 was modified to recommend water over nutritive and nonnutritive         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sweetened beverages, and Recommendation 5.22 was added to state that nonnutritive sweeteners can be used        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> instead of sugar-sweetened products in moderation and for short term to reduce overall calorie and carbohydrate <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> intake.\\n\\nRecommendation 5.23 was added to emphasize the screening for malnutrition, especially for those who  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> have undergone metabolic surgery and for those being treated with weight management pharmacological             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> therapies.\\n\\nRecommendation 5.25 was revised to use actionable language.\\n\\nRecommendation 5.26 was added to   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> address the issue of sodium–glucose cotransporter (SGLT) inhibition being associated with ketoacidosis under    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> certain conditions. It provides guidance on awareness, prevention, risk mitigation, and dietary                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> adjustments.\\n\\nRecommendation 5.29 was added to encourage intake of plant-based proteins and fiber, and        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Recommendation 5.31 was added to encourage limiting foods high in saturated fats to reduce cardiovascular       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> disease risk.\\n\\nTwo new recommendations were added for religious fasting. Recommendation 5.32 states to use    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the Diabetes and Ramadan International Alliance comprehensive prefasting risk assessment for risk               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> stratification of people with diabetes prior to engaging in religious fasting. Recommendation 5.33 was created  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to provide guidance to health care professionals caring for people with diabetes who participate in religious   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> fasting.\\n\\nAdditionally, newly added [**Fig. 5.1**](https://doi.org/10.2337/dc25-S005) illustrates differences <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and similarities between religious and intermittent fasting for people with diabetes. [**Table                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 5.4**](https://doi.org/10.2337/dc25-S005) includes a risk calculation and suggested risk score for people with  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes who seek to fast during Ramadan, and [**Table 5.5**](https://doi.org/10.2337/dc25-S005) includes       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> information about medication changes during fasting.\\n\\nIn the “Physical Activity” subsection, Recommendation   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 5.34 was updated to include a statement about limiting the amount of time spent sedentary, which includes       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recreational screen time.\\n\\nRecommendation 5.38 was modified to state that prolonged sitting should be         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> interrupted at least every 30 min for glycemic benefits.\\n\\nRecommendation 5.39 was added to counsel adults and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> youth receiving weight management pharmacotherapy or metabolic surgery to meet physical activity                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommendations. The accompanying text addresses the concern of sarcopenic obesity with use of incretin         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> therapies and metabolic surgery.\\n\\nIn the “Smoking Cessation: Tobacco, E-cigarettes, and Cannabis” subsection, <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Recommendation 5.42 was added to advise people with type 1 diabetes and those with other forms of diabetes at   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> risk for diabetic ketoacidosis (DKA) to not use recreational cannabis in any form due to the risk of cannabis   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hyperemesis syndrome. The accompanying text describes cannabis hyperemesis syndrome and its diagnostic          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> criteria.\\n\\nRecommendation 5.43 in “Supporting Positive Health Behaviors” was updated to include               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> health-related quality of life as an outcome when using behavioral health strategies to support self-management <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and healthy behaviors.\\n\\nRecommendation 5.45 in “Psychosocial Care” was revised to state the specific          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> psychosocial concerns health care professionals should screen for including diabetes distress, depression,      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> anxiety, fear of hypoglycemia, and disordered eating behaviors.\\n\\nRecommendation 5.48 in “Diabetes Distress”   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was updated to recommend the frequency of at least annual screening for diabetes distress in people with        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes, caregivers, and family members.\\n\\nRecommendation 5.49 in “Anxiety” was updated to recommend          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> screening for anxiety, which is in accordance with the U.S. Preventive Services Task Force recommendation for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> screening for anxiety.\\n\\nRecommendation 5.50 in “Anxiety” was added to include a recommendation for screening  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for fear of hypoglycemia in people with diabetes at risk for hypoglycemia or fear of                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypoglycemia.\\n\\nRecommendation 5.51 in “Depression” was modified to have more actionable language for the      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> importance of depression rescreening.\\n\\nRecommendation 5.54 in “Disordered Eating Behavior” was updated to     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommend screening for disordered or disrupted eating using validated screening measures. The accompanying     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> text describes the disordered or disrupted eating behaviors commonly reported in people with                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes.\\n\\n[**Tables 5.7**](https://doi.org/10.2337/dc25-S005) and                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [**5.8**](https://doi.org/10.2337/dc25-S005) were added to illustrate psychosocial concerns and their           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> association with diabetes-related outcomes in adults with type 1 and type 2 diabetes, respectively.\\n\\n###      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Section 6. Glycemic Goals and Hypoglycemia\\n\\n((https://doi.org/10.2337/dc25-S006))\\n\\nRecommendation 6.12 was  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> added to promote routine screening for fear of hypoglycemia in individuals at risk for hypoglycemia.\\n\\nA new   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> subsection entitled “Hyperglycemic Crises: Diagnosis, Management, and Prevention” was added to cover the        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> epidemiology, diagnostic criteria, and outpatient prevention of DKA and the hyperglycemic hyperosmolar state    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (HHS).\\n\\nNew recommendations on routine assessment of history of DKA and HHS (recommendation 6.20) and         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> providing structured prevention education (Recommendation 6.21) in the outpatient setting were                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> added.\\n\\n[**Tables 6.9**](https://doi.org/10.2337/dc25-S006) and [**6.10**](https://doi.org/10.2337/dc25-S006) <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> were added and include risk factors for hyperglycemic crises as well as clinical presentation of DKA and HHS in <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> people with diabetes, respectively.\\n\\n[**Figure 6.2**](https://doi.org/10.2337/dc25-S006) was revised to       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> provide a specific and actionable approach to selecting individual glycemic goals, accounting for health status <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and other person- and treatment-specific factors favoring more or less stringent goals.\\n\\n### Section 7.       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Technology\\n\\n((https://doi.org/10.2337/dc25-S007))\\n\\nRecommendation 7.8 was modified to emphasize    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> consideration for starting diabetes technology early, even at diagnosis.\\n\\nRecommendation 7.9 was added to     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> emphasize that reports for all continuous glucose monitoring (CGM) devices, connected insulin devices, and      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> continuous subcutaneous insulin infusion and automated insulin delivery (AID) systems should be standardized    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with at a minimum the ambulatory glucose profile and weekly summary. In addition, there should be options for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> raw data or daily and weekly reports available to the health care professionals.\\n\\nRecommendation 7.14 was     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> modified to make the clinician aware of potential interference of medications and other substances on glucose   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> levels measured by blood glucose meters.\\n\\n[**Table 7.2**](https://doi.org/10.2337/dc25-S007) was modified to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> include the various potential substances or medical conditions that may affect glucose levels when measured by  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> blood glucose meters.\\n\\n[**Table 7.3**](https://doi.org/10.2337/dc25-S007) was modified to include the         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> description of over-the-counter CGM devices.\\n\\nRecommendation 7.15 was modified to support the use of          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> real-time CGM (rtCGM) and intermittently scanned CGM (isCGM) for youth and adults with diabetes (type 1 or type <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2) on any type of insulin therapy based on the most recent literature.\\n\\nRecommendation 7.16 was added to      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> consider the use of rtCGM or isCGM in adults with type 2 diabetes on glucose-lowering agents other than insulin <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to achieve and maintain individualized glycemic goals.\\n\\nRecommendation 7.18 was modified to align with        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Section 15, “Management of Diabetes in Pregnancy,” and reflect the update of CGM benefits in type 1 diabetes    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and pregnancy and other types of diabetes in pregnancy.\\n\\nThe text on CGM was expanded to include the updated  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sensors integrated with AID systems and to update the most recent literature evidence supporting the benefits   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of CGM in individuals with type 2 diabetes on glucose-lowering agents other than insulin from clinical trials   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and real-world studies. Furthermore, the CGM section was expanded to include the need to standardize any        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes technology device reports and to provide clinicians not only with single page summaries but also with  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> access to detailed reports and even raw data from devices, especially those reporting insulin dose              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> modifications, such as AID systems.\\n\\nThe text on insulin pumps and AID systems was greatly expanded to        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> discuss the features of the various AID systems and their data from pivotal trials and real-world studies in    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> type 1 and type 2 diabetes.\\n\\nRecommendation 7.29 was modified to include provision of support and diabetes    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> management advice in people with diabetes using open-source closed-loop systems.\\n\\nThe text for open-source    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> closed-loop systems was also expanded to include the most recent published evidence on the safety and           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> effectiveness of these systems in people with type 1 diabetes.\\n\\nRecommendation 7.30 was expanded to include   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the benefits of combining technology with online or virtual coaching to improve glycemic outcomes in            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> individuals with diabetes and prediabetes.\\n\\nRecommendation 7.32 was refined to emphasize the importance of    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> continuing the use of insulin pumps or AID in people with diabetes while hospitalized when clinically           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> appropriate and with confirmatory point-of-care blood glucose measurements for insulin dose adjustments and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypoglycemia assessment and treatment. The use of these devices in the inpatient setting should be contingent   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> on the availability of infrastructure support and institutional diabetes technology protocols.\\n\\n### Section   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 8. Obesity and Weight Management for the Prevention and Treatment of Type 2                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes\\n\\n((https://doi.org/10.2337/dc25-S008))\\n\\nRecommendation 8.2a was updated to clarify that additional <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> measurements of body fat distribution are warranted if BMI is indeterminant.\\n\\nRecommendation 8.2b was revised <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to recommend monitoring of obesity-related anthropometric measurements at least every 3 months during active    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> weight management treatment.\\n\\nDiscussion of weight stigma and bias toward people living in larger bodies was  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> added to the text.\\n\\nRecommendation 8.11 was enhanced to reflect the importance of continued monitoring,       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> support, and interventions for individuals who have achieved weight loss goals to support the maintenance of    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> these goals long term.\\n\\nRecommendation 8.18 was added to recommend screening for malnutrition for people with <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes and obesity who have lost significant weight.\\n\\nRecommendation 8.19 was added to recommend continuing <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> weight management pharmacotherapy, as indicated, beyond reaching weight loss goals to maintain health benefits  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and avoid weight regain and worsening of cardiometabolic abnormalities that often result from sudden            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> discontinuation of weight management pharmacotherapy.\\n\\nRecommendation 8.25 was revised to emphasize use of a  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CGM device to improve safety in individuals with post–metabolic surgery hypoglycemia.\\n\\nUpdated [**Tables      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 8.1**](https://doi.org/10.2337/dc25-S008) and [**8.2**](https://doi.org/10.2337/dc25-S008) provide detailed     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> information on the efficacy, common side effects, safety considerations, and costs of approved weight           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> management pharmacotherapy options.\\n\\nDiscussion of medication cost and access barriers was added to the text, <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> including suggestions to members of the interprofessional diabetes care team on mitigating financial            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> barriers.\\n\\n### Section 9. Pharmacologic Approaches to Glycemic                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Treatment\\n\\n((https://doi.org/10.2337/dc25-S009))\\n\\nThis section was reorganized and expanded with two new    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> subsections: _1_) a subsection titled “Additional Recommendations for All Individuals With Diabetes” that       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> includes new recommendations as well as recommendations previously listed with those for individuals with type  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1 or type 2 diabetes if pertinent to individuals regardless of their type of diabetes, and _2_) a subsection    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> titled “Special Circumstances and Populations.”\\n\\n[**Figure 9.1**](https://doi.org/10.2337/dc25-S009) was      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> revised for clarity, and a general statement was added to [**Table 9.1**](https://doi.org/10.2337/dc25-S009) on <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dose adjustments when using AID systems.\\n\\nThe subsection on insulin administration technique was expanded to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> address inhaled insulin and use of insulin bolus patches.\\n\\nRecommendation 9.8 was revised to emphasize the    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> importance of selecting glucose-lowering medications that provide sufficient effectiveness and achieve and      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> maintain multiple treatment goals simultaneously, including improving cardiovascular, kidney, weight, and other <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> relevant outcomes, reducing hypoglycemia risk, and considering cost, access, risk for adverse reactions, and    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> individual preferences.\\n\\nRecommendations were revised to explicitly advise on choice of pharmacotherapy for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> individuals with type 2 diabetes and established or high risk of atherosclerotic cardiovascular disease (ASCVD) <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (Recommendation 9.10), heart failure (Recommendation 9.11), and chronic kidney disease (CKD) (Recommendation    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9.12) to improve health outcomes for individuals with these conditions irrespective of A1C.\\n\\nRecommendation   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9.12 was added to recommend use of GLP-1 RA with demonstrated benefits in individuals with type 2 diabetes,     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> symptomatic heart failure with preserved ejection fraction, and obesity.\\n\\nRecommendation 9.13 was revised to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommend use of either SGLT2 inhibitor or GLP-1 RA with demonstrated benefits in individuals with type 2       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes and CKD.\\n\\nRecommendations 9.15 and 9.16 were added to recommend treatment of individuals with type 2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes and MASLD or MASH with GLP-1 RA, dual GIP and GLP-1 RA, pioglitazone, or a combination of GLP-1 RA and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pioglitazone based on the staging of liver disease risk and need for weight management.\\n\\n[**Figure            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9.3**](https://doi.org/10.2337/dc25-S009) and the text discussing choice of glucose-lowering therapy in adults  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with type 2 diabetes were extensively revised to facilitate evidence-based selection of glucose-lowering        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> therapies based on individualized treatment goals. Considerations of glucose-lowering medication effects on     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MASLD and MASH were added to [**Fig. 9.3**](https://doi.org/10.2337/dc25-S009).\\n\\n[**Table                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9.2**](https://doi.org/10.2337/dc25-S009) was simplified and revised to better highlight important              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> considerations when choosing medications for lowering glucose in type 2 diabetes.\\n\\nRecommendation 9.20 was    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> clarified to recommend reassessing the need for and/or dose of medications with higher hypoglycemia risk (i.e., <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sulfonylureas, meglitinides, and insulin) when initiating a new glucose-lowering medication to minimize the     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> risk of hypoglycemia and treatment burden.\\n\\nRecommendation 9.21 was added to advise against concurrent use of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> a dipeptidyl peptidase 4 inhibitor with a GLP-1 RA due to lack of additional glucose lowering beyond that of a  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GLP-1 RA alone.\\n\\nRecommendation 9.24 was clarified by specifying that a GLP-1 RA or a dual GIP and GLP-1 RA   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> is preferred to insulin in adults with type 2 diabetes only in the absence of evidence of insulin               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> deficiency.\\n\\nText in the “Basal Insulin” section was revised to provide guidance on switching between         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> different basal insulin formulations.\\n\\n[**Figure 9.4**](https://doi.org/10.2337/dc25-S009) was revised for    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> clarity, and the list of options for prandial insulin was expanded.\\n\\nRecommendation 9.27 was revised to       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> remove consideration of basal insulin doses exceeding 0.5 units/kg/day as evidence of overbasalization.         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Instead, signs of overbasalization including significant bedtime-to-morning or postprandial-to-preprandial      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability should be   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> used.\\n\\n[**Tables 9.3**](https://doi.org/10.2337/dc25-S009) and [**9.4**](https://doi.org/10.2337/dc25-S009)   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> were updated with glucose-lowering medication and insulin costs as of 1 July 2024, and an expanded discussion   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> on medication costs and affordability was added to the text.\\n\\nIn the new subsection “Special Circumstances    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Populations,” Recommendations 9.31a, 9.31b, and 9.31c were added to advise on actions to take when          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> medications are not available (such as medication shortages); Recommendations 9.32a and 9.32b were added to     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> address care considerations for individuals of childbearing potential; and Recommendation 9.33 was added to     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> provide guidance on mitigating risk of ketoacidosis when individuals at risk for ketoacidosis or who follow a   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ketogenic eating pattern are treated with SGLT inhibition. Additional text in this subsection discusses         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> considerations for glucose-lowering pharmacotherapy for individuals with diabetes secondary to chemotherapy and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with other types of diabetes (i.e., pancreatogenic diabetes, cystic fibrosis–related diabetes, posttransplant   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes, maturity-onset diabetes of the young, and neonatal diabetes).\\n\\n### Section 10. Cardiovascular       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease and Risk Management\\n\\n((https://doi.org/10.2337/dc25-S010))\\n\\nRecommendation 10.1 was updated with    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> details on the frequency of recommended blood pressure monitoring.\\n\\n[**Figure                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 10.2**](https://doi.org/10.2337/dc25-S010) was updated to provide clarity on medication classes for the         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> treatment of confirmed hypertension in nonpregnant people with diabetes.\\n\\nRecommendation 10.12 was modified   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to specify appropriate monitoring for increased serum creatinine levels, serum potassium levels, and            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypokalemia when ACE inhibitors, angiotensin receptor blockers (ARBs), or mineralocorticoid receptor            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> antagonists are used.\\n\\nRecommendation 10.13 was added to specify hypertension treatment options that should   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> be avoided during pregnancy and in sexually active individuals of childbearing potential not using reliable     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> contraception.\\n\\nRecommendation 10.26 was added to recommend that in most cases lipid-lowering agents should   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> be discontinued prior to conception and avoided in sexually active individuals of childbearing potential not    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> using reliable contraception, unless the benefits may outweigh the risk.\\n\\n[**Figures                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 10.3**](https://doi.org/10.2337/dc25-S010) and [**10.4**](https://doi.org/10.2337/dc25-S010) were added to      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> illustrate recommendations for primary prevention and secondary prevention of ASCVD, respectively, in people    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with diabetes using cholesterol-lowering therapy.\\n\\nTriglyceride thresholds were updated in Recommendations    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 10.31 and 10.32.\\n\\nThe criteria for coronary artery disease investigations in Recommendation 10.39b were       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> revised to include signs or symptoms of cardiac or associated vascular disease or electrocardiogram             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> abnormalities.\\n\\nRecommendation 10.41 was modified to include screening for peripheral artery disease (PAD)    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with ankle-brachial index testing in asymptomatic people with diabetes aged ≥65 years, microvascular disease in <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> any location, or foot complications or any end-organ damage from diabetes if a PAD diagnosis would change       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> management. PAD screening should also be considered in individuals with diabetes duration ≥10 years and high    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cardiovascular risk.\\n\\nFor individuals with type 2 diabetes, obesity, and symptomatic heart failure with       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> preserved ejection fraction, Recommendation 10.46d was added to recommend treatment with a GLP-1 RA with        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> demonstrated benefit in this population to reduce heart failure–related symptoms, reduce physical limitations,  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and improve exercise function.\\n\\n[**Figure 10.5**](https://doi.org/10.2337/dc25-S010) was added to illustrate  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommendations for screening for asymptomatic and undiagnosed cardiovascular disease, and [**Fig.              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 10.6**](https://doi.org/10.2337/dc25-S010) was added to provide an overview of recommendations for the          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> prevention of the development of symptomatic heart failure in people with diabetes.\\n\\n### Section 11. Chronic  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Kidney Disease and Risk Management\\n\\n((https://doi.org/10.2337/dc25-S011))\\n\\nRecommendation 11.3 was amended  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for clarity about optimizing blood pressure management goals.\\n\\nRecommendation 11.4a was revised to clarify    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> that ACE inhibitors or ARBs should be titrated to the maximally tolerated dose to prevent the progression of    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CKD and reduce cardiovascular events in nonpregnant individuals with diabetes and                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypertension.\\n\\nRecommendation 11.4b was modified to specify appropriate monitoring for increased serum        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> creatinine levels, serum potassium levels, and hypokalemia when ACE inhibitors, ARBs, or mineralocorticoid      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> receptor antagonists are used.\\n\\nRecommendation 11.5b was updated to state that for people with type 2         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes and CKD, a GLP-1 RA with demonstrated benefit in this population should be used to reduce              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cardiovascular risk and kidney disease progression.\\n\\nRecommendation 11.6 was added to state that potentially  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> harmful antihypertensive medications in pregnancy should be avoided in sexually active individuals of           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> childbearing potential not using reliable contraception and to switch to options considered safer prior to      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> conception and during pregnancy.\\n\\nRecommendation 11.7 was updated to specify reducing urinary albumin by ≥30% <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to slow progression of CKD.\\n\\nRecommendation 11.8 was updated to specify protein goals for individuals with    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> stage 3 or higher CKD and those who are treated with dialysis.\\n\\n[**Table                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 11.1**](https://doi.org/10.2337/dc25-S011) was added to include reasons to consider non–diabetes-related kidney <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diseases in a person with CKD and diabetes, and [**Table 11.3**](https://doi.org/10.2337/dc25-S011) was added   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to include suggestions for interventions that lower albuminuria.\\n\\n### Section 12. Retinopathy, Neuropathy,    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Foot Care\\n\\n((https://doi.org/10.2337/dc25-S012))\\n\\nRecommendation 12.5 was updated to specify            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> involvement of an ophthalmologist for more frequent examinations if retinopathy is progressing or sight         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> threatening.\\n\\nRecommendation 12.8 wording was changed to reflect that a dilated eye exam should be performed  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> before and in the first trimester, rather than one or the other.\\n\\nRecommendation 12.19 was modified to        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> include additional screening criteria for symptoms and signs of autonomic neuropathy.\\n\\nRecommendation 12.22   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was updated to recommend against opioid use for neuropathic pain treatment due to the potential for adverse     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> events, and the narrative text was updated to expand on this.\\n\\nA short discussion on the role of weight       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> management and neuropathy was added to the narrative text.\\n\\nRecommendation 12.24 was updated to include the   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Ipswich touch test as an option for neurological assessment.\\n\\nRecommendation 12.29 was expanded to include    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the importance of smoke cessation and referral for counseling for individuals who smoke and have a prior        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> history of lower-extremity complications, loss of protective sensation, structural abnormalities, or            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> PAD.\\n\\nIncreasing role of surgery in diabetic foot management was added to the narrative text of foot care     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> section.\\n\\n### Section 13. Older Adults\\n\\n((https://doi.org/10.2337/dc25-S013))\\n\\nThe 4Ms framework of       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> age-friendly health systems (Mentation, Medications, Mobility, and What Matters Most) as it applies to diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> management in older adults was introduced and illustrated in the new [**Fig.                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 13.1**](https://doi.org/10.2337/dc25-S013).\\n\\nRecommendation 13.8a was modified to include time in range and   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> time below range in addition to A1C treatment goals for older adults who are otherwise healthy with few and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> stable chronic conditions and intact cognitive functional status.\\n\\nRecommendation 13.8b was modified to       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> include time in range and time below range in addition to A1C treatment goals for older adults who have         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> intermediate or complex health who are clinically heterogeneous with variable life expectancy.\\n\\n[**Table      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 13.1**](https://doi.org/10.2337/dc25-S013) was modified to include a column on reasonable CGM goals for each    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> health status category.\\n\\nIn the “Treatment” section, the appropriate selection and use of SGLT2 inhibitors in <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> older adults was expanded.\\n\\n### Section 14. Children and                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Adolescents\\n\\n((https://doi.org/10.2337/dc25-S014))\\n\\nRecommendation 14.4 in the “Type 1 Diabetes” section    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was added to emphasize key nutrition principles.\\n\\nRecommendation 14.10 was altered to emphasize limits on     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sedentary activity.\\n\\nRecommendation 14.21 was changed to state that insulin pumps should be offered to anyone <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with type 1 diabetes who can use the devices safely.\\n\\nRecommendation 14.24 was modified to remove lack of     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> access as a reason for less stringent A1C goals.\\n\\nRecommendation 14.26 was altered to include weight gain as  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> a balancing measure for more stringent A1C goals.\\n\\nRecommendation 14.36 was changed to exclude secondary      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> causes of hypertension.\\n\\nRecommendation 14.41 was updated to include the use of age-approved                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> statins.\\n\\nRecommendation 14.50 was modified to state that screening should be repeated at a minimum of 2-year <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> intervals or more frequently if screening is normal and BMI is increasing.\\n\\nRecommendation 14.57 was revised  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to include the key nutritional principles and provide specific examples of healthy food choices and what foods  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> should be avoided.\\n\\nRecommendation 14.60 was changed to recommend an A1C goal of &lt;6.5% (&lt;48 mmol/mol) for     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> most children and adolescents with type 2 diabetes who have a low risk of hypoglycemia and a higher risk of     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> complications.\\n\\nRecommendation 14.65 was revised to change the terminology from “hyperglycemic hyperosmolar   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> nonketotic syndrome” to “hyperglycemic hyperosmolar state” and include intravenous fluid as the initial step to <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> treat severe hyperglycemia (blood glucose ≥600 mg/dL) once the diagnosis is confirmed.\\n\\nThe narrative was     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> updated to reinforce the benefits and safety of GLP-1 RAs in decreasing A1C, weight, blood pressure, and        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> insulin dose reduction. [**Figure 14.1**](https://doi.org/10.2337/dc25-S014) was updated to reflect the         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> revision in this recommendation.\\n\\nRecommendation 14.73 was modified to reflect that excluding secondary       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypertension is an essential step in hypertension management.\\n\\nRecommendation 14.104 was revised to state     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> that vaping and electronic cigarettes are both discouraged.\\n\\nRecommendation 14.105 in the “Substance Use in   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Pediatric Diabetes” section was added to state that all youth with diabetes should be advised not to use        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cannabis recreationally in any form.\\n\\nRecommendation 14.108 was modified to encourage pediatric diabetes      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> specialists to partner with youth with diabetes and their caregivers to engage in shared                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> decision-making.\\n\\n[**Tables 14.1 _A_**](https://doi.org/10.2337/dc25-S014) and [**14.1                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> _B_**](https://doi.org/10.2337/dc25-S014) were modified to include changes made throughout Section 14.\\n\\n###   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Section 15. Management of Diabetes in Pregnancy\\n\\n((https://doi.org/10.2337/dc25-S015))\\n\\nSection 15 was      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> restructured to discuss the care of pregnant individuals with type 1 diabetes, type 2 diabetes, and GDM in all  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sections and to discuss aspects of management in each relevant subsection (e.g., preconception care and         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pharmacotherapy); consequently, the order of appearance of some of the recommendations                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> changed.\\n\\nRecommendation 15.7 wording was changed to reflect that a dilated eye exam should be performed      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> before and in the first trimester, rather than one or the other.\\n\\n[**Table                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 15.1**](https://doi.org/10.2337/dc25-S015) was updated with a folic acid supplement recommendation of 400–800   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> μg/day and clarification for which checklist items are only for individuals with preexisting diabetes and not   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for individuals with prediabetes or a history of GDM, and specific immunizations were omitted and               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> referenced.\\n\\nIn Recommendation 15.10, the benefits of CGM use in type 1 diabetes and pregnancy were           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> clarified, and an addition of its potential to be beneficial in other types of diabetes in pregnancy was        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> added.\\n\\nRecommendation 15.12 no longer states that CGM metrics should not be used as a substitute for blood   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> glucose monitoring; the recommendation now states that CGM may be used in conjunction with blood glucose        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> monitoring to achieve glycemic goals.\\n\\nGlucose goals for preexisting diabetes, GDM treated with insulin, and  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GDM not treated with insulin are consolidated into a new [**Table                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 15.2**](https://doi.org/10.2337/dc25-S015).\\n\\n“Management of Gestational Diabetes Mellitus” and “Management of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Preexisting Type 1 Diabetes and Type 2 Diabetes Pregnancy” were merged into one subsection, titled “Management  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of Diabetes in Pregnancy,” which includes all aspects of management for all types of diabetes (e.g., nutrition, <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> physical activity, and pharmacotherapy).\\n\\nRecommendation 15.14 provides more clarification on the recommended <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> eating pattern in pregnancy.\\n\\nInsulin recommendations that were previously split into separate                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommendations for preexisting diabetes and GDM were merged.\\n\\nThere are two new recommendations regarding    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> AID use in type 1 diabetes and pregnancy. Recommendation 15.19 states that AID systems are recommended if the   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> system has a pregnancy-specific glucose goal. Recommendation 15.20 states that AID systems may be considered    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for select individuals with an experienced health care team if the system does not have a pregnancy-specific    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> glucose goal or algorithm.\\n\\nRecommendation 15.21 provides more clarification for why metformin and glyburide  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> should not be first-line agents for management of diabetes in pregnancy.\\n\\nThe narrative for subsection        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> “Physical Activity” includes recommended activity levels for pregnancy, as these pertain to individuals with    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> any type of diabetes in pregnancy.\\n\\nThe “Insulin” subsection includes information on different insulin        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> delivery modalities used during labor and delivery or postpartum.\\n\\nThe recommendation to explicitly measure   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> blood pressure during pregnancy is now mentioned in the narrative of the “Preeclampsia and Aspirin” subsection  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> per the recent guidelines of the U.S. Preventive Services Task Force.\\n\\nRecommendation 15.25 was split into    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> two recommendations. Recommendation 15.25a provides more examples of potentially harmful medications in         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pregnancy. Recommendation 15.25b recommends that lipid-lowering medications be avoided in most circumstances in <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pregnancy but that statins may be considered for use in high-risk individuals (such as those with prior ASCVD   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and familial hypercholesterolemia) when benefits outweigh risks. The narrative discusses Recommendation 15.25b  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> in more detail and includes discussion of studies of pravastatin use in pregnancy.\\n\\n### Section 16. Diabetes  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care in the Hospital\\n\\n((https://doi.org/10.2337/dc25-S016))\\n\\nDiabetes care in the hospital stresses         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> identification and treatment of dysglycemia and provides glycemic goals. For the treatment of persistent        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hyperglycemia starting at a threshold of ≥180 mg/dL (≥10.0 mmol/L), Recommendation 16.4a was amended to reflect <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> that insulin should be initiated or intensified for the majority of critically ill individuals, and             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Recommendation 16.4b was added to state that insulin and/or other glucose-lowering therapies should be          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> initiated or intensified for the majority of noncritically ill individuals.\\n\\nRecommendation 16.5a was updated <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to state that a glycemic goal of 140–180 mg/dL (7.8–10.0 mmol/L) is recommended for most critically ill         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> individuals, but more stringent individualized glycemic goals may be appropriate if they can be achieved        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> without significant hypoglycemia. Recommendation 16.5b was updated to recommend a glycemic goal of 100–180      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mg/dL (5.6–10.0 mmol/L) for most noncritically ill individuals if it can be achieved without significant        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypoglycemia.\\n\\nRecommendation 16.7 was amended for clarity on the use of insulin pump or AID continuation and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> their use in people with diabetes who are hospitalized, when clinically appropriate.\\n\\nRecommendation 16.8a    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> was added to state that continuous intravenous insulin infusion is recommended for achieving glycemic goals and <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> avoiding hypoglycemia in critically ill individuals.\\n\\nThe language regarding a hypoglycemia management        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> surveillance protocol for health systems was updated for clarity in Recommendation 16.12.\\n\\nGuidance regarding <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> use of GLP-1 RA and dual GIP and GLP-1 RA medications in the perioperative setting and regarding instructions   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> in preparation for procedures or surgery has been added to the narrative text.\\n\\nRecommendations 16.14 and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 16.15 were added for DKA and HHS management; transition to maintenance subcutaneous insulin administration and  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> discharge planning were added. Additionally, the newly added [**Fig. 16.1**](https://doi.org/10.2337/dc25-S016) <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> includes treatment pathways for DKA and HHS.\\n\\n### Section 17. Diabetes                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Advocacy\\n\\n((https://doi.org/10.2337/dc25-S017))\\n\\nThe subsections “Diabetes Care in the School Setting” and  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> “Diabetes and Driving” were updated with information from recently published advocacy statements. The           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> subsection “Diabetes Management in Detention Facilities” was added with information from a recently published   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> advocacy statement.\\n\\n*A complete list of members of the American Diabetes Association Professional Practice   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee can be found at (https://doi.org/10.2337/dc25-SINT).\\n\\nDuality of interest information for each      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> author is available at [10.2337/dc25-SDIS](https://doi.org/10.2337/dc25-SDIS).\\n\\nSuggested citation: American  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Association Professional Practice Committee. Summary of revisions: Standards of Care in Diabetes—2025. <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Care 2025;48(Suppl. 1):S6–S13\\n\\n© 2024 by the American Diabetes Association\\n\\n2024\\n\\nReaders may    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> use this article as long as the work is properly cited, the use is educational and not for profit, and the work <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> is not altered. More information is available at                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://www.diabetesjournals.org/journals/pages/license).\\n\\n[](https://diabetesjournals.org/care/article/48/S <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> upplement_1/S6/157564/Summary-of-Revisions-Standards-of-Care-in-Diabetes)\\n\\n329,024                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Views\\n\\n[11](https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS: <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 001378283000018&amp;DestLinkType=CitingArticles&amp;DestApp=WOS_CPL)Web of Science\\n\\n[![Image 6: Article has an        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> altmetric score of                                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 25](https://badges.altmetric.com/?size=128&amp;score=25&amp;types=mttttttu)](https://www.altmetric.com/details.php?doma <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> in=diabetesjournals.org&amp;citation_id=171817539)\\n\\n[View Metrics](javascript:;)\\n\\n[×Close                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Modal](javascript:;)\\n\\n### Email alerts\\n\\n[Article Activity Alert](javascript:;)\\n\\n[Online Ahead of Print    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Alert](javascript:;)\\n\\n[Latest Issue Alert](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\nWe Recommend\\n\\n*  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Issues and                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Events](https://rev.trendmd.com/open/hgx1w40eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91cm5 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1DYX <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> JlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiJmNTE1MmU3Z <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> S1lOWU3LTQwNTItOGFiMC0zYzk4ZmNjYTIwMDkiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvZGlhYmV0 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ZXMvYXJ0aWNsZS83MC83LzE2MDIvMTM3ODYwL0lzc3Vlcy1hbmQtRXZlbnRzP3NlYXJjaHJlc3VsdD0xIiwiZGVzdGluYXRpb25QdWJsaWNhdGl <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> vbklkIjoiYzAyM2Y5ZmUtNTJkNS00NWNmLWIyZGUtNGRiMGUxOWE5OGJhIiwiZGVzdGluYXRpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAsInNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> i1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmYtNDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xv <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLCJhZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFN <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTU0LCJjYW1wYWlnblZlcnNpb24iOjIsImNhbXBhaWduVmFyaWFudCI6MywiY29zdCI6MTAwLCJjYW <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1wYWlnbkFkR3JvdXBJZCI6MTU0LCJjYW1wYWlnbkFkSWQiOjE1NCwiY2FtcGFpZ25BZElkZW50aWZpZXIiOiI0YTY0ZjY1Ni1lZjAxLTRkMTgtY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mJkYy02NzBmMjlkZGRhZDIiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiI0MWY5OTY2Zi1hYTRhLTQ1MmItODBlMi1kMDcxNDU4ODIxZmMi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> LCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW9uSWQiOjYwLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0YW1wIjoxNzU1NjE1MDgwODY3LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5cGUiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> VUeXBlIjowfQ3m1klri)American Diabetes Association, Diabetes, 2021 \\n*   [Issues and                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Events](https://rev.trendmd.com/open/4lpk5vseyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91cm5 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1DYX <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> JlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI0Y2MwNTMyZ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> C0zYTdkLTRkMzQtYjViMi1lODBkMzhmMjY3OWEiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXMuZGlhYmV0ZXNqb3VybmFscy5v <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cmcvY29udGVudC83MC81LzEyMDkiLCJkZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiJjMDIzZjlmZS01MmQ1LTQ1Y2YtYjJkZS00ZGIwZTE5YTk <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4YmEiLCJkZXN0aW5hdGlvbkNvbnRlbnRUeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9saWN5VHlwZSI6MCwic2Vzc2lvbklkIjoiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> TY1MTFjYjMtNWEyZi00MDU3LWJkMzMtZTZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUw <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NTI1OTgzNTliNCIsImFkU2xvdEV2ZW50VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNTQsImNhbXBhaWduVmV <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> yc2lvbiI6MiwiY2FtcGFpZ25WYXJpYW50IjozLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNTQsImNhbXBhaWduQWRJZCI6MTU0LC <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> JjYW1wYWlnbkFkSWRlbnRpZmllciI6IjRhNjRmNjU2LWVmMDEtNGQxOC1iYmRjLTY3MGYyOWRkZGFkMiIsImNhbXBhaWduQWRCdWNrZXRSZW1vd <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GVJZCI6IjQxZjk5NjZmLWFhNGEtNDUyYi04MGUyLWQwNzE0NTg4MjFmYyIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25P <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cmdhbml6YXRpb25JZCI6NjAsInRyYWNraW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 3NzAwMCwidHlwZSI6MCwidmVyc2lvbiI6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB96zv9dv4)American Diabetes Association,     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes, 2021 \\n*   [Standards of Care in Diabetes—2023 Abridged for Primary Care                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Providers](https://rev.trendmd.com/open/s182jy6eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI0YjdkNm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Q1NS00ZWQ0LTQxOTMtOGY2MS1lY2M2ODBkZTQzOTMiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvY2xpb <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mljYWwvYXJ0aWNsZS80MS8xLzQvMTQ4MDI5L1N0YW5kYXJkcy1vZi1DYXJlLWluLURpYWJldGVzLTIwMjMtQWJyaWRnZWQtZm9yIiwiZGVzdGlu <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YXRpb25QdWJsaWNhdGlvbklkIjoiZGZjNmI2NmEtZWE4NC00NzE4LWJiOWMtOWY0YTQ1ZWM4YWRlIiwiZGVzdGluYXRpb25Db250ZW50VHlwZXM <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> iOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAsInNlc3Npb25JZCI6ImFhMG <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> VmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmYtNDA1Ny1iZDMzLWU2ZjRkN <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> jZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLCJhZFNsb3RFdmVudFRyYWNr <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> aW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTU0LCJjYW1wYWlnblZlcnNpb24iOjIsImNhbXBhaWduVmFyaWFudCI6Myw <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> iY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTU0LCJjYW1wYWlnbkFkSWQiOjE1NCwiY2FtcGFpZ25BZElkZW50aWZpZXIiOiI0YTY0Zj <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Y1Ni1lZjAxLTRkMTgtYmJkYy02NzBmMjlkZGRhZDIiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJlNDc3MDhmNy00Mzc4LTRmZjAtOTdmN <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> y0zMzY2ZGFiMTBiZTAiLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW9uSWQiOjYwLCJ0cmFja2luZ1Ns <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5cGUiOjAsInZlcnNpb24iOiIwLjU <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQ487qzxq)American Diabetes Association, Clin Diabetes, 2023 \\n*   [Introduction:  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Standards of Care in Diabetes—2024 Abridged for Primary Care                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Professionals](https://rev.trendmd.com/open/ltuxgqreyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVz <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> am91cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> vZi1DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI5YW <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> E3MmFmYy1iOGJiLTQ2YWItYTBlMi03MDkyOWM3MDQ5MzIiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2xpbmljYWwvYXJ0aWNsZS80Mi8yLzE4MS8xNTQ0NjgvSW50cm9kdWN0aW9uLVN0YW5kYXJkcy1vZi1DYXJlLWluLURpYWJldGVzLTIwMjQiLCJk <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiJkZmM2YjY2YS1lYTg0LTQ3MTgtYmI5Yy05ZjRhNDVlYzhhZGUiLCJkZXN0aW5hdGlvbkNvbnRlbnR <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> UeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwic2Vzc2lvbklkIj <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> oiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi00MDU3LWJkMzMtZ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> TZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsImFkU2xvdEV2ZW50 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNTQsImNhbXBhaWduVmVyc2lvbiI6MiwiY2FtcGFpZ25WYXJpYW5 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0IjozLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNTQsImNhbXBhaWduQWRJZCI6MTU0LCJjYW1wYWlnbkFkSWRlbnRpZmllciI6Ij <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> RhNjRmNjU2LWVmMDEtNGQxOC1iYmRjLTY3MGYyOWRkZGFkMiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImU0NzcwOGY3LTQzNzgtNGZmM <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> C05N2Y3LTMzNjZkYWIxMGJlMCIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb25JZCI6NjAsInRyYWNr <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> aW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZSI6MCwidmVyc2lvbiI <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB9p36vumh)American Diabetes Association Primary Care Advisory Group, Clin    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes, 2024 \\n*   [Standards of Medical Care in Diabetes—2022 Abridged for Primary Care                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Providers](https://rev.trendmd.com/open/42osx7deyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI3NTQxY2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> VjMy03MTEzLTQyYjUtODUzYS05MDRlYjI2ZjM4OTciLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vZGlhYmV0ZXNqb3VybmFscy5vcmcvY2xpb <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mljYWwvYXJ0aWNsZS80MC8xLzEwLzEzOTAzNS9TdGFuZGFyZHMtb2YtTWVkaWNhbC1DYXJlLWluLURpYWJldGVzLTIwMjIiLCJkZXN0aW5hdGlv <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> blB1YmxpY2F0aW9uSWQiOiJkZmM2YjY2YS1lYTg0LTQ3MTgtYmI5Yy05ZjRhNDVlYzhhZGUiLCJkZXN0aW5hdGlvbkNvbnRlbnRUeXBlcyI6WzV <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwic2Vzc2lvbklkIjoiYWEwZWYxYj <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> MtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi00MDU3LWJkMzMtZTZmNGQ2NmFiM <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Tk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsImFkU2xvdEV2ZW50VHJhY2tpbmci <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> OnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNTQsImNhbXBhaWduVmVyc2lvbiI6MiwiY2FtcGFpZ25WYXJpYW50IjozLCJjb3N <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNTQsImNhbXBhaWduQWRJZCI6MTU0LCJjYW1wYWlnbkFkSWRlbnRpZmllciI6IjRhNjRmNjU2LW <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> VmMDEtNGQxOC1iYmRjLTY3MGYyOWRkZGFkMiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImU0NzcwOGY3LTQzNzgtNGZmMC05N2Y3LTMzN <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> jZkYWIxMGJlMCIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb25JZCI6NjAsInRyYWNraW5nU2x1Z3Mi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Ont9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZSI6MCwidmVyc2lvbiI6IjAuNTU4LjA <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> iLCJjcmVhdGl2ZVR5cGUiOjB9fo60ufx)American Diabetes Association, Clin Diabetes, 2022 \\n\\n*   [Diabetes can be    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> managed as well in primary care as in                                                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hospital](https://rev.trendmd.com/open/qirdz9feyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91c <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> m5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1D <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiIzYjU3NmY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0YS0yNjJmLTRmZjItYjU1Zi1lNGZhODdmYTA0NTQiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMTcvNz <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> E1NS8wLjgiLCJkZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiI2OTVjNjAyNy05ZTMyLTRjNTEtYjgzOC05MWRmNzgwNWVmZTgiLCJkZXN0aW5hd <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GlvbkNvbnRlbnRUeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> c2Vzc2lvbklkIjoiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi0 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0MDU3LWJkMzMtZTZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsIm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> FkU2xvdEV2ZW50VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNjAsImNhbXBhaWduVmVyc2lvbiI6MTI3NSwiY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2FtcGFpZ25WYXJpYW50IjoyLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNjAsImNhbXBhaWduQWRJZCI6MTYwLCJjYW1wYWlnbkFk <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SWRlbnRpZmllciI6IjllOTkzNjEwLWY5ZjgtNDM1Ny04NWRhLThkYTBhMzQ3NzM5NiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImE0ZTJ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hYmRlLTI1NTgtNDIyMS1hMDIxLTA4MGMyZjdmYjkwNyIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 5JZCI6NjIsInRyYWNraW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SI6MCwidmVyc2lvbiI6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB9babs8ui)British Medical Journal Publishing Group, The    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> BMJ, 1998 \\n*   [American Diabetes Association issues new guidelines for type 1                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes](https://rev.trendmd.com/open/410iis1eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91c <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> m5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1D <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiIyMzBkODc <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0Mi1kYWM1LTRkZDgtYTI1MS01MzMzZjBhMjdjZTUiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zNDgvYm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1qLmc0MTE5IiwiZGVzdGluYXRpb25QdWJsaWNhdGlvbklkIjoiNjk1YzYwMjctOWUzMi00YzUxLWI4MzgtOTFkZjc4MDVlZmU4IiwiZGVzdGluY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> XRpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAs <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> InNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> tNDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLC <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> JhZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTYwLCJjYW1wYWlnblZlcnNpb24iOjEyNzUsI <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mNhbXBhaWduVmFyaWFudCI6MiwiY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTYwLCJjYW1wYWlnbkFkSWQiOjE2MCwiY2FtcGFpZ25B <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ZElkZW50aWZpZXIiOiI5ZTk5MzYxMC1mOWY4LTQzNTctODVkYS04ZGEwYTM0NzczOTYiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJhNGU <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> yYWJkZS0yNTU4LTQyMjEtYTAyMS0wODBjMmY3ZmI5MDciLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 9uSWQiOjYyLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5c <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GUiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQm2d8avx)Michael McCarthy, The BMJ, 2014 \\n*   [Changed <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> criteria for diabetes need further                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> research](https://rev.trendmd.com/open/a1lkbq6eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91c <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> m5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1D <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiJiZGU5ODk <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> zZS1kYzA3LTQ0YjQtOTQxYS0xOTQwMTQ4NTc0OTEiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMTcvNz <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> E1NS8wLjMiLCJkZXN0aW5hdGlvblB1YmxpY2F0aW9uSWQiOiI2OTVjNjAyNy05ZTMyLTRjNTEtYjgzOC05MWRmNzgwNWVmZTgiLCJkZXN0aW5hd <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GlvbkNvbnRlbnRUeXBlcyI6WzVdLCJpcCI6IjM0Ljk2LjQ5LjE0MiIsImNvdW50cnlDb2RlIjoiVVMiLCJwcml2YWN5UG9saWN5VHlwZSI6MCwi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> c2Vzc2lvbklkIjoiYWEwZWYxYjMtZDQwZS00NGViLWJkNmEtNzNiNzAwNWQ1YWNiIiwiYWRTZXRJZGVudGlmaWVyIjoiYTY1MTFjYjMtNWEyZi0 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0MDU3LWJkMzMtZTZmNGQ2NmFiMTk5IiwiYWRTbG90SWRlbnRpZmllciI6ImM3OTU3ZmM2LTUyNjEtNDdkOC04NzI4LWUwNTI1OTgzNTliNCIsIm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> FkU2xvdEV2ZW50VHJhY2tpbmciOnRydWUsImFkU2xvdElkIjo2NTA5LCJjYW1wYWlnbklkIjoxNjAsImNhbXBhaWduVmVyc2lvbiI6MTI3NSwiY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2FtcGFpZ25WYXJpYW50IjoyLCJjb3N0IjoxMDAsImNhbXBhaWduQWRHcm91cElkIjoxNjAsImNhbXBhaWduQWRJZCI6MTYwLCJjYW1wYWlnbkFk <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SWRlbnRpZmllciI6IjllOTkzNjEwLWY5ZjgtNDM1Ny04NWRhLThkYTBhMzQ3NzM5NiIsImNhbXBhaWduQWRCdWNrZXRSZW1vdGVJZCI6ImE0ZTJ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hYmRlLTI1NTgtNDIyMS1hMDIxLTA4MGMyZjdmYjkwNyIsInNvdXJjZU9yZ2FuaXphdGlvbklkIjo2MCwiZGVzdGluYXRpb25Pcmdhbml6YXRpb2 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 5JZCI6NjIsInRyYWNraW5nU2x1Z3MiOnt9LCJ0aW1lc3RhbXAiOjE3NTU2MTUwODA4NjgsInN0YXJ0VGltZSI6MTc1NTYxNTA3NzAwMCwidHlwZ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SI6MCwidmVyc2lvbiI6IjAuNTU4LjAiLCJjcmVhdGl2ZVR5cGUiOjB969z2q2s)British Medical Journal Publishing Group, The    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> BMJ, 1998 \\n*   [Effective diabetes care: a need for realistic                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> targets](https://rev.trendmd.com/open/3u6nbk3eyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91cm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1DY <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> XJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiJiNGZmMWYw <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NS1jMjY3LTQwYzItYmQ4OC1hYzdmY2YxMjU0ZmEiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMjQvNzM <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1My8xNTc3IiwiZGVzdGluYXRpb25QdWJsaWNhdGlvbklkIjoiNjk1YzYwMjctOWUzMi00YzUxLWI4MzgtOTFkZjc4MDVlZmU4IiwiZGVzdGluYX <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Rpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjAsI <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> nNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMmYt <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiLCJ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTYwLCJjYW1wYWlnblZlcnNpb24iOjEyNzUsIm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NhbXBhaWduVmFyaWFudCI6MiwiY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTYwLCJjYW1wYWlnbkFkSWQiOjE2MCwiY2FtcGFpZ25BZ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ElkZW50aWZpZXIiOiI5ZTk5MzYxMC1mOWY4LTQzNTctODVkYS04ZGEwYTM0NzczOTYiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJhNGUy <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YWJkZS0yNTU4LTQyMjEtYTAyMS0wODBjMmY3ZmI5MDciLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0aW9 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> uSWQiOjYyLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5cG <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> UiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQubd3vas)Peter Winocour, The BMJ, 2002 \\n*   [Shifting   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of care for diabetes from secondary to primary care, 1990-5: review of general                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> practices](https://rev.trendmd.com/open/fxp0eeieyJzb3VyY2VUeXBlIjoyLCJzb3VyY2VVcmwiOiJodHRwczovL2RpYWJldGVzam91 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cm5hbHMub3JnL2NhcmUvYXJ0aWNsZS80OC9TdXBwbGVtZW50XzEvUzYvMTU3NTY0L1N1bW1hcnktb2YtUmV2aXNpb25zLVN0YW5kYXJkcy1vZi1 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> DYXJlLWluLURpYWJldGVzIiwic291cmNlSWQiOm51bGwsInNvdXJjZVB1YmxpY2F0aW9uSWQiOm51bGwsImRlc3RpbmF0aW9uSWQiOiI0Njc4OD <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> k3OS02ZGY2LTRhYjktYTQzNC02NDMzYjhmMzM5ODUiLCJkZXN0aW5hdGlvblVybCI6Imh0dHBzOi8vd3d3LmJtai5jb20vY29udGVudC8zMTYvN <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> zE0My8xNTA1IiwiZGVzdGluYXRpb25QdWJsaWNhdGlvbklkIjoiNjk1YzYwMjctOWUzMi00YzUxLWI4MzgtOTFkZjc4MDVlZmU4IiwiZGVzdGlu <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YXRpb25Db250ZW50VHlwZXMiOls1XSwiaXAiOiIzNC45Ni40OS4xNDIiLCJjb3VudHJ5Q29kZSI6IlVTIiwicHJpdmFjeVBvbGljeVR5cGUiOjA <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sInNlc3Npb25JZCI6ImFhMGVmMWIzLWQ0MGUtNDRlYi1iZDZhLTczYjcwMDVkNWFjYiIsImFkU2V0SWRlbnRpZmllciI6ImE2NTExY2IzLTVhMm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> YtNDA1Ny1iZDMzLWU2ZjRkNjZhYjE5OSIsImFkU2xvdElkZW50aWZpZXIiOiJjNzk1N2ZjNi01MjYxLTQ3ZDgtODcyOC1lMDUyNTk4MzU5YjQiL <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CJhZFNsb3RFdmVudFRyYWNraW5nIjp0cnVlLCJhZFNsb3RJZCI6NjUwOSwiY2FtcGFpZ25JZCI6MTYwLCJjYW1wYWlnblZlcnNpb24iOjEyNzUs <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ImNhbXBhaWduVmFyaWFudCI6MiwiY29zdCI6MTAwLCJjYW1wYWlnbkFkR3JvdXBJZCI6MTYwLCJjYW1wYWlnbkFkSWQiOjE2MCwiY2FtcGFpZ25 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> BZElkZW50aWZpZXIiOiI5ZTk5MzYxMC1mOWY4LTQzNTctODVkYS04ZGEwYTM0NzczOTYiLCJjYW1wYWlnbkFkQnVja2V0UmVtb3RlSWQiOiJhNG <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> UyYWJkZS0yNTU4LTQyMjEtYTAyMS0wODBjMmY3ZmI5MDciLCJzb3VyY2VPcmdhbml6YXRpb25JZCI6NjAsImRlc3RpbmF0aW9uT3JnYW5pemF0a <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> W9uSWQiOjYyLCJ0cmFja2luZ1NsdWdzIjp7fSwidGltZXN0YW1wIjoxNzU1NjE1MDgwODY4LCJzdGFydFRpbWUiOjE3NTU2MTUwNzcwMDAsInR5 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cGUiOjAsInZlcnNpb24iOiIwLjU1OC4wIiwiY3JlYXRpdmVUeXBlIjowfQotlh5ol)Elizabeth C Goyder, The BMJ, 1998             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\n\\n[Powered by](https://www.trendmd.com/how-it-works-readers)\\n\\n*   [Privacy                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> policy](https://www.trendmd.com/privacy)\\n*   [Google Analytics                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> settings](https://www.trendmd.com/google-analytics)\\n\\n*   Online ISSN 1935-5548\\n*   Print ISSN                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0149-5992\\n\\n### Journals\\n\\n*   [Diabetes](https://diabetesjournals.org/diabetes)\\n*   [Diabetes               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://diabetesjournals.org/care)\\n*   [Diabetes, Obesity, and Cardiometabolic                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CARE](https://diabetesjournals.org/docm-care)\\n*   [Clinical                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://diabetesjournals.org/clinical)\\n*   [Diabetes                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Spectrum](https://diabetesjournals.org/spectrum)\\n*   [Standards of Medical Care in                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [Scientific Sessions                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [BMJ Open Diabetes   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Research &amp; Care](https://drc.bmj.com/)\\n\\n### Books\\n\\n*                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [ShopDiabetes.org](https://shopdiabetes.org/collections/professional-books)\\n*   [ADA Professional              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Books](https://diabetesjournals.org/books)\\n\\n### Clinical Compendia\\n\\n*   [Clinical Compendia                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Home](https://diabetesjournals.org/compendia)\\n\\n### News\\n\\n*   [Latest                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> News](https://www.diabetes.org/newsroom)\\n*   [DiabetesPro                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SmartBrief](https://www2.smartbrief.com/signupSystem/subscribe.action?pageSequence=1&amp;briefName=diabetespro)\\n\\n <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ### Podcasts\\n\\n*   [Diabetes Core                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Update](https://diabetesjournals.org/journals/pages/diabetes-core-update-podcasts)\\n*   [Diabetes Care \\\"On     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Air\\\"](https://sites.libsyn.com/453336/site)\\n*   [DiabetesBio](https://sites.libsyn.com/499063/site)\\n*        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes Day by Day](https://sites.libsyn.com/435096/site)\\n*   [Diabetes Core Update: Special                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n\\n### Other\\n\\n*  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Special Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n*              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [DiabetesPro®](https://professional.diabetes.org/)\\n*   [Diabetes Food                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Hub™](https://www.diabetesfoodhub.org/)\\n*   [Insulin Affordability](https://doi.org/10.2337/dci18-0019)\\n*     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Know Diabetes By Heart™](https://www.knowdiabetesbyheart.org/)\\n\\n### About\\n\\n*   [About the                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ADA](https://www.diabetes.org/about-us)\\n*   [Journal                                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n*   [For                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n*   [Advertising in ADA                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Journals](https://diabetesjournals.org/journals/pages/advertising)\\n*   [Reprints and Permission for            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reuse](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n*   [Copyright Notice/Public      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Access Policy](https://diabetesjournals.org/journals/pages/license)\\n*   [Privacy                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policy](https://diabetes.org/about-us/policies/privacy-policy)\\n\\n### Resources\\n\\n*   [ADA Professional        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Membership](https://professional.diabetes.org/membership)\\n*   [ADA Member                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Directory](http://professional.diabetes.org/directory)\\n*                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes.org](http://www.diabetes.org/)\\n\\n[![Image                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 7](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/logo-umbrella-footer.sv <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> g?versionId=6302)](https://diabetes.org/)\\n\\n*   [X (Twitter)](https://twitter.com/ADA_Pubs)\\n*                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Facebook](https://www.facebook.com/adaPublications)\\n*                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [LinkedIn](https://www.linkedin.com/company/american-diabetes-association/)\\n\\n*   [Contact                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us](https://diabetesjournals.org/contact-us)\\n*   [Cookie                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policy](https://diabetesjournals.org/journals/pages/Policies)\\n*                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Accessibility](https://diabetesjournals.org/pages/Accessibility)\\n*   [Terms &amp;                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Conditions](https://diabetes.org/about-us/policies/terms-of-use)\\n*   [Get Adobe Acrobat                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reader](https://get.adobe.com/reader/)\\n*   © Copyright American Diabetes Association\\n\\n[_Close                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Modal_](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\n##### This Feature Is Available To Subscribers          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Only\\n\\n[Sign                                                                                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> In](https://diabetesjournals.org/sign-in?returnUrl=%2fcare%2farticle%2f48%2fSupplement_1%2fS6%2f157564%2fSummar <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> y-of-Revisions-Standards-of-Care-in-Diabetes) or [Create an                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Account](https://diabetesjournals.org/my-account/register?siteId=1000003&amp;returnUrl=%2fcare%2farticle%2f48%2fSup <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> plement_1%2fS6%2f157564%2fSummary-of-Revisions-Standards-of-Care-in-Diabetes)\\n\\n[_Close                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Modal_](javascript:;)\\n\\n[_Close Modal_](javascript:;)\\n\\n This site uses cookies. By continuing to use our     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> website, you are agreeing to                                                                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://www.diabetesjournals.org/content/privacy-policy-american-diabetes-association-journals)\\n\\n[Accept](ja <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> vascript:;)\\n\\nclose                                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> advertisement\\n\\n\\n##Source\\nhttps://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Rev <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> isions-Standards-of-Care-in-Diabetes\", \"## Title\\n2025 ADA Standards of Medical Care in Diabetes:               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Updates!\\n\\n## Content\\n2025 ADA Standards of Medical Care in Diabetes: Updates! Although the ADA Standards of  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care is a living document throughout the year, annually in Dec/Jan they release a large update. For the         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> purposes of this edition of Pharm Aid, I have highlighted the updates that are pertinent to primary care        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> practice in the table below. Please find the full Standards of Care here:                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> https://professional.diabetes.org/standards-of-care This site includes the full standards in PDF and other      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> useful tools: • Full Standards of Care 2025 • Slide Decks: o Full Standards of Care 2025 (349 slides) o         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Abridged Standards of Care 2024 (107 slides – with easy to follow graphics) • Free Updated APP ----including    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> interactive tools! The KEY highlights are for 2025 are: 1. Continued emphasis on: a. Person-first, inclusive,   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> empowering terminology and consideration for Social Determinants of Health. i. Avoid the term “diabetic” –      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> instead use PERSON with DIABETES (PWD) b. NEW terminology: Cardiorenal metabolic disease or                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> cardiovascular-kidney-metabolic health (CKM) c. Weight-based approach to treatment and use of medications to    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> help with weight loss d. Team-based care e. Broader use of CGM – beyond just persons on insulin 2. Glycemic     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Algorithm continues to aligns with EASD/ADA and AACE: Choose agents with a focus on drug efficacy, Cardiorenal  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> risk reduction, and weight loss. ADDED drugs indicated for MASLD or MASH 3. Endorsements: a. American Society   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for Bone and Mineral Research (Bone Health in Section 4) b. The Obesity Society (Section 8 – Obesity and Weight <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Management) c. American College of Cardiology (Section 10 – CV disease and risk management) d. NEW this year:   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the American Geriatrics Society (Section 13 – Older Adults) 4. TYPE 1 DIABETES updates: a. Antibody based       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> screening for pre-symptomatic T1D in family members of people w/T1 and others at risk: i. Type 1 DM risk: use   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> islet autoantibody tests and criteria for preclinical stages of type 1 to look for potential to delay onset     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> using teplizumab-mzwv (Tzield) in: 1. All 1st degree relatives of PWT1D 2. Newly diagnosed adults 3. Based on   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Consensus guidance b. Autoimmune Disease Screening in Type 1: 1. THYROID: Initial and REPEAT screenings         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommended at regular intervals 2. Celiac: in presence of GI symptoms, or clinical suspicion c. NEW            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommendations for persons at risk of DKA: AVOID CANNABIS due to risk of hyperemesis syndrome 5. Drug Updates: <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> a. Use of GLP1-RA i. How to handle shortages and substitutions ii. Expanded recommendations: Established/High   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Risk for ASCVD, HFpef, CKD 6. Liver Updates: a. Change in Terminology i. Nonalcoholic fatty liver disease       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (NAFLD) updated to: metabolic dysfunction–associated steatotic liver disease (MASLD) ii. Nonalcoholic           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> steatohepatitis (NASH) updated to and metabolic dysfunction–associated steatohepatitis (MASH) b. Drug Therapy   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for MASLD/MASH: i. DM meds with potential benefits: GLP1-RA, GIP/GLP1-RA and pioglitazone (phase 2 trial data)  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1. Use combination pio/GLP in adults with biopsy proven MASH or at higher risk of fibrosis ii. Resmetirom –     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> thyroid hormone receptor beta agonist approved for MASLD with fibrosis- treatment in adults (see Section 4) –   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to be prescribed by specialists only 7. Screening Updates: a. General: i. Assessment for disability at initial  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> visit, with functional decline assessment at each visit ii. PAD screening – using ankle-brachial index testing  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> in asymptomatic persons at risk for PAD, or any person with DM &gt; 10 years duration and high CV risk b.          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Male/Female sexual health i. Men – screen for erectile dysfunction, and monitor serum testosterone if           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> symptomatic of hypogonadism in men ii. Women – sexual health, and symptoms of genitourinary syndrome of         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> menopause c. Psychosocial issues: i. Screen PWD and caregivers for concerns including diabetes distress,        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> depression, anxiety, fear of hypoglycemia, and disordered eating behaviors d. Fasting: i. Utilize the Diabetes  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Ramadan International Alliance comprehensive pre-fasting risk assessment to stratify risk UPDATES by        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SECTION Section 1: Improving Care and Promoting Health in Populations 1. Promotes the use of interprofessional  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> teams and quality improvement initiatives – with actionable guidance on how to improve care delivery, and how   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to screen for, measure and address health disparities, affordability, and social determinants of health. 2.     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Continues to include information on online platforms to support behavior change/well-being Section 2: Diagnosis <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Classification of DM 1. Same 4 categories of Dx: Type 1, Type 2, DM due to other causes, GDM 2. DIAGNOSIS   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> parameters are the same, with more guidance and the addition of random plasma glucose in a symptomatic person:  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 3. NEW TABLE 2.3 – considerations related to the interpretation of lab measurements 4. NEW recommendation for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> approach to the person with features of BOTH Type 1 and Type 2 diabetes. Continues to differentiate forms of    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetes: Type 1, LADA, Type 2, monogenic syndromes (MODY), pancreatic disease (CF, pancreatitis),              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> drug/chemical induced, gestational 5. NEW emphasis on the importance of antibody based screening for            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pre-symptomatic Type 1 in persons with Family History or elevated genetic risk. Reminder: teplizumab-mzwv       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> infusion is available to delay onset of type 1 in persons &gt; 8 yrs. with stage 2 type 1. (Info in Section 3) 6.  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> GDM subsection updated 7. UPDATED: immune checkpoint inhibitors, role of gut microbiome, and monogenic diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 8. Screening thresholds: a. All adults should be screened starting at age 35 b. All overweight/obese adults     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (BMI&gt; 25) with any risk factors (FH, high-risk race, ASCVD, HTN, HLD, PCOS, inactivity) i. If results are       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> normal, screen every 3 years ii. If pre-DM level (A1C 5.7 – 6.4%), re-test yearly c. Youth: screen all who are  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> overweight with 1 or more additional risk factors d. Screen for people on medications with risks for            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hyperglycemia: glucocorticoids, statins, thiazides, HIV meds (baseline and q 3-6 months), 2nd generation        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> anti-psychotics (baseline and 12-16 wks. later) Section 3: Prevention or Delay of Diabetes and Associated       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comorbidities 1. Emphasis on INDIVIDUAL Risk/Benefit Assessment of pre-diabetes 2. NEW: highlights SLEEP as a   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> central component (equal to eating patterns and physical activity) for management 3. Non-Drug: a. All           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> overweight/obesity persons at risk should get INTENSIVE lifestyle behavior change referral b. Care Goals:       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Include 3-7% weight loss/prevention of weight gain with attention to CV risk i. INTENSIVE goals recommended if  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> BMI &gt; 35 kg/m2, A1C &gt; 6%, Hx of GDM c. Recommend local DPP:                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> https://www.cdc.gov/diabetes/prevention/find-a-program.html d. NEW: discussion on the use of VITAMIN D to       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> prevent Type 2 DM (advocated by the US Endocrine Society). Dose is not clear, and more research is needed for a <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommendation. 4. Drug Therapy: (no changes) a. Consider anti-hyperglycemic drug therapy to reduce progression <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to DM in high risk individuals b. Metformin – consider in pts 25-59 years with BMI &gt; 35 kg/m2, fasting PG &gt; 110 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mg/dL , A1C &gt; 6%, women w/GDM c. Recommend PIOGLITAZONE to reduce risk of stroke/MI in people w/stroke hx and   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pre-DM, although need to balance w/the risk of weight gain, edema, and fractures (lower dose) Section 4:        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Comprehensive Medical Evaluation and Assessment of Comorbidities 1. Immunization Updates: a. Table 4.3 includes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> consideration for: COVID-19, Hepatitis B, Influenza, Pneumococcal, RSV, Tdap, Zoster 2. BONE HEALTH updates: a. <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> When to do Bone Mineral Density (BMD) testing i. Initial: All older adults (&gt;65 yo), and younger persons with   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> multiple risk factors every 2 to 3 years b. In those at risk: i. Avoid meds with association to higher fracture <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> risk (pioglitazone, sulfonylureas) ii. Avoid meds with hypoglycemia or fall risk c. Recommended Calcium intake  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1000-1200mg/day with Vitamin D d. When to start antiresorptive and osteoanabolic agents: i. Older adults at     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> high risk of fracture: Risk Assessment Tool score (&gt;3% for hip, &gt; 20% for osteoporotic), BMD T-score &lt; 2, hx of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> fracture (hip/pelvis, vertebral, forearm) 3. NEW subsection: DENTAL CARE a. Dental Exam at least once per year  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4. Updates to assessment for: a. Disability and decline (every visit) b. Sexual health, erectile dysfunction    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and potential hypogonadism in men 5. NEW Subsection: FEMALE SEXUAL DYSFUNCTION a. Ask about sexual health (esp  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> w/hx of depression, anxiety, UTIs) b. Screen for s/sx of genitourinary syndrome of menopause 6. NEW Updates to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> LIVER: a. Terminology changed: i. Nonalcoholic fatty liver disease (NAFLD) is now: metabolic                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dysfunction–associated steatotic liver disease (MASLD) ii. Nonalcoholic steatohepatitis (NASH) was updated to   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and metabolic dysfunction– associated steatohepatitis (MASH) • SCREENING recommendations: LFTs should be        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> monitored and if ALT elevated, assess risk and/or refer to liver specialist • RISK stratification: Use          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Fibrosis-4 Index to assess, or FIB-4 (FIB-4&gt; 1.3), then refer to GI or hepatologist. See Figure 4.2 –           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diagnostic algorithm • NEW: MASLD Treatment Algorithm (Fig 4.3): MANAGE with weight loss, meds with evidence    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (GLP1-RA, dual GLP/GIP, Pioglitazone) • NEW: treatment with a thyroid hormone receptor beta agonist             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (resmetirom) in adults with prediabetes, type 2 and MASLD with moderate or advanced liver fibrosis. Med to be   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dosed and monitored by specialty Section 5: Facilitating Positive Health Behaviors and Well-being to Improve    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health Outcomes 1. NEW - Screen people with diabetes, caregivers, and family for diabetes distress at the same  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> critical times as screening for DSMES needs: UPDATED in 2024: DSMES should be provided to ALL persons with DM   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> at least 5 critical times: at diagnosis, annually, when not meeting targets/complication factors arise, during  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> transitions of life and care 2. Re-enforced the use of technology for Diabetes Self-Management Education and    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Support (DSMES)– mobile apps, simulation tools, digital coaching are effective methods AND recommended a focus  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> on Social Determinants of Health for design and delivery of education programs. 3. Dietary Recommendations: a.  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Emphasis on the quality of food sources (nutrient-dense, high-fiber, non-processed, healthy fats) regardless of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> carbohydrate amount eaten. b. See TABLE 5.3 – Nutrition Behaviors to ENCOURAGE c. Impact of high protein/high   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> fat mixed meals and insulin dosing adjustments noted d. Continue screening for food insecurity e. Non-nutritive <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> sweetener section expanded: conditional recommendations – still recommended over sugar-sweetened products, but  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> in moderation for SHORT TERM f. WATER is preferred over nutritive and non-nutritive sweetened beverages (DIET)  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> g. UPDATED information on religious fasting and chrono nutrition 4. NEW: FASTING guidance: -- Risk              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Stratification is recommended BEFORE religious fasting – see the NEW guidance for this that comes from Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Ramadan International Alliance a. Fig 5.1 – differences between religious and intermittent fasting b. Table <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 5.4 – Risk calculation and scoring c. Table 5.5 – Med changes during fasting 5. Weight loss: a. Goal: 3-7%      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> based on nutrition, physical activity, and behavior therapy i. up to 15%: to support possible REMISSION of DM   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> b. NEW recommendation: Counsel patients who are losing weight to include muscle-strengthening exercise in order <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to avoid sarcopenia. 6. Smoking Cessation: NEW – recommendation to AVOID cannabis due to risk of cannabis       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hyperemesis syndrome and potential DKA 7. Psychosocial Care – REVISED to recommend routine/at least annual      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> screening for diabetes distress, depression, anxiety, fear of hypoglycemia, and disordered eating behavior – in <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> PWD and caregivers a. Table 5.7 – Association of PS concerns and DM -related outcomes Section 6: Glycemic Goals <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and Hypoglycemia 1. NEW subsection: epidemiology, diagnostic criteria &amp; outpatient prevention of DKA and HHS a. <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NEW Tables: risk factors and clinical presentation of DKA and HHS 2. NEW graphic to help clarify                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Individualization of A1C Goals: a. This helps to support when DEINTENSIFYING medications is appropriate when    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the harms of treatment (hypoglycemia) may be greater than the benefits and goals should be adjusted. (Decreased <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> life expectancy, co-morbidities) Section 7: Diabetes Technology 1. CGM should be offered for ALL PWD (at        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diagnosis) that can understand how to use it a. Higher recommendation for persons on multiple daily injections  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> or pumps, or medications that can cause hypoglycemia. b. Benefits in PWT2 and non-intensive therapy are also    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> highlighted 2. MODIFIED: a. Table 7.2 and 7.4 – ALL potential substances/medical conditions that can affect     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> glucose levels b. Includes NEW OTC CGM devices in this section c. Sections on insulin pumps and AID systems     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with clinical trial data d. Recommendation to combine technology with online or virtual coaching e. Emphasis to <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> use Pumps and AIDs in hospitalized patients that already use them Section 8: Obesity and Weight Management for  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the Prevention and Treatment of Type 2 DM 1. &gt;90% of PWT2D are obese 2. REVISIONS include recommendations to:   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> a. Avoid therapeutic inertia and address weight stigma and bias b. Monitor anthropometric measurements at least <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> every 3 months during active weight loss 3. AFTER achieving weight loss goals: a. CONTINUE monitoring and       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> support to MAINTAIN weight loss b. CONTINUE weight loss pharmacotherapy to reduce cv risks c. Screen for        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Malnutrition d. Utilize CGM post-metabolic surgery to improve safety from hypoglycemia risks 4. UPDATED Drug    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Therapy a. TABLES updated: efficacy, adr’s, safety, costs of approved options b. Efficacy: Tirzepatide          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (Mounjaro®, Zepbound®) &gt; Semaglutide (Ozempic®, Wegovy®) &gt; Liraglutide (Victoza®, Saxenda®) &gt; Dulaglutide       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (Trulicity®) &gt; Exenatide (Bydureon®) c. 2025 New agent (not yet in guidelines) to watch: Triple Agonist:        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Retatrutide Section 9: Pharmacologic Approaches to Glycemic Treatment 1. RE-organized and EXPANDED 2. NEW       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SUB-SECTION: Special Circumstances and Populations: a. Continue to routinely assess ALL PWD for financial       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> obstacles and cost reduction b. NEW: Guidance on how to handle med shortages c. Recommendations for med choice  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> for persons of childbearing potential (use of contraception, glycemic goals, how to prepare for pregnancy) i.   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Decreased efficacy of oral contraception when using GLP1-RA or GIP drugs d. Guidance to mitigate DKA in persons <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> on SGLT-2 inhibitors and ketogenic diet: knowing risks and signs, and having tools to measure ketones e.        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Considerations for PWD secondary to chemotherapy, or with other types of DM i. Specific chemo agents can        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> increase insulin resistance: in those cases, metformin is the treatment of choice, followed by pioglitazone or  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SGLT2-i 3. NEW: INSULIN administration section expanded to include INHALED insulin and BOLUS patches 4.         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ALGORITHM updates: a. Includes healthy behaviors, education, avoidance of therapeutic inertia, and SDOH b.      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Prioritize agents to meet MULTIPLE TX GOALS: Efficacy, improve cv, kidney, liver, weight, reduce hypoglycemia   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> with consideration for COST, ACCESS, Risk of ADRs, and PWD preference c. NEW: assess the need or dose of drugs  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> that have a higher hypo risk (SFU, meglitinides, insulin), and DECREASE when adding new meds d. NEW: GLP-1RA    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> recommended for PWD and symptomatic HF with preserved EF, and obesity – irrespective of A1C (although the       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> algorithm still only has SGLT2-inhibitors on it for HF) e. AVOID using DPP4-inhibitors with GLP1-RA (lack of    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> benefit) f. ADDED: recommendations for PWD and MASLD or MASH g. Where does Metformin fit? – As an add on to any <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of the drugs used for co-morbidities, and as a starting agent for persons without any of the co-morbidities:    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ASCVD (Or high risk) Independent of A1c Heart Failure CKD eGFR 20 – 60 ml/min/1.73m2 And/or albuminuria (ACR&gt;   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 30) On Max tolerated ACEi or ARB NEW: MASLD or MASH GLP1-RAs: Dula/Lira/Sema- -or- SGLT2-i Cana/Dapa/Empa- -Or  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> combo- SGLT2-i Cana/Dapa/ Empa/Ertu GLP1-RA (sema) if symptomatic and pEF &amp; obesity NEW: EITHER GLP1-RA Sema &gt;  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Lira &gt; Dulaglutide -or- SGLT2-I: cana/dapa/empa- w/eGFR &gt; 20 -Or combo- GLP1-RA or GIP/GLP1-RA (esp if obese)   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Pioglitazone (NOT if obese) -Or combo of GLP/pio- CKD: i. SGLT2-inhibitor is recommended to prevent CKD         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> progression, although glycemic benefit is reduced at eGFR &lt; 45 ml/min. ii. If eGFR &lt; 30 ml/min – GLP-1RA is     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> preferred 5. INSULIN UPDATES: a. GLP1-RA or GLP/GIP – PREFERRED to insulin when there is NO evidence of insulin <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> deficiency b. INSULIN recommended for A1C &gt; 10% or symptomatic (polyuria/polydipsia, weight loss,               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> hypertriglyceridemia, ketosis) c. If insulin IS used, combination with GLP or GLP/GIP is recommended d. NEW –   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> guidance on switching between basal insulins: e. Usually unit:unit, although in persons on tight management or  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> high risk of hypo, cut dose 10-20% when switching. f. NEW: When assessing for over-basalization, basal dose &gt;   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 0.5 U/kg/day has been REMOVED! Instead, assess by significant HS to AM -or- pre to post prandial differences (&gt; <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 50 mg/dL), hypoglycemia occurrence, and high glycemic variability g. REMINDER: i. When initiating insulin,      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CONTINUE Metformin, SGLT2-I, GLP1-RA ii. STOP sulfonylureas, meglitinides and Dpp-4i --- they have NO           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> additional beneficial effects on cv/kidney/weight/liver… and increase risk of hypoglycemia and wt gain Section  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 10: Cardiovascular Disease and Risk Management Endorsed by ACC and AHA 1. TO reduce complications, include all  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 4: a. Glycemic Management b. BP Management c. Lipid Management d. Use Agents with CV and Kidney benefit         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (GLP1-RA and SGLT2-inhibitors) NEW Screening Recommendations: 2. HTN Recommendations: Diagnosis remains: a.     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Elevated BP: &gt; 130 mmHg systolic OR &gt; 80 mmHg diastolic -OR- a single BP &gt; 180/110 mmHg b. BP GOAL: &lt; 130/80    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> mmHg if can be done safely i. Initiate lifestyle interventions if BP &gt; 120/80 mmHg ii. Start an agent if BP &gt;   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 130/80 mmHg iii. Start 2 agents if BP &gt; 150/90 mmHg c. CLARITY on med classes: ACE-I/ARB, Thiazide or CCB i.    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ACE-I or ARB: FIRST LINE if CAD, or UACR &gt; 30 mg/g 1. MONITOR SCr, Potassium 2. AVOID if childbearing potential <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> without contraception: ACE-I, ARB, MRAs, neprilysin inhibitors ii. DIURETICS: monitor Scr/potassium 7-14 days   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> after initiation iii. MRA (spironolactone/eplerenone) – use for resistant HTN (if already on 3 recommended      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> classes, and secondary causes ruled out) iv. Beta-blockers – only if prior MI, active angina, or HFrEF d. In    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Pregnancy: Initiate therapy if BP &gt; 140/90 mmHg i. Drugs considered effective and safe: methyldopa, labetalol,  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> nifedipine ER ii. BP &lt; 90/60 mmHg – DE-intensify therapy 3. STATIN recommendations: a. NEW – avoid in           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> childbearing potential persons not using reliable contraception b. NEW – figures 10.3 and 10.4: Intolerance to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> statin therapy: 4. HYPERTRIGLYCERIDEMIA: a. NEW – Thresholds updated: i. FASTING &gt; 150 mg/dL -or- NON-FASTING &gt; <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 175 mg/dL ii. Fasting &gt; 500 mg/dL: evaluate for secondary causes and consider fibrates or fish oil to reduce    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pancreatitis risk iii. If ASCVD, addition of icosapent ethyl can be considered if TG 150 – 499 mg/dL 5. HEART   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> FAILURE (HF): a. NEW – Figure 10.6 – Recommendations for prevention of symptomatic HF: b. EDUCATE on DKA s/sx,  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> management (hold the med when ill) for any persons on SGLT2i and ketogenic diets Section 11: Chronic Kidney     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease and Risk Management ALIGNS with KDIGO consensus report: https://kdigo.org/guidelines/diabetes-ckd/ •    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Categorize patients with DKD by measuring BOTH eGFR and ALBUMINURIA a. Need 2 of 3 urine albumin-to-creatinine  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ratio (UACR) collected and abnormal b. Albuminuria as a target: in pts with CKD and &gt; 300mg/day urine albumin   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> i. GOAL: to reduce albuminuria by &gt; 30% &amp; to slow progression of CKD. Treatment • ACE-I or ARB: IF they have    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> albuminuria (UACR &gt; 30 mg/g) • NO NEED for ACEI or ARB in people with NORMAL BP, normal UACR and normal eGFR •  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NEW: If on ACE-I or ARB: titrate to MAX tolerated dose • If already on MAX tolerated ACEI or ARB, ADD           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> finerenone(NSMRA) if eGFR &gt; 25 - to improve CV outcomes and reduce progression of CKD. • NEW: if on ACE-I or    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ARB or NSMRA: Monitor SCr &amp; Potassium TREATMENT of GLYCEMIA in a Person with CKD: • SGLT2i is recommended for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> patients with an eGFR &lt; 60 ml/min and UACR &gt; 200 mg/g (or any level) --- do not initiate if eGFR&lt; 20 ml/min •   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NEW: GLP-1 RA with demonstrated benefit (semaglutide at this time) should be used REFER to NEPHROLOGY: •        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Continuous increase in urinary albumin or decrease in eGFR • eGFR &lt; 30 ml/min Section 12: Retinopathy,          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Neuropathy, and Foot Care 1. Eyes: Initial dilated and comprehensive exam at diagnosis and again every 1 to 2   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> years if no evidence of retinopathy and glycemia is within goal range. 2. NEUROPATHY: Additional screening      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> criteria for AUTONOMIC Neuropathy recommended: a. Ask about symptoms: orthostatic dizziness, syncope, early     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> satiety, ED, changes in sweating patterns, dry cracked skin in extremities, resting tachycardia b. Assess for   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> PAD via food screening, educate and REFER for work up 3. NEUROPATHY TREATMENT to include: a. Glycemic, lipid,   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> BP and weight control b. Meds: gabapentinoids, SNRIs, TCA, sodium channel blockers c. NEW: AVOID Opioids 4.     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NEW: Foot Care – increasing role of surgery a. Annual distal symmetric polyneuropathy assessment: monofilament, <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> vibration, and vascular assessment. If ANY sensory loss, recommend feet inspection at EVERY VISIT b.            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Re-enforced: The importance of smoking cessation for PAD prevention! Section 13: Older Adults UPDATE: 4Ms       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> framework: Mentation, Medications, Mobility, and what Matters Most REMINDERS: Older adults who are otherwise    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> healthy with few coexisting chronic conditions can have adult glycemic goals of A1C &lt; 7-7.5% and TIR ~ 70%.     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Individualize using the 4 M’s 1. Deintensification goals – reduce risk of hypoglycemia (increase A1C target to  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> &lt; 7.5% or &lt; 8%) a. AVOID hypo-glycemia causing medications; switch to those with lower risks b. Include agents  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to reduce cardiorenal risk, regardless of glycemia. 2. Simplification goals – decrease polypharmacy, regimen,   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> burden of disease – see Figure 13.1 for algorithm Section 14: Children and Adolescents Many small updates to    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> this section. Re-enforced the importance of treatment (due to rapid progression of complications in youth) and  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> psychosocial care: clarify diabetes distress and lower engagement in self-management behavior. Of note: • BP:   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Lifestyle modification, weight management o If needed, ACE-I or ARB, with reliable contraception if indicated • <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Lipids: Lifestyle o Age-approved statins (rosuvastatin &gt;6 years old) with LDL goal &lt; 100 mg/dL o WITH reliable  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> contraception if indicated • Key nutritional principles include specific examples of healthy food choices and   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> what to avoid • NEW: A1C goal &lt; 6.5% - for most children and adolescents • NEW: Benefits and Safety of GLP-1    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> RAs reinforced • NEW: avoid vaping, avoid cannabis NEW: Treatment choices: 2. If additional medication is       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> needed: (&gt; 10 years old) • Consider these meds before intensifying insulin: • GLP1-RAs approved for use in      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> adolescents: (in addition to metformin) o &gt; 12 years old: Liraglutide (Victoza), exenatide (Bydureon) and       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Semaglutide (Wygovy) o &gt; 10 years old: Dulaglutide (Trulicity) • SGLT2-inhibitor: empagliflozin (Jardiance®)    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Section 15: Management of Diabetes in Pregnancy (PG) NEW: RESTRUCTURED: the care of Pregnant women with all     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> types: T1, T2 and GDM. Instead of separate sections, they are merged NEW: Table 15.1 updates: Added Folic Acid  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 400-800 mcg/day, update on immunizations • Updates: expanded use of CGM, and considerations for AID • Glycemic  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Goals: ALL pregnant persons should monitor fasting, pre-prandial and postprandial glucose o Goals: ▪ Fasting &lt;  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 95 mg/dL (70-95 mg/dL) ▪ 1 h Postprandial &lt; 140 mg/dL (110 – 140 mg/dL) ▪ 2 h postprandial &lt; 120 mg/dL (100 –   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 120 mg/dL) o CGM goals: ▪ Target Range: 63-140 mg/dL ▪ Time below range goal &lt; 4%, (&lt;1% below 54 mg/dL) ▪ Time  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> above range goal &lt; 25 % o A1C is lower due to increased RBC turnover, so goal of &lt; 6% is ideal Blood Pressure   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Targets remain: • Goal: 110-135/85 mmHg • Treat if &gt; 140/90 mmHg • Updates to use of Aspirin therapy for        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> preeclampsia to match US Preventative Services Task Force • Further Explanation on why hyperglycemia in PG      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> should NOT be treated with metformin and glyburide as first line agents; LIFESTYLE and INSULIN are recommended. <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> If on metformin for PCOS, it should be stopped after the 1st trimester • Updated: o Harmful meds in pregnancy   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> to stop: ACE-I, ARBs, MRAs o Consider statin continuation in high-risk persons when benefit &gt; risk Section 16:  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Care in the Hospital Treatment should start at a threshold of &gt; 180 mg/dL • Individualize Targets: if  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> can be reached WITHOUT significant hypoglycemia • Critically ill target range of 140-180 mg/dL o Recommend      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> continuous IV insulin infusion • Noncritically ill patients: Target ranges 100 – 180 mg/dL • Preferred regimen  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> is basal, prandial, with correction insulin doses NEW: • While in hospital: continue insulin pump or AID when   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> clinically appropriate • Guidance on use of GLP agents in the perioperative setting included in the narrative   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> NEW for DKA/HHS: • Transition to subcutaneous insulin administration outlined • Fig 16.1 – new treatment        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pathways for DKA and HHS Section 17: Diabetes Advocacy Updated advocacy statement on Diabetes care in the       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> school setting and Diabetes and Driving New subsection on Diabetes Management in Detention Facilities American  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Association Professional Practice Committee. Standards of care in diabetes—2025. Diabetes Care 1       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> January                                                                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 2025;48(Supplement_1):S1-S352.\\n\\n##Source\\nhttps://www.wafp.org/assets/files/2025_ADA_Updates_All_Sections_95. <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pdf\", \"## Title\\nVolume 48 Issue Supplement_1 | Diabetes Care\\n\\n## Content\\nVolume 48 Issue Supplement_1 |     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes Care | American Diabetes Association\\n\\n===============\\n[Skip to Main                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Content](https://diabetesjournals.org/care/issue/48/Supplement_1#skipNav)\\n\\n[![Image 1: American Diabetes      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Association                                                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)_O <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> pen Menu_](javascript:;)\\n\\n[![Image 2: American Diabetes Association                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Logo](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/logo-umbrella.svg)]( <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> https://diabetesjournals.org/)[Close](javascript:;)\\n\\n*   [Professional                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Books](https://diabetesjournals.org/books)\\n*   [Clinical Compendia](https://diabetesjournals.org/compendia)\\n* <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Journals _Open Menu_](javascript:;)\\n    *   [Journals Home](https://diabetesjournals.org/journals)\\n    *     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes](https://diabetesjournals.org/diabetes)\\n    *   [Diabetes Care](https://diabetesjournals.org/care)\\n <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> *   [Clinical Diabetes](https://diabetesjournals.org/clinical)\\n    *   [Diabetes                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Spectrum](https://diabetesjournals.org/spectrum)\\n    *   [Diabetes, Obesity, and Cardiometabolic               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> CARE](https://diabetesjournals.org/docm-care)\\n    *   [BMJ Open Diabetes Research &amp; Care Open External         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://drc.bmj.com/)\\n    *   [Journal Article                                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n\\n*   [ADA Standards of <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [ADA Meeting                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [Podcasts _Open      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Professional News Open         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> External Link](https://professional.diabetes.org/)\\n\\n[_Search Dropdown Menu_](javascript:;)\\n\\nheader          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> search\\n\\nsearch input Search input auto suggest \\n\\nfilter your search \\n\\n[Search](javascript:;)\\n\\n[Advanced <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Search](https://diabetesjournals.org/advanced-search)\\n\\n[_User Tools Dropdown_](javascript:;)\\n\\n[Sign In      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> _Open Menu_](javascript:;)\\n\\n[![Image 3: Diabetes                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://ada.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/care/care-header-97500660.svg)](https: <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> //diabetesjournals.org/care)\\n\\n[_Toggle Menu_ Menu](javascript:;)\\n*   [Articles &amp; Issues _Open                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [Current Issue](https://diabetesjournals.org/care/issue)\\n    *   [Online Ahead   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of Print](https://diabetesjournals.org/care/online-ahead-of-print)\\n    *   [ADA Standards of                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n    *   [Issue                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Archive](https://diabetesjournals.org/care/issue-covers)\\n    *   [Featured Article                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Collections](https://diabetesjournals.org/journals/pages/diabetes_care_featured_collection)\\n    *   [All       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Article Collections](https://diabetesjournals.org/journals/collections)\\n    *   [Saved                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Searches](https://diabetesjournals.org/my-account/saved-searches)\\n\\n*   [Review                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Articles](https://diabetesjournals.org/collection/2178/Review-Articles)\\n*   [Info &amp; About _Open                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [About the Journal](https://diabetesjournals.org/care/pages/about-the-journal)\\n  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> *   [About the Editors](https://diabetesjournals.org/care/pages/Editorial_Board)\\n    *   [ADA Journal          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n    *   [Reuse, Licensing, and     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Public Access](https://diabetesjournals.org/journals/pages/license)\\n    *   [Reprints and                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Permissions](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n    *                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Advertising](https://diabetesjournals.org/journals/pages/advertising)\\n\\n*   [Podcasts _Open                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [All ADA Podcasts](https://diabetesjournals.org/journals/pages/podcasts)\\n    *   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [DiabetesBio Open External Link](https://diabetesbio.libsyn.com/)\\n    *   [Diabetes Care On Air Open External  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://diabetescareonair.libsyn.com/site)\\n    *   [Diabetes Core Update Open External                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link](https://docupdate.libsyn.com/site)\\n    *   [Diabetes Core Update Special                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n    *   [Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Day by Day Open External Link](https://diabetesdaybyday.libsyn.com/site)\\n\\n*   [Submit &amp; Review _Open          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [Instructions for                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Authors](https://diabetesjournals.org/care/pages/instructions-for-authors)\\n    *   [Submit a Manuscript Open   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> External Link](http://mc.manuscriptcentral.com/diabetescare)\\n    *   [Submit Cover                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Artwork](https://diabetesjournals.org/care/pages/submit_a_cover_image)\\n    *   [Guidance for                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n\\n*   [Subscribe _Open                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Menu_](javascript:;)\\n    *   [Individual                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Subscriptions](https://diabetesjournals.org/journals/pages/individual-subscriptions)\\n    *   [Email            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Alerts](https://diabetesjournals.org/my-account/alerts)\\n    *   [Institutional                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Subscriptions](https://diabetesjournals.org/journals/pages/institutional_subscriptions)\\n    *   [Access        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Institutional Usage                                                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reports](https://diabetesjournals.org/journals/pages/access-institutional-usage-reports)\\n\\n[Skip Nav           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Destination](https://diabetesjournals.org/care/issue/48/Supplement_1#)\\n\\nIssues\\n======\\n\\nSelect Year         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\n\\nIssue \\n\\n[Volume 48, Issue Supplement_1](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> January 2025\\n\\n[![Image 4: Diabetes Care Cover Image for Volume 48, Issue                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Supplement_1](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/m_diacare <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> _48_supplement_1_cover.png?Expires=1758638061&amp;Signature=tsRky5lPZ-16NyGxHsqrxBouoDXlxnN57vQ-9YyZNi77R3DMLbvfdNg <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 8f0sclCHxw~HNtctPdRGY1r88tBEyawz8yd4nRP5r52xOY01egzMTeeByJ0HbxJikbS4PxjvLLysBUKSQFzxTwLcazql9PGXm-~SrYClxiaQs7s <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> L5k-z0qLrz~DvbfnB0RrttRNHPuFiCcmB4I0ePC8vnr-lDtdCY6~F0ztPpQ1pea6~YLfzgVmPuzz~7nIhqFwIaGFdoOIneuUay9pZRFQ8fEdysH <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ~lVY6LaUOag95KKeu6XH4Lo9awqTqOPekqoKPVpdbAQxB1TnmLjx2EGc2FyDxiHmA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)](https:// <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> diabetesjournals.org/care/issue/48/Supplement_1)\\n\\n[All                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Issues](https://diabetesjournals.org/care/issue/browse-by-year)\\n\\n*   [Cover Image](javascript:;)#### Cover    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Image\\n\\n![Image 5: Issue cover                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> image](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/diacare_48_suppl <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ement_1_coverfig.png?Expires=1758638061&amp;Signature=ZEMis5fuLT55dKIErWQfVh~10x1nVMu0GEjCW9TwKy8o501Q52EZ5t-U6Dair <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> gWqCztu4DH9clg2QY2HeGnsJNqYRl0JiKbilWaOZKYNaz~dQUde8yBzyrfRrJ9XH6CmWONAbAPTwYSq32vp3SB~jaD4R~K5t1x81tF3xS5tc6XS <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> xwTfKTPfgKfnboLsLgj9paZvd9JQxg1hxXkxqUCYNfXe1h7d06yOr0RjNFNse-OZyX5oe0hDCsx-0f7DmXsBY-GV9ZmXRSaTGyI47FwLLhNBHKm <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> qU6Qz6SHL9vUO5UJa5hVMAyXzkF2vw8n36942jc~wSLSPX5GDLHm9z5eRFg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)   \\n*   _PDF    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Icon_[_PDF Link_ Table of                                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Contents](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/toc.pdf?Expir <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> es=1758638061&amp;Signature=0i7yam0Q8gx22R39sKdA2yGqUWJCDiEYKWn0iN-Xg0brqJy54tItri8Yv1Jcq6mcQ6CC3GR0~Av6KePk8pc7M5X <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ehiH3xp4HrnGWaF8qphJK7RPkXjt61vwDvPM2tZ6ukGeNciR0BnsgpIS6mxXmdRZoskhYwRYfggg6Lc7v4Ec99yxw5eWerTRnuCOYtFVGvaVbGy <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SNCSWPdNybYQ-wYifj33IBHK3oAxfaE0iD9cUpqG-gFWmvid6~36EuVaH3zk5jQCPATXzezxxNhmBcMJsJLDTlZgQCaCEXKJJIrs4YNNigaY8Wg <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Q38zxD4X5RAsn-~nSHS0LiCL6yFGFEvNw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\\n*   _PDF Icon_[_PDF Link_ Standards of   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care                                                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (PDF)](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/standards-of-car <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> e-2025.pdf?Expires=1758638061&amp;Signature=mtVgD6fn5mJYnPE~FA7KpDwv-TbRBuTNGlqz6v-U78Nel6WzdhVVxvOnh0wGojU40r7HXjU <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> oQljMzrCCq-Rb1TGQrGrpyJUs84fQ-cD4869dIVYoqe4GIvxa1B8-Qb4WneiuxC3aaxcpy95yji489lJxMnk6teE1KekMHKJr3B2WKQth-fgN0x <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> x5Zzi0Q0v48cIly4mAlMyjwnWm5EcCrdyebll6QpgaClnI1duens~bQv-dDs0R6-z70xOxnSgtMEpGiZuLU0pnsx0iTPwUJLJmnqn5vxBu7DWB- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> EBOlF~uI7VdczQVYMK8FU1LgPtRIlTG6Ybh-hWP-PcVNyK1sw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\\n*   _PDF Icon_[_PDF      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Link_ Editorial                                                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Board](https://ada.silverchair-cdn.com/ada/content_public/journal/care/issue/48/supplement_1/7/ed_board.pdf?Exp <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ires=1758638061&amp;Signature=AzekLMO5lGilJb9sstZ5d-SsSAsav2OYfceKBJ-BMOjhAwQxdHGxLyhhVBNX4n9XdHKglff3wY~4V5kVE6miA <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> A-IiavfhLu5so-Y72TlCd-~aP6FqV~ln8Mw1fCoodRorCLXWq4R9pwHKYuyB99lPptJRnd2D0TKU5uOKz~3iusalWdprFzisbFoYQzxXrTxHcUA <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> uqn1~6SEHDoLKlSUi5JSuKWHKrYeDnin0kLTB0jaAx8SMzlGo9hkxn5ZZp2XBFBpnVER1QFShO-ybBGfwCVNVxBJ-AQ1G3-88X1-ikR31EWVdJ~ <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Z~cleQppXNJbBG8-XCFqb-Tg964DYw6O17Q__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\\n\\nISSN 0149-5992\\n\\nEISSN              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 1935-5548\\n\\nClose navigation menu\\n\\nIn this Issue\\n\\n*   [Introduction and                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Methodology](https://diabetesjournals.org/care/issue/48/Supplement_1#24260-157562) \\n*   [Summary of            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Revisions](https://diabetesjournals.org/care/issue/48/Supplement_1#24261-157564) \\n*   [Standards of Care in    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/issue/48/Supplement_1#24262-157553) \\n*                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Disclosures](https://diabetesjournals.org/care/issue/48/Supplement_1#24263-157567) \\n*                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Index](https://diabetesjournals.org/care/issue/48/Supplement_1#24264-157560) \\n\\nIssue Navigation\\n\\nSearch    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> within issue: \\n\\n[Search within issue](javascript:;)\\n\\n#### Introduction and Methodology\\n\\n#####             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Introduction and Methodology: Standards of Care in                                                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S1/157562/Introduction-and-Methodology <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -Standards-of-Care-in)\\n\\n[American Diabetes Association Professional Practice                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S1/157562/Introduction-and-Methodology-Standards-of-Care-in)\\n\\n[Open the PDF for in another              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S1/791585/dc25sint.pdf)\\n\\nDiabetes Care  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S1-S5. doi:(https://doi.org/10.2337/dc25-SINT)\\n\\n#### Summary of Revisions\\n\\n#####     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Summary of Revisions: Standards of Care in                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standar <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ds-of-Care-in-Diabetes)\\n\\n[American Diabetes Association Professional Practice                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S6/157564/Summary-of-Revisions-Standards-of-Care-in-Diabetes)\\n\\n[Open the PDF for in another             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S6/791587/dc25srev.pdf)\\n\\nDiabetes Care  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S6-S13. doi:(https://doi.org/10.2337/dc25-SREV)\\n\\n#### Standards of Care in             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025\\n\\n##### [1. Improving Care and Promoting Health in Populations: Standards of Care in             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S14/157553/1-Improving-Care-and-Promot <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ing-Health-in)\\n\\n[American Diabetes Association Professional Practice                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S14/157553/1-Improving-Care-and-Promoting-Health-in)\\n\\n[Open the PDF for in another                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S14/791468/dc25s001.pdf)\\n\\nDiabetes Care <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S14-S26. doi:(https://doi.org/10.2337/dc25-S001)\\n\\n##### [2. Diagnosis and              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Classification of Diabetes: Standards of Care in                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classificat <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ion-of-Diabetes)\\n\\n[American Diabetes Association Professional Practice                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S27/157566/2-Diagnosis-and-Classification-of-Diabetes)\\n\\n[Open the PDF for in another                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S27/791502/dc25s002.pdf)\\n\\nDiabetes Care <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S27-S49. doi:(https://doi.org/10.2337/dc25-S002)\\n\\n##### [3. Prevention or Delay of     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes and Associated Comorbidities: Standards of Care in                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S50/157550/3-Prevention-or-Delay-of-Di <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> abetes-and-Associated)\\n\\n[American Diabetes Association Professional Practice                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S50/157550/3-Prevention-or-Delay-of-Diabetes-and-Associated)\\n\\n[Open the PDF for in another              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S50/791483/dc25s003.pdf)\\n\\nDiabetes Care <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S50-S58. doi:(https://doi.org/10.2337/dc25-S003)\\n\\n##### [4. Comprehensive Medical      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Evaluation and Assessment of Comorbidities: Standards of Care in                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S59/157568/4-Comprehensive-Medical-Eva <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> luation-and-Assessment)\\n\\n[American Diabetes Association Professional Practice                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S59/157568/4-Comprehensive-Medical-Evaluation-and-Assessment)\\n\\n[Open the PDF for in another             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S59/791510/dc25s004.pdf)\\n\\nDiabetes Care <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S59-S85. doi:(https://doi.org/10.2337/dc25-S004)\\n\\n##### [5. Facilitating Positive      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S86/157563/5-Facilitating-Positive-Hea <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> lth-Behaviors-and-Well)\\n\\n[American Diabetes Association Professional Practice                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S86/157563/5-Facilitating-Positive-Health-Behaviors-and-Well)\\n\\n[Open the PDF for in another             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S86/791496/dc25s005.pdf)\\n\\nDiabetes Care <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> December 2024, Vol.48, S86-S127. doi:(https://doi.org/10.2337/dc25-S005)\\n\\n##### [6. Glycemic Goals and        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Hypoglycemia: Standards of Care in                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S128/157561/6-Glycemic-Goals-and-Hypog <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> lycemia-Standards-of)\\n\\n[American Diabetes Association Professional Practice                                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S128/157561/6-Glycemic-Goals-and-Hypoglycemia-Standards-of)\\n\\n[Open the PDF for in another               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S128/791506/dc25s006.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S128-S145. doi:(https://doi.org/10.2337/dc25-S006)\\n\\n##### [7. Diabetes            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Technology: Standards of Care in                                                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S146/157557/7-Diabetes-Technology-Stan <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> dards-of-Care-in)\\n\\n[American Diabetes Association Professional Practice                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S146/157557/7-Diabetes-Technology-Standards-of-Care-in)\\n\\n[Open the PDF for in another                   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S146/791474/dc25s007.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S146-S166. doi:(https://doi.org/10.2337/dc25-S007)\\n\\n##### [8. Obesity and Weight  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes–2025](https://diabetesjournals.org/care/article/48/Supplement_1/S167/157555/8-Obesity-and-Weight-Manag <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ement-for-the-Prevention)\\n\\n[American Diabetes Association Professional Practice                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S167/157555/8-Obesity-and-Weight-Management-for-the-Prevention)\\n\\n[Open the PDF for in another           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S167/791462/dc25s008.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S167-S180. doi:(https://doi.org/10.2337/dc25-S008)\\n\\n##### [9. Pharmacologic       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Approaches to Glycemic Treatment: Standards of Care in                                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S181/157569/9-Pharmacologic-Approaches <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -to-Glycemic-Treatment)\\n\\n[American Diabetes Association Professional Practice                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S181/157569/9-Pharmacologic-Approaches-to-Glycemic-Treatment)\\n\\n[Open the PDF for in another             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S181/791515/dc25s009.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S181-S206. doi:(https://doi.org/10.2337/dc25-S009)\\n\\n##### [10. Cardiovascular     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease and Risk Management: Standards of Care in                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S207/157549/10-Cardiovascular-Disease- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and-Risk-Management)\\n\\n[American Diabetes Association Professional Practice                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S207/157549/10-Cardiovascular-Disease-and-Risk-Management)\\n\\n[Open the PDF for in another                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S207/791453/dc25s010.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S207-S238. doi:(https://doi.org/10.2337/dc25-S010)\\n\\n##### [11. Chronic Kidney     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Disease and Risk Management: Standards of Care in                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S239/157554/11-Chronic-Kidney-Disease- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and-Risk-Management)\\n\\n[American Diabetes Association Professional Practice                                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S239/157554/11-Chronic-Kidney-Disease-and-Risk-Management)\\n\\n[Open the PDF for in another                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S239/791464/dc25s011.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S239-S251. doi:(https://doi.org/10.2337/dc25-S011)\\n\\n##### [12. Retinopathy,       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Neuropathy, and Foot Care: Standards of Care in                                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S252/157552/12-Retinopathy-Neuropathy- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> and-Foot-Care-Standards)\\n\\n[American Diabetes Association Professional Practice                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S252/157552/12-Retinopathy-Neuropathy-and-Foot-Care-Standards)\\n\\n[Open the PDF for in another            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S252/791472/dc25s012.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S252-S265. doi:(https://doi.org/10.2337/dc25-S012)\\n\\n##### [13. Older Adults:      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Standards of Care in                                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S266/157556/13-Older-Adults-Standards- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of-Care-in-Diabetes-2025)\\n\\n[American Diabetes Association Professional Practice                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S266/157556/13-Older-Adults-Standards-of-Care-in-Diabetes-2025)\\n\\n[Open the PDF for in another           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S266/791479/dc25s013.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S266-S282. doi:(https://doi.org/10.2337/dc25-S013)\\n\\n##### [14. Children and       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Adolescents: Standards of Care in                                                                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S283/157559/14-Children-and-Adolescent <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> s-Standards-of-Care-in)\\n\\n[American Diabetes Association Professional Practice                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S283/157559/14-Children-and-Adolescents-Standards-of-Care-in)\\n\\n[Open the PDF for in another             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S283/791491/dc25s014.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S283-S305. doi:(https://doi.org/10.2337/dc25-S014)\\n\\n##### [15. Management of      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes in Pregnancy: Standards of Care in                                                                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S306/157565/15-Management-of-Diabetes- <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> in-Pregnancy-Standards)\\n\\n[American Diabetes Association Professional Practice                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S306/157565/15-Management-of-Diabetes-in-Pregnancy-Standards)\\n\\n[Open the PDF for in another             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S306/791470/dc25s015.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S306-S320. doi:(https://doi.org/10.2337/dc25-S015)\\n\\n##### [16. Diabetes Care in   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> the Hospital: Standards of Care in                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S321/157551/16-Diabetes-Care-in-the-Ho <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> spital-Standards-of-Care)\\n\\n[American Diabetes Association Professional Practice                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S321/157551/16-Diabetes-Care-in-the-Hospital-Standards-of-Care)\\n\\n[Open the PDF for in another           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S321/791476/dc25s016.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S321-S334. doi:(https://doi.org/10.2337/dc25-S016)\\n\\n##### [17. Diabetes Advocacy: <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Standards of Care in                                                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S335/157558/17-Diabetes-Advocacy-Stand <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ards-of-Care-in-Diabetes)\\n\\n[American Diabetes Association Professional Practice                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Committee](https://diabetesjournals.org/care/search-results?f_AllAuthors=American+Diabetes+Association+Professi <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> onal+Practice+Committee+)\\n\\n[Abstracts](javascript:;)\\n\\n[View article titled,                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S335/157558/17-Diabetes-Advocacy-Standards-of-Care-in-Diabetes)\\n\\n[Open the PDF for in another           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S335/791489/dc25s017.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S335-S336. doi:(https://doi.org/10.2337/dc25-S017)\\n\\n#### Disclosures\\n\\n#####     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Disclosures: Standards of Care in                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S337/157567/Disclosures-Standards-of-C <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> are-in-Diabetes-2025)\\n\\n[View article titled,                                                                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S337/157567/Disclosures-Standards-of-Care-in-Diabetes-2025)\\n\\n[Open the PDF for in another               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S337-S343. doi:(https://doi.org/10.2337/dc25-SDIS)\\n\\n#### Index\\n\\n#####           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Index](https://diabetesjournals.org/care/article/48/Supplement_1/S344/157560/Index)\\n\\n[Extract](javascript:;) <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> \\n\\n[View article titled,                                                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text](https://diabetesjournals.org/care/article/48/Supplem <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ent_1/S344/157560/Index)\\n\\n[Open the PDF for in another                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> window](https://diabetesjournals.org/care/article-pdf/48/Supplement_1/S344/791494/dc25in01.pdf)\\n\\nDiabetes     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Care December 2024, Vol.48, S344-S352. doi:(https://doi.org/10.2337/dc25-in01)\\n\\n### Email alerts\\n\\n[Online   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Ahead of Print Alert](javascript:;)\\n\\n[Latest Issue Alert](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\n### <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> RSS Feeds\\n\\n[Current Issue RSS Feed](https://diabetesjournals.org/rss/site_1000003/1000004.xml)\\n\\n[RSS Feed - <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Advance Access](https://diabetesjournals.org/rss/site_1000003/advanceAccess_1000004.xml)\\n\\n*   [Most           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Read](javascript:;)\\n*   [Most Cited](javascript:;)\\n\\n[2. Diagnosis and Classification of Diabetes: Standards  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> of Care in                                                                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566/2-Diagnosis-and-Classificat <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ion-of-Diabetes)\\n\\n[9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S181/157569/9-Pharmacologic-Approaches <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -to-Glycemic-Treatment)\\n\\n[Hyperglycemic Crises in Adults With Diabetes: A Consensus                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Report](https://diabetesjournals.org/care/article/47/8/1257/156808/Hyperglycemic-Crises-in-Adults-With-Diabetes <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> -A)\\n\\n[Summary of Revisions: Standards of Care in                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes—2025](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standar <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ds-of-Care-in-Diabetes)\\n\\n[Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Glucose                                                                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Monitoring](https://diabetesjournals.org/care/article/41/11/2275/36593/Glucose-Management-Indicator-GMI-A-New-T <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> erm-for)\\n\\n*   Online ISSN 1935-5548\\n*   Print ISSN 0149-5992\\n\\n### Journals\\n\\n*                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes](https://diabetesjournals.org/diabetes)\\n*   [Diabetes Care](https://diabetesjournals.org/care)\\n*    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes, Obesity, and Cardiometabolic CARE](https://diabetesjournals.org/docm-care)\\n*   [Clinical            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://diabetesjournals.org/clinical)\\n*   [Diabetes                                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Spectrum](https://diabetesjournals.org/spectrum)\\n*   [Standards of Medical Care in                             <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Diabetes](https://diabetesjournals.org/care/issue/48/Supplement_1)\\n*   [Scientific Sessions                    <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Abstracts](https://diabetesjournals.org/journals/pages/scientific-sessions-abstracts)\\n*   [BMJ Open Diabetes   <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Research &amp; Care](https://drc.bmj.com/)\\n\\n### Books\\n\\n*                                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [ShopDiabetes.org](https://shopdiabetes.org/collections/professional-books)\\n*   [ADA Professional              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Books](https://diabetesjournals.org/books)\\n\\n### Clinical Compendia\\n\\n*   [Clinical Compendia                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Home](https://diabetesjournals.org/compendia)\\n\\n### News\\n\\n*   [Latest                                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> News](https://www.diabetes.org/newsroom)\\n*   [DiabetesPro                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> SmartBrief](https://www2.smartbrief.com/signupSystem/subscribe.action?pageSequence=1&amp;briefName=diabetespro)\\n\\n <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ### Podcasts\\n\\n*   [Diabetes Core                                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Update](https://diabetesjournals.org/journals/pages/diabetes-core-update-podcasts)\\n*   [Diabetes Care \\\"On     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Air\\\"](https://sites.libsyn.com/453336/site)\\n*   [DiabetesBio](https://sites.libsyn.com/499063/site)\\n*        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes Day by Day](https://sites.libsyn.com/435096/site)\\n*   [Diabetes Core Update: Special                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Editions](https://diabetesjournals.org/journals/pages/diabetes-core-update-special-editions)\\n\\n### Other\\n\\n*  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Special Collections](https://diabetesjournals.org/journals/pages/journals_special_collections)\\n*              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [DiabetesPro®](https://professional.diabetes.org/)\\n*   [Diabetes Food                                          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Hub™](https://www.diabetesfoodhub.org/)\\n*   [Insulin Affordability](https://doi.org/10.2337/dci18-0019)\\n*     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Know Diabetes By Heart™](https://www.knowdiabetesbyheart.org/)\\n\\n### About\\n\\n*   [About the                  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ADA](https://www.diabetes.org/about-us)\\n*   [Journal                                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policies](https://diabetesjournals.org/journals/pages/ada-journal-policies)\\n*   [For                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reviewers](https://diabetesjournals.org/journals/pages/reviewers)\\n*   [Advertising in ADA                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Journals](https://diabetesjournals.org/journals/pages/advertising)\\n*   [Reprints and Permission for            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reuse](https://diabetesjournals.org/journals/pages/reprints-and-permissions)\\n*   [Copyright Notice/Public      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Access Policy](https://diabetesjournals.org/journals/pages/license)\\n*   [Privacy                               <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policy](https://diabetes.org/about-us/policies/privacy-policy)\\n\\n### Resources\\n\\n*   [ADA Professional        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Membership](https://professional.diabetes.org/membership)\\n*   [ADA Member                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Directory](http://professional.diabetes.org/directory)\\n*                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Diabetes.org](http://www.diabetes.org/)\\n\\n[![Image                                                            <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> 6](https://ada.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/images/umbrella/logo-umbrella-footer.sv <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> g?versionId=6302)](https://diabetes.org/)\\n\\n*   [X (Twitter)](https://twitter.com/ADA_Pubs)\\n*                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Facebook](https://www.facebook.com/adaPublications)\\n*                                                         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [LinkedIn](https://www.linkedin.com/company/american-diabetes-association/)\\n\\n*   [Contact                     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Us](https://diabetesjournals.org/contact-us)\\n*   [Cookie                                                       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Policy](https://diabetesjournals.org/journals/pages/Policies)\\n*                                                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Accessibility](https://diabetesjournals.org/pages/Accessibility)\\n*   [Terms &amp;                                 <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Conditions](https://diabetes.org/about-us/policies/terms-of-use)\\n*   [Get Adobe Acrobat                        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Reader](https://get.adobe.com/reader/)\\n*   © Copyright American Diabetes Association\\n\\n[_Close                <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Modal_](javascript:;)\\n\\n[Close Modal](javascript:;)\\n\\n##### This Feature Is Available To Subscribers          <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Only\\n\\n[Sign In](https://diabetesjournals.org/sign-in?returnUrl=%2fcare%2fissue%2f48%2fSupplement_1) or        <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> [Create an                                                                                                      <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Account](https://diabetesjournals.org/my-account/register?siteId=1000003&amp;returnUrl=%2fcare%2fissue%2f48%2fSuppl <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> ement_1)\\n\\n[_Close Modal_](javascript:;)\\n\\n[_Close Modal_](javascript:;)\\n\\n This site uses cookies. By       <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> continuing to use our website, you are agreeing to                                                              <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (https://www.diabetesjournals.org/content/privacy-policy-american-diabetes-association-journals)\\n\\n[Accept](ja <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> vascript:;)\\n\\nclose advertisement\\n\\n\\n##Source\\nhttps://diabetesjournals.org/care/issue/48/Supplement_1\"]     <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 54379\n",
            "Token count (response): 554\n",
            "------------------------- TOKEN USAGE -------------------------\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[32m╭─\u001b[0m\u001b[32m────────────────────────────────────────────────\u001b[0m\u001b[32m 🤖 Assistant \u001b[0m\u001b[32m─────────────────────────────────────────────────\u001b[0m\u001b[32m─╮\u001b[0m\n",
              "\u001b[32m│\u001b[0m The latest methods for diabetes management, as outlined in the **2025 Standards of Care in Diabetes** by the    \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m American Diabetes Association (ADA), include several key updates and recommendations aimed at improving patient \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m outcomes. Here are some of the most notable advancements:                                                       \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m ### Key Updates in Diabetes Management (2025)                                                                   \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 1. **Medication Recommendations**:                                                                              \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - **GLP-1 Receptor Agonists**: Recommended for individuals with type 2 diabetes and chronic kidney disease   \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m to reduce the risk of heart disease and protect kidney function.                                                \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - **Dual GIP and GLP-1 Receptor Agonists**: Suggested for those with type 2 diabetes, obesity, and heart     \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m failure to manage glucose levels and alleviate heart failure symptoms.                                          \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 2. **Nutrition and Lifestyle**:                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Emphasis on **evidence-based healthy eating patterns**, including plant-based proteins and fiber, while    \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m limiting saturated fats and sugary beverages.                                                                   \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Recommendations for weight loss strategies, particularly for those with type 2 diabetes and nonalcoholic   \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m fatty liver disease (NAFLD).                                                                                    \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 3. **Technology Integration**:                                                                                  \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Increased guidance on incorporating diabetes technology, such as continuous glucose monitoring (CGM), into \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m treatment plans to enhance management and monitoring of diabetes.                                               \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 4. **Screening and Diagnosis**:                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Introduction of **antibody-based testing** for individuals at risk of developing type 1 diabetes,          \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m particularly those with a family history.                                                                       \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Updated screening protocols for various comorbidities, including cardiovascular disease and kidney health. \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 5. **Psychosocial Considerations**:                                                                             \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Routine screening for diabetes distress, depression, and anxiety, emphasizing the importance of mental     \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m health in diabetes management.                                                                                  \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 6. **Special Populations**:                                                                                     \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Tailored recommendations for older adults and children, focusing on individualized care and the unique     \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m challenges faced by these groups.                                                                               \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m 7. **Comprehensive Care Approach**:                                                                             \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m    - Encouragement of a **team-based care model** that includes various healthcare professionals to address the \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m multifaceted needs of individuals with diabetes.                                                                \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m ### Resources for Further Information                                                                           \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m - For a detailed overview of the 2025 Standards of Care, you can access the full document                       \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m (https://diabetesjournals.org/care/issue/48/Supplement_1) (ADA, January 2025).                                  \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m - Additional insights and updates can be found in the [Summary of                                               \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m Revisions](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-o \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m f-Care-in-Diabetes) (ADA, December 2024).                                                                       \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m These updates reflect a growing understanding of diabetes management that prioritizes personalized care, the    \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m integration of technology, and a holistic approach to health and well-being.                                    \u001b[32m│\u001b[0m\n",
              "\u001b[32m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008000; text-decoration-color: #008000\">╭───────────────────────────────────────────────── 🤖 Assistant ──────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> The latest methods for diabetes management, as outlined in the **2025 Standards of Care in Diabetes** by the    <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> American Diabetes Association (ADA), include several key updates and recommendations aimed at improving patient <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> outcomes. Here are some of the most notable advancements:                                                       <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> ### Key Updates in Diabetes Management (2025)                                                                   <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 1. **Medication Recommendations**:                                                                              <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - **GLP-1 Receptor Agonists**: Recommended for individuals with type 2 diabetes and chronic kidney disease   <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> to reduce the risk of heart disease and protect kidney function.                                                <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - **Dual GIP and GLP-1 Receptor Agonists**: Suggested for those with type 2 diabetes, obesity, and heart     <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> failure to manage glucose levels and alleviate heart failure symptoms.                                          <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 2. **Nutrition and Lifestyle**:                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Emphasis on **evidence-based healthy eating patterns**, including plant-based proteins and fiber, while    <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> limiting saturated fats and sugary beverages.                                                                   <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Recommendations for weight loss strategies, particularly for those with type 2 diabetes and nonalcoholic   <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> fatty liver disease (NAFLD).                                                                                    <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 3. **Technology Integration**:                                                                                  <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Increased guidance on incorporating diabetes technology, such as continuous glucose monitoring (CGM), into <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> treatment plans to enhance management and monitoring of diabetes.                                               <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 4. **Screening and Diagnosis**:                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Introduction of **antibody-based testing** for individuals at risk of developing type 1 diabetes,          <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> particularly those with a family history.                                                                       <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Updated screening protocols for various comorbidities, including cardiovascular disease and kidney health. <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 5. **Psychosocial Considerations**:                                                                             <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Routine screening for diabetes distress, depression, and anxiety, emphasizing the importance of mental     <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> health in diabetes management.                                                                                  <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 6. **Special Populations**:                                                                                     <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Tailored recommendations for older adults and children, focusing on individualized care and the unique     <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> challenges faced by these groups.                                                                               <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> 7. **Comprehensive Care Approach**:                                                                             <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>    - Encouragement of a **team-based care model** that includes various healthcare professionals to address the <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> multifaceted needs of individuals with diabetes.                                                                <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> ### Resources for Further Information                                                                           <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> - For a detailed overview of the 2025 Standards of Care, you can access the full document                       <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> (https://diabetesjournals.org/care/issue/48/Supplement_1) (ADA, January 2025).                                  <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> - Additional insights and updates can be found in the [Summary of                                               <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> Revisions](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-o <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> f-Care-in-Diabetes) (ADA, December 2024).                                                                       <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> These updates reflect a growing understanding of diabetes management that prioritizes personalized care, the    <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> integration of technology, and a holistic approach to health and well-being.                                    <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "The latest methods for diabetes management, as outlined in the **2025 Standards of Care in Diabetes** by the American Diabetes Association (ADA), include several key updates and recommendations aimed at improving patient outcomes. Here are some of the most notable advancements:\n\n### Key Updates in Diabetes Management (2025)\n\n1. **Medication Recommendations**:\n   - **GLP-1 Receptor Agonists**: Recommended for individuals with type 2 diabetes and chronic kidney disease to reduce the risk of heart disease and protect kidney function.\n   - **Dual GIP and GLP-1 Receptor Agonists**: Suggested for those with type 2 diabetes, obesity, and heart failure to manage glucose levels and alleviate heart failure symptoms.\n\n2. **Nutrition and Lifestyle**:\n   - Emphasis on **evidence-based healthy eating patterns**, including plant-based proteins and fiber, while limiting saturated fats and sugary beverages.\n   - Recommendations for weight loss strategies, particularly for those with type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).\n\n3. **Technology Integration**:\n   - Increased guidance on incorporating diabetes technology, such as continuous glucose monitoring (CGM), into treatment plans to enhance management and monitoring of diabetes.\n\n4. **Screening and Diagnosis**:\n   - Introduction of **antibody-based testing** for individuals at risk of developing type 1 diabetes, particularly those with a family history.\n   - Updated screening protocols for various comorbidities, including cardiovascular disease and kidney health.\n\n5. **Psychosocial Considerations**:\n   - Routine screening for diabetes distress, depression, and anxiety, emphasizing the importance of mental health in diabetes management.\n\n6. **Special Populations**:\n   - Tailored recommendations for older adults and children, focusing on individualized care and the unique challenges faced by these groups.\n\n7. **Comprehensive Care Approach**:\n   - Encouragement of a **team-based care model** that includes various healthcare professionals to address the multifaceted needs of individuals with diabetes.\n\n### Resources for Further Information\n- For a detailed overview of the 2025 Standards of Care, you can access the full document [here](https://diabetesjournals.org/care/issue/48/Supplement_1) (ADA, January 2025).\n- Additional insights and updates can be found in the [Summary of Revisions](https://diabetesjournals.org/care/article/48/Supplement_1/S6/157564/Summary-of-Revisions-Standards-of-Care-in-Diabetes) (ADA, December 2024).\n\nThese updates reflect a growing understanding of diabetes management that prioritizes personalized care, the integration of technology, and a holistic approach to health and well-being."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"Please recommend a right doctor\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=True)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 863
        },
        "id": "7GjCO1r_EsnN",
        "outputId": "a0493e14-36e1-4e3b-b426-aa3fcee02dee"
      },
      "id": "7GjCO1r_EsnN",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[34m╭─\u001b[0m\u001b[34m──────────────────────────────────────────────────\u001b[0m\u001b[34m 🧑 Human \u001b[0m\u001b[34m───────────────────────────────────────────────────\u001b[0m\u001b[34m─╮\u001b[0m\n",
              "\u001b[34m│\u001b[0m Please recommend a right doctor                                                                                 \u001b[34m│\u001b[0m\n",
              "\u001b[34m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #000080; text-decoration-color: #000080\">╭─────────────────────────────────────────────────── 🧑 Human ────────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #000080; text-decoration-color: #000080\">│</span> Please recommend a right doctor                                                                                 <span style=\"color: #000080; text-decoration-color: #000080\">│</span>\n",
              "<span style=\"color: #000080; text-decoration-color: #000080\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 54945\n",
            "Token count (response): 18\n",
            "------------------------- TOKEN USAGE -------------------------\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[31m╭─\u001b[0m\u001b[31m───────────────────────────────────────────────\u001b[0m\u001b[31m ⚙️ Tool Request \u001b[0m\u001b[31m────────────────────────────────────────────────\u001b[0m\u001b[31m─╮\u001b[0m\n",
              "\u001b[31m│\u001b[0m                                                                                                                 \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m 🔧 Tool Call: recommend_doctor                                                                                  \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m    Args: {                                                                                                      \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m   \"query\": \"diabetes management\"                                                                                \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m }                                                                                                               \u001b[31m│\u001b[0m\n",
              "\u001b[31m│\u001b[0m    ID: call_SCjPBRhckmYOtkFJ2Zrs1k6P                                                                            \u001b[31m│\u001b[0m\n",
              "\u001b[31m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #800000; text-decoration-color: #800000\">╭──────────────────────────────────────────────── ⚙️ Tool Request ─────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>                                                                                                                 <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span> 🔧 Tool Call: recommend_doctor                                                                                  <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>    Args: {                                                                                                      <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>   \"query\": \"diabetes management\"                                                                                <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span> }                                                                                                               <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">│</span>    ID: call_SCjPBRhckmYOtkFJ2Zrs1k6P                                                                            <span style=\"color: #800000; text-decoration-color: #800000\">│</span>\n",
              "<span style=\"color: #800000; text-decoration-color: #800000\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[33m╭─\u001b[0m\u001b[33m───────────────────────────────────────────────\u001b[0m\u001b[33m 🔧 Tool Output \u001b[0m\u001b[33m────────────────────────────────────────────────\u001b[0m\u001b[33m─╮\u001b[0m\n",
              "\u001b[33m│\u001b[0m {\"recommended_doctor\": \"```json\\n{\\n    \\\"name\\\": \\\"Dr. Janet Dyne\\\",\\n    \\\"specialization\\\": \\\"Endocrinology  \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m (Diabetes Care)\\\",\\n    \\\"available_timings\\\": \\\"10:00 AM - 1:00 PM\\\",\\n    \\\"location\\\": \\\"City Health         \u001b[33m│\u001b[0m\n",
              "\u001b[33m│\u001b[0m Clinic\\\",\\n    \\\"contact\\\": \\\"janet.dyne@healthclinic.com\\\"\\n}\\n```\"}                                           \u001b[33m│\u001b[0m\n",
              "\u001b[33m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #808000; text-decoration-color: #808000\">╭──────────────────────────────────────────────── 🔧 Tool Output ─────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> {\"recommended_doctor\": \"```json\\n{\\n    \\\"name\\\": \\\"Dr. Janet Dyne\\\",\\n    \\\"specialization\\\": \\\"Endocrinology  <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> (Diabetes Care)\\\",\\n    \\\"available_timings\\\": \\\"10:00 AM - 1:00 PM\\\",\\n    \\\"location\\\": \\\"City Health         <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">│</span> Clinic\\\",\\n    \\\"contact\\\": \\\"janet.dyne@healthclinic.com\\\"\\n}\\n```\"}                                           <span style=\"color: #808000; text-decoration-color: #808000\">│</span>\n",
              "<span style=\"color: #808000; text-decoration-color: #808000\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 55061\n",
            "Token count (response): 101\n",
            "------------------------- TOKEN USAGE -------------------------\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "\u001b[32m╭─\u001b[0m\u001b[32m────────────────────────────────────────────────\u001b[0m\u001b[32m 🤖 Assistant \u001b[0m\u001b[32m─────────────────────────────────────────────────\u001b[0m\u001b[32m─╮\u001b[0m\n",
              "\u001b[32m│\u001b[0m I recommend the following doctor for diabetes management:                                                       \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m ### Dr. Janet Dyne                                                                                              \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m - **Specialization**: Endocrinology (Diabetes Care)                                                             \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m - **Available Timings**: 10:00 AM - 1:00 PM                                                                     \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m - **Location**: City Health Clinic                                                                              \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m - **Contact**: (mailto:janet.dyne@healthclinic.com)                                                             \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m                                                                                                                 \u001b[32m│\u001b[0m\n",
              "\u001b[32m│\u001b[0m You can book an appointment with Dr. Dyne by emailing her directly.                                             \u001b[32m│\u001b[0m\n",
              "\u001b[32m╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯\u001b[0m\n"
            ],
            "text/html": [
              "<pre style=\"white-space:pre;overflow-x:auto;line-height:normal;font-family:Menlo,'DejaVu Sans Mono',consolas,'Courier New',monospace\"><span style=\"color: #008000; text-decoration-color: #008000\">╭───────────────────────────────────────────────── 🤖 Assistant ──────────────────────────────────────────────────╮</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> I recommend the following doctor for diabetes management:                                                       <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> ### Dr. Janet Dyne                                                                                              <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> - **Specialization**: Endocrinology (Diabetes Care)                                                             <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> - **Available Timings**: 10:00 AM - 1:00 PM                                                                     <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> - **Location**: City Health Clinic                                                                              <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> - **Contact**: (mailto:janet.dyne@healthclinic.com)                                                             <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span>                                                                                                                 <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">│</span> You can book an appointment with Dr. Dyne by emailing her directly.                                             <span style=\"color: #008000; text-decoration-color: #008000\">│</span>\n",
              "<span style=\"color: #008000; text-decoration-color: #008000\">╰─────────────────────────────────────────────────────────────────────────────────────────────────────────────────╯</span>\n",
              "</pre>\n"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "I recommend the following doctor for diabetes management:\n\n### Dr. Janet Dyne\n- **Specialization**: Endocrinology (Diabetes Care)\n- **Available Timings**: 10:00 AM - 1:00 PM\n- **Location**: City Health Clinic\n- **Contact**: [janet.dyne@healthclinic.com](mailto:janet.dyne@healthclinic.com)\n\nYou can book an appointment with Dr. Dyne by emailing her directly."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"How to prevent panic attacks\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "rOP5AGDOLqlP",
        "outputId": "ca02cc35-f09e-4c91-f696-d55ac2b2505c"
      },
      "id": "rOP5AGDOLqlP",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 55174\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 85811\n",
            "Token count (response): 643\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "To prevent panic attacks, consider the following strategies based on the latest recommendations:\n\n### 11 Effective Methods to Prevent Panic Attacks\n\n1. **Practice Muscle Relaxation Techniques**:\n   - Engage in progressive muscle relaxation by tensing and then relaxing different muscle groups to reduce tension and anxiety.\n\n2. **Acknowledge the Panic Attack**:\n   - Remind yourself that panic attacks are temporary and will pass. Understanding that these feelings are not life-threatening can help reduce fear.\n\n3. **Deep Breathing Exercises**:\n   - Practice deep breathing techniques, such as inhaling deeply through your nose and exhaling slowly through your mouth. Techniques like the 4-7-8 breathing method can be particularly effective.\n\n4. **Find a Peaceful Spot**:\n   - If possible, move to a quieter environment to help calm your mind and focus on your breathing.\n\n5. **Focus on an Object**:\n   - Ground yourself by concentrating on a physical object in your environment. Describe its features to yourself to redirect your focus.\n\n6. **Use the 5-4-3-2-1 Method**:\n   - Identify five things you can see, four things you can touch, three things you can hear, two things you can smell, and one thing you can taste to help ground yourself.\n\n7. **Repeat a Mantra**:\n   - Use a calming phrase or mantra to help center your thoughts and reduce anxiety.\n\n8. **Engage in Light Exercise**:\n   - Activities like walking can help release endorphins and improve your mood, although be mindful as exercise can sometimes initially increase heart rate.\n\n9. **Take Prescribed Medications**:\n   - If you have been prescribed medication for anxiety or panic attacks, ensure you take it as directed.\n\n10. **Communicate with Others**:\n    - Inform someone you trust about your panic attacks so they can provide support if needed.\n\n11. **Identify Triggers**:\n    - Keep a journal to track when panic attacks occur and identify potential triggers. Understanding your triggers can help you manage or avoid them.\n\n### Additional Long-term Strategies\n- **Cognitive Behavioral Therapy (CBT)**: This therapy can help you develop coping strategies and change negative thought patterns.\n- **Regular Exercise**: Engaging in physical activity can help manage stress and anxiety levels.\n- **Mindfulness and Meditation**: Practicing mindfulness can help you stay present and reduce anxiety over time.\n- **Healthy Lifestyle Choices**: Maintain a balanced diet, avoid excessive caffeine and alcohol, and ensure you get enough sleep.\n\n### When to Seek Help\nIf panic attacks are frequent or interfere with your daily life, consider speaking with a healthcare professional for further evaluation and treatment options.\n\nFor more detailed information, you can refer to the sources:\n- [Medical News Today](https://www.medicalnewstoday.com/articles/321510) (Updated April 29, 2025)\n- [Harvard Health](https://www.health.harvard.edu/mind-and-mood/panic-attacks-recognizing-and-managing-panic-attacks-and-preventing-future-attacks) (Published May 24, 2024)"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"Research on the latest methods of cancer treatment\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 426
        },
        "id": "8QK2aagP0sU2",
        "outputId": "6f1ef07f-9ce1-4832-e2da-638fca4a5a39"
      },
      "id": "8QK2aagP0sU2",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 86469\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n"
          ]
        },
        {
          "output_type": "error",
          "ename": "BadRequestError",
          "evalue": "Error code: 400 - {'error': {'message': \"This model's maximum context length is 128000 tokens. However, your messages resulted in 151226 tokens (151156 in the messages, 70 in the functions). Please reduce the length of the messages or functions.\", 'type': 'invalid_request_error', 'param': 'messages', 'code': 'context_length_exceeded'}}",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mBadRequestError\u001b[0m                           Traceback (most recent call last)",
            "\u001b[0;32m/tmp/ipython-input-3658128472.py\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0mquery\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m\"Research on the latest methods of cancer treatment\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 2\u001b[0;31m \u001b[0moutput\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mcall_conversational_agent\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0magent\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mquery\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0muid\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mverbose\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;32mFalse\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
            "\u001b[0;32m/tmp/ipython-input-2004578426.py\u001b[0m in \u001b[0;36mcall_conversational_agent\u001b[0;34m(agent, prompt, user_session_id, verbose)\u001b[0m\n\u001b[1;32m     14\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     15\u001b[0m     \u001b[0;31m# Iterate through each step of the streamed agent output\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 16\u001b[0;31m     \u001b[0;32mfor\u001b[0m \u001b[0mevent\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mevents\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     17\u001b[0m         \u001b[0;31m# If verbose mode is enabled, print each intermediate message\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     18\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mverbose\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langgraph/pregel/main.py\u001b[0m in \u001b[0;36mstream\u001b[0;34m(self, input, config, context, stream_mode, print_mode, output_keys, interrupt_before, interrupt_after, durability, subgraphs, debug, **kwargs)\u001b[0m\n\u001b[1;32m   2645\u001b[0m                     \u001b[0;32mfor\u001b[0m \u001b[0mtask\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mloop\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmatch_cached_writes\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2646\u001b[0m                         \u001b[0mloop\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0moutput_writes\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtask\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mid\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtask\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwrites\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcached\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;32mTrue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2647\u001b[0;31m                     for _ in runner.tick(\n\u001b[0m\u001b[1;32m   2648\u001b[0m                         \u001b[0;34m[\u001b[0m\u001b[0mt\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mt\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mloop\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtasks\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mvalues\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mif\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0mt\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwrites\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2649\u001b[0m                         \u001b[0mtimeout\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mstep_timeout\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langgraph/pregel/_runner.py\u001b[0m in \u001b[0;36mtick\u001b[0;34m(self, tasks, reraise, timeout, retry_policy, get_waiter, schedule_task)\u001b[0m\n\u001b[1;32m    160\u001b[0m             \u001b[0mt\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtasks\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    161\u001b[0m             \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 162\u001b[0;31m                 run_with_retry(\n\u001b[0m\u001b[1;32m    163\u001b[0m                     \u001b[0mt\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    164\u001b[0m                     \u001b[0mretry_policy\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langgraph/pregel/_retry.py\u001b[0m in \u001b[0;36mrun_with_retry\u001b[0;34m(task, retry_policy, configurable)\u001b[0m\n\u001b[1;32m     40\u001b[0m             \u001b[0mtask\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mwrites\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mclear\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     41\u001b[0m             \u001b[0;31m# run the task\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 42\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mtask\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mproc\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minvoke\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mtask\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minput\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mconfig\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     43\u001b[0m         \u001b[0;32mexcept\u001b[0m \u001b[0mParentCommand\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mexc\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     44\u001b[0m             \u001b[0mns\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0mstr\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mconfig\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mCONF\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mCONFIG_KEY_CHECKPOINT_NS\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langgraph/_internal/_runnable.py\u001b[0m in \u001b[0;36minvoke\u001b[0;34m(self, input, config, **kwargs)\u001b[0m\n\u001b[1;32m    655\u001b[0m                     \u001b[0;31m# run in context\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    656\u001b[0m                     \u001b[0;32mwith\u001b[0m \u001b[0mset_config_context\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mconfig\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mrun\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mcontext\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 657\u001b[0;31m                         \u001b[0minput\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mcontext\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mrun\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mstep\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minvoke\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0minput\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mconfig\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    658\u001b[0m                 \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    659\u001b[0m                     \u001b[0minput\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mstep\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minvoke\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0minput\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mconfig\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langgraph/_internal/_runnable.py\u001b[0m in \u001b[0;36minvoke\u001b[0;34m(self, input, config, **kwargs)\u001b[0m\n\u001b[1;32m    399\u001b[0m                 \u001b[0mrun_manager\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mon_chain_end\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mret\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    400\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 401\u001b[0;31m             \u001b[0mret\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    402\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mrecurse\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0misinstance\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mret\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mRunnable\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    403\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mret\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minvoke\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0minput\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mconfig\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/tmp/ipython-input-200370830.py\u001b[0m in \u001b[0;36mtool_calling_llm\u001b[0;34m(state)\u001b[0m\n\u001b[1;32m     16\u001b[0m     \u001b[0mcurrent_state\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mstate\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m\"messages\"\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     17\u001b[0m     \u001b[0mstate_with_instructions\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mAGENT_SYS_PROMPT\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mcurrent_state\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 18\u001b[0;31m     \u001b[0mresponse\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mllm_with_tools\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0minvoke\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mstate_with_instructions\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     19\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     20\u001b[0m     \u001b[0mtoken_usage\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mresponse\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0musage_metadata\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langchain_core/runnables/base.py\u001b[0m in \u001b[0;36minvoke\u001b[0;34m(self, input, config, **kwargs)\u001b[0m\n\u001b[1;32m   5439\u001b[0m         \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0mOptional\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mAny\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   5440\u001b[0m     ) -> Output:\n\u001b[0;32m-> 5441\u001b[0;31m         return self.bound.invoke(\n\u001b[0m\u001b[1;32m   5442\u001b[0m             \u001b[0minput\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   5443\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_merge_configs\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mconfig\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langchain_core/language_models/chat_models.py\u001b[0m in \u001b[0;36minvoke\u001b[0;34m(self, input, config, stop, **kwargs)\u001b[0m\n\u001b[1;32m    381\u001b[0m         return cast(\n\u001b[1;32m    382\u001b[0m             \u001b[0;34m\"ChatGeneration\"\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 383\u001b[0;31m             self.generate_prompt(\n\u001b[0m\u001b[1;32m    384\u001b[0m                 \u001b[0;34m[\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_convert_input\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0minput\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    385\u001b[0m                 \u001b[0mstop\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mstop\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langchain_core/language_models/chat_models.py\u001b[0m in \u001b[0;36mgenerate_prompt\u001b[0;34m(self, prompts, stop, callbacks, **kwargs)\u001b[0m\n\u001b[1;32m   1004\u001b[0m     ) -> LLMResult:\n\u001b[1;32m   1005\u001b[0m         \u001b[0mprompt_messages\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m[\u001b[0m\u001b[0mp\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mto_messages\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mp\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mprompts\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1006\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mprompt_messages\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mstop\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mstop\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcallbacks\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mcallbacks\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1007\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1008\u001b[0m     \u001b[0;34m@\u001b[0m\u001b[0moverride\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langchain_core/language_models/chat_models.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self, messages, stop, callbacks, tags, metadata, run_name, run_id, **kwargs)\u001b[0m\n\u001b[1;32m    823\u001b[0m             \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    824\u001b[0m                 results.append(\n\u001b[0;32m--> 825\u001b[0;31m                     self._generate_with_cache(\n\u001b[0m\u001b[1;32m    826\u001b[0m                         \u001b[0mm\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    827\u001b[0m                         \u001b[0mstop\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mstop\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langchain_core/language_models/chat_models.py\u001b[0m in \u001b[0;36m_generate_with_cache\u001b[0;34m(self, messages, stop, run_manager, **kwargs)\u001b[0m\n\u001b[1;32m   1070\u001b[0m             \u001b[0mresult\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgenerate_from_stream\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0miter\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mchunks\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1071\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0minspect\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0msignature\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_generate\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mparameters\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"run_manager\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1072\u001b[0;31m             result = self._generate(\n\u001b[0m\u001b[1;32m   1073\u001b[0m                 \u001b[0mmessages\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mstop\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mstop\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mrun_manager\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mrun_manager\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1074\u001b[0m             )\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/langchain_openai/chat_models/base.py\u001b[0m in \u001b[0;36m_generate\u001b[0;34m(self, messages, stop, run_manager, **kwargs)\u001b[0m\n\u001b[1;32m   1175\u001b[0m             \u001b[0mgeneration_info\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m{\u001b[0m\u001b[0;34m\"headers\"\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0mdict\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mraw_response\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mheaders\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m}\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1176\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1177\u001b[0;31m             \u001b[0mresponse\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mclient\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcreate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mpayload\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1178\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_create_chat_result\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mresponse\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mgeneration_info\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1179\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/openai/_utils/_utils.py\u001b[0m in \u001b[0;36mwrapper\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    285\u001b[0m                         \u001b[0mmsg\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34mf\"Missing required argument: {quote(missing[0])}\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    286\u001b[0m                 \u001b[0;32mraise\u001b[0m \u001b[0mTypeError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mmsg\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 287\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    288\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    289\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mwrapper\u001b[0m  \u001b[0;31m# type: ignore\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/openai/resources/chat/completions/completions.py\u001b[0m in \u001b[0;36mcreate\u001b[0;34m(self, messages, model, audio, frequency_penalty, function_call, functions, logit_bias, logprobs, max_completion_tokens, max_tokens, metadata, modalities, n, parallel_tool_calls, prediction, presence_penalty, prompt_cache_key, reasoning_effort, response_format, safety_identifier, seed, service_tier, stop, store, stream, stream_options, temperature, tool_choice, tools, top_logprobs, top_p, user, verbosity, web_search_options, extra_headers, extra_query, extra_body, timeout)\u001b[0m\n\u001b[1;32m   1148\u001b[0m     ) -> ChatCompletion | Stream[ChatCompletionChunk]:\n\u001b[1;32m   1149\u001b[0m         \u001b[0mvalidate_response_format\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mresponse_format\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1150\u001b[0;31m         return self._post(\n\u001b[0m\u001b[1;32m   1151\u001b[0m             \u001b[0;34m\"/chat/completions\"\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1152\u001b[0m             body=maybe_transform(\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/openai/_base_client.py\u001b[0m in \u001b[0;36mpost\u001b[0;34m(self, path, cast_to, body, options, files, stream, stream_cls)\u001b[0m\n\u001b[1;32m   1257\u001b[0m             \u001b[0mmethod\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"post\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0murl\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mpath\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mjson_data\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mbody\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mfiles\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mto_httpx_files\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfiles\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0moptions\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1258\u001b[0m         )\n\u001b[0;32m-> 1259\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mcast\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mResponseT\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mrequest\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mcast_to\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mopts\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mstream\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mstream\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mstream_cls\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mstream_cls\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1260\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1261\u001b[0m     def patch(\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/openai/_base_client.py\u001b[0m in \u001b[0;36mrequest\u001b[0;34m(self, cast_to, options, stream, stream_cls)\u001b[0m\n\u001b[1;32m   1045\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1046\u001b[0m                 \u001b[0mlog\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdebug\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"Re-raising status error\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1047\u001b[0;31m                 \u001b[0;32mraise\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_make_status_error_from_response\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0merr\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mresponse\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1048\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1049\u001b[0m             \u001b[0;32mbreak\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mBadRequestError\u001b[0m: Error code: 400 - {'error': {'message': \"This model's maximum context length is 128000 tokens. However, your messages resulted in 151226 tokens (151156 in the messages, 70 in the functions). Please reduce the length of the messages or functions.\", 'type': 'invalid_request_error', 'param': 'messages', 'code': 'context_length_exceeded'}}"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We get the dreaded **maximum context length exceeded** error above! Now let's do some context engineering to prevent this!"
      ],
      "metadata": {
        "id": "Yd8RhcX31IXf"
      },
      "id": "Yd8RhcX31IXf"
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Optimize your Health Assistant Agentic AI System with Memory Context Engineering\n",
        "\n",
        "This section optimizes the base agent to be better, cheaper, and more reliable by controlling context growth and normalizing tool outputs.  \n",
        "\n",
        "We introduce memory-aware techniques that keep only the most relevant history, compress verbose tool results, and enforce tight token capping so the agent stays responsive even over long sessions and does not error out\n",
        "\n",
        "Key optimizations:\n",
        "- **Context Trimming**: Apply a recency message trimmer to retain only the most recent, agent memory history while discarding older history.\n",
        "- **Tool Output Summarization**: Wrap tool executions with an LLM summarizer that converts long raw results into concise, structured summarized content.\n",
        "- **Context Limit Guards**: Enforce upper bounds on message/tool payload size, and standardize return schemas to reduce downstream parsing errors.\n",
        "- **Stateful Memory**: Continue using a checkpointer so multi-turn sessions share context without exceeding the model’s context window.\n",
        "\n",
        "These changes improve the overall agent in terms of being able to retain and leverage richer and longer context over multiple interactions without erroring out.\n"
      ],
      "metadata": {
        "id": "tg1m-rgy1H64"
      },
      "id": "tg1m-rgy1H64"
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Create a mapping of `{tool name : actual tool implementation}`\n",
        "\n",
        "Establish a canonical lookup between the LLM’s requested tool name and the executable tool function.  \n",
        "\n"
      ],
      "metadata": {
        "id": "JFaFw_go1dNh"
      },
      "id": "JFaFw_go1dNh"
    },
    {
      "cell_type": "code",
      "source": [
        "tools_by_name = {tool.name: tool for tool in tools}\n",
        "tools_by_name"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "wEYhgGQFLj9q",
        "outputId": "54937f46-647c-4eaf-9f4a-f4d33d0c42f3"
      },
      "id": "wEYhgGQFLj9q",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'search_web_extract_info': StructuredTool(name='search_web_extract_info', description='Search the web for a query. Useful for general information or general news.', args_schema=<class 'langchain_core.utils.pydantic.search_web_extract_info'>, func=<function search_web_extract_info at 0x7da4ac80ccc0>),\n",
              " 'recommend_doctor': StructuredTool(name='recommend_doctor', description=\"Recommend the most suitable doctor based on the user's symptoms.\", args_schema=<class 'langchain_core.utils.pydantic.recommend_doctor'>, func=<function recommend_doctor at 0x7da4ac74bf60>)}"
            ]
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Define Agent Node Functions & Graph\n",
        "\n",
        "Refactor the graph to include trimming and summarization steps in the control flow.\n",
        "\n",
        "Graph outline:\n",
        "- **Context Trimmer Node**: Prunes history to a target token budget before each LLM turn.\n",
        "- **Agent (LLM) Node**: Reads system prompt + trimmed history; decides whether to answer or call a tool.\n",
        "- **Tool+Summarizer Node**: Executes the selected tool via `tools_by_name`, then immediately summarizes/normalizes the results and appends a compact `ToolMessage`.\n",
        "- **Router**: If more info is needed, loop back to the Agent; otherwise transition to `END`.\n"
      ],
      "metadata": {
        "id": "qWityWdr1pLA"
      },
      "id": "qWityWdr1pLA"
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain_core.messages import trim_messages\n",
        "from langgraph.graph.message import RemoveMessage, REMOVE_ALL_MESSAGES\n",
        "from langchain_core.messages import ToolMessage\n",
        "\n",
        "TOOL_SUMMARIZER_PROMPT = \"\"\"Given the following context information,\n",
        "summarize it ensuring to retain all relevant / essential information.\n",
        "Your goal is simply to reduce the size of the context to a more manageable size.\n",
        "Follow these exact rules for summarization:\n",
        "- If the context is structured information like a dict or JSON - keep as it is\n",
        "- If the context is text create a comprehensive report of approx 40000 words max\n",
        "\"\"\"\n",
        "\n",
        "# Custom Tools node function\n",
        "# - trims tool call response to < 128K tokens\n",
        "# - summarizes tool call response to around 40K words\n",
        "def tool_node_with_summarization(state: dict):\n",
        "    \"\"\"Performs the tool call\"\"\"\n",
        "\n",
        "    result = []\n",
        "    for tool_call in state[\"messages\"][-1].tool_calls:\n",
        "        # call the tool - based on the requested tool call name and arguments\n",
        "        tool = tools_by_name[tool_call[\"name\"]]\n",
        "        tool_results = tool.invoke(tool_call[\"args\"])\n",
        "        if type(tool_results) == list:\n",
        "            tool_results = [str(doc) for doc in tool_results]\n",
        "        else:\n",
        "            tool_results = [str(tool_results)]\n",
        "        # trim tool response context to < LLM max context window\n",
        "        trimmed_tool_results = trim_messages(\n",
        "            tool_results,\n",
        "            max_tokens=126000,              # GPT-4o-mini supports up to ~128K tokens\n",
        "            strategy=\"first\",                # Retain the top content (which came first)\n",
        "            token_counter=ChatOpenAI(model=\"gpt-4o-mini\"),  # Use LLM-based token counting\n",
        "            allow_partial=True              # Allow partial trimming of messages if needed\n",
        "        )\n",
        "        print('-'*25, 'Summarizing Tool Results', '-'*25)\n",
        "        # Summarize the tool response context further\n",
        "        # You can handle various types of tool calls in different ways in this node\n",
        "        summarized_tool_results = llm.invoke([{\"role\":\"system\", \"content\":TOOL_SUMMARIZER_PROMPT},\n",
        "                                              {\"role\":\"user\", \"content\" : str(trimmed_tool_results)}])\n",
        "        # add transformed tool response context as tool message in agent state\n",
        "        result.append(ToolMessage(content=summarized_tool_results.content,\n",
        "                                  tool_call_id=tool_call[\"id\"]))\n",
        "    return {\"messages\": result}\n",
        "\n",
        "# Memory Context Trimmer node function\n",
        "# Takes the memory history of agent messages and retains the most recent K messages\n",
        "def context_trimmer_node(state: State) -> State:\n",
        "    # Trim the context history to fit within the model's token limit\n",
        "    print('-'*25, 'Trimming overall context if needed', '-'*25)\n",
        "    trimmed_state = trim_messages(\n",
        "        state[\"messages\"],\n",
        "        max_tokens=16,      # last 4 interactions - 1 agent interaction here is 4 messages (input, tool call, tool result, reponse)\n",
        "        strategy=\"last\",    # Retain the most recent messages\n",
        "        token_counter=len,  # Use number of state messages based counting\n",
        "        allow_partial=True  # Allow partial trimming of messages if needed\n",
        "    )\n",
        "\n",
        "    return {\"messages\": [RemoveMessage(id=REMOVE_ALL_MESSAGES)] + trimmed_state} # update memory with recent history only\n",
        "\n",
        "\n",
        "# Create the node function that handles reasoning and planning using the LLM\n",
        "def tool_calling_llm(state: State) -> State:\n",
        "    # get agent state and then get next step (response) from llm\n",
        "    current_state = state[\"messages\"]\n",
        "    state_with_instructions = [AGENT_SYS_PROMPT] + current_state\n",
        "    response = [llm_with_tools.invoke(state_with_instructions)]\n",
        "\n",
        "    token_usage = response[0].usage_metadata\n",
        "    print('-'*25, 'TOKEN USAGE', '-'*25)\n",
        "    print(\"Token count (input context):\", token_usage['input_tokens'])\n",
        "    print(\"Token count (response):\", token_usage['output_tokens'])\n",
        "    print('-'*25, 'TOKEN USAGE', '-'*25)\n",
        "\n",
        "    # Return the updated state containing the new message\n",
        "    return {\"messages\": response}\n",
        "\n",
        "# Conditional edge function to route to the tool node or end based upon whether the LLM made a tool call\n",
        "def tool_calling_routing(state: State) -> str:\n",
        "    \"\"\"Decide if we should continue the loop or stop based upon whether the LLM made a tool call\"\"\"\n",
        "\n",
        "    messages = state[\"messages\"]\n",
        "    last_message = messages[-1]\n",
        "    # If the LLM makes a tool call, then perform an action\n",
        "    if last_message.tool_calls:\n",
        "        return \"tool_call\"\n",
        "    # Otherwise, we stop (reply to the user)\n",
        "    return \"stop_agent\"\n",
        "\n",
        "\n",
        "# Build the graph\n",
        "builder = StateGraph(State)\n",
        "\n",
        "# Add nodes\n",
        "builder.add_node(\"context_trimmer\", context_trimmer_node)\n",
        "builder.add_node(\"tool_calling_llm\", tool_calling_llm)\n",
        "builder.add_node(\"tools_node_with_summarizer\", tool_node_with_summarization)\n",
        "\n",
        "# Add edges\n",
        "builder.add_edge(START, \"context_trimmer\")\n",
        "# Conditional edge\n",
        "builder.add_conditional_edges(\n",
        "    \"tool_calling_llm\",\n",
        "    tool_calling_routing, # conditional routing function\n",
        "    {\n",
        "        \"stop_agent\": END,\n",
        "        \"tool_call\": \"tools_node_with_summarizer\"\n",
        "    }\n",
        ")\n",
        "builder.add_edge(\"tools_node_with_summarizer\", \"context_trimmer\") # this is the key feedback loop in the agentic system\n",
        "builder.add_edge(\"context_trimmer\", \"tool_calling_llm\")\n",
        "# Compile Agent Graph with memory\n",
        "memory = MemorySaver()\n",
        "agent = builder.compile(checkpointer=memory)"
      ],
      "metadata": {
        "id": "PLAc_ZOVNugi"
      },
      "id": "PLAc_ZOVNugi",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "agent"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 389
        },
        "id": "a4FVflAKd4hL",
        "outputId": "fced6e2a-e553-4360-85fa-419609195d3c"
      },
      "id": "a4FVflAKd4hL",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<langgraph.graph.state.CompiledStateGraph object at 0x7da4a72b8210>"
            ],
            "image/png": "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\n"
          },
          "metadata": {},
          "execution_count": 18
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Test Agent on Sample Queries"
      ],
      "metadata": {
        "id": "1le3gKMn3Lh0"
      },
      "id": "1le3gKMn3Lh0"
    },
    {
      "cell_type": "code",
      "source": [
        "uid = 'user001'\n",
        "query = \"Tell me latest and best methods for diabetes management\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 955
        },
        "id": "2QjmtWUfd49k",
        "outputId": "7ad9fed8-e2ef-4301-8449-bb789969652e"
      },
      "id": "2QjmtWUfd49k",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 220\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- Summarizing Tool Results -------------------------\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 916\n",
            "Token count (response): 528\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "The latest methods for diabetes management in 2025 emphasize a combination of updated guidelines, innovative medications, and advanced technology. Here are the key highlights:\n\n### 1. Updated Standards of Care\n- **Source**: American Diabetes Association (ADA), December 9, 2024\n- **Key Updates**:\n  - **Continuous Glucose Monitors (CGMs)**: Recommended for adults with type 2 diabetes to improve glucose control.\n  - **Medication Guidance**: Focus on GLP-1 receptor agonists for heart and kidney health, addressing medication shortages.\n  - **Nutrition**: Emphasis on plant-based diets and increased fiber intake.\n  - **Older Adults**: Specific recommendations for managing diabetes in older populations, considering social determinants of health.\n  - **Complications Management**: New guidelines for screening and managing diabetes-related complications.\n\n### 2. Top Diabetes Medications\n- **Key Drugs**:\n  - **GLP-1 Receptor Agonists**: Effective for weight management and blood sugar control.\n  - **SGLT2 Inhibitors**: Provide heart and kidney protection.\n  - **Once-Weekly Insulin**: Reduces the frequency of injections.\n  - **Combination Therapies**: New GLP-1 and GIP receptor agonists show superior results.\n  - **Non-Injectable Treatments**: Oral GLP-1 agonists and inhalable insulin are becoming more popular.\n\n### 3. Technological Innovations\n- **AI and Predictive Modeling**: AI tools can predict type 1 diabetes up to a year before symptoms appear, allowing for earlier intervention.\n- **Patch Pumps**: Innovations like Medtronic's MiniMed Fit simplify insulin delivery.\n- **Beta Cell Therapy**: Vertex's zimislecel therapy shows promise in restoring insulin-producing cells in type 1 diabetes patients.\n- **Sensor Innovations**: New sensors, such as Biolinq's intradermal sensor, enhance glucose monitoring.\n- **Remote Monitoring**: Programs utilizing CGMs have shown significant improvements in patient outcomes, especially in underserved populations.\n\n### Conclusion\nThe integration of innovative treatments and technologies, along with a focus on personalized care, aims to enhance the quality of life for individuals living with diabetes. For more detailed information, healthcare professionals and stakeholders can refer to the full guidelines available through the ADA.\n\nFor further reading, you can check the full guidelines and updates from the ADA [here](https://www.diabetes.org/). \n\n### Publication Date\n- **December 9, 2024** (for the ADA guidelines)"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"Please recommend a right doctor\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 460
        },
        "id": "mGZJCLDwepVp",
        "outputId": "1dcea117-9312-4611-d10e-82c230c852fa"
      },
      "id": "mGZJCLDwepVp",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 1456\n",
            "Token count (response): 18\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- Summarizing Tool Results -------------------------\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 1565\n",
            "Token count (response): 99\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "I recommend the following doctor for diabetes management:\n\n### Dr. Janet Dyne\n- **Specialization**: Endocrinology (Diabetes Care)\n- **Available Timings**: 10:00 AM - 1:00 PM\n- **Location**: City Health Clinic\n- **Contact**: [janet.dyne@healthclinic.com](mailto:janet.dyne@healthclinic.com)\n\nYou can book an appointment by emailing Dr. Dyne directly."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"How to prevent panic attacks\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "12dynaOKewwu",
        "outputId": "96815be8-3032-4cdf-efb1-cb5ec12be86f"
      },
      "id": "12dynaOKewwu",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 1676\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- Summarizing Tool Results -------------------------\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 2350\n",
            "Token count (response): 495\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "To prevent panic attacks, it's important to understand their symptoms, causes, and effective management strategies. Here are some key approaches:\n\n### Understanding Panic Attacks\nPanic attacks are sudden episodes of intense fear that can trigger severe physical reactions. Common symptoms include:\n- Rapid heart rate\n- Sweating\n- Trembling or shaking\n- Shortness of breath\n- Chest pain\n- Nausea\n- Dizziness\n- Feelings of unreality or detachment\n\n### Causes and Triggers\nWhile the exact cause is not fully understood, several factors may contribute:\n- **Genetics**: Family history of anxiety disorders.\n- **Mental Health Conditions**: Co-occurring conditions like depression or PTSD.\n- **Stressful Life Events**: Major life changes or traumatic experiences.\n- **Substance Use**: Caffeine, alcohol, and certain medications.\n\n### Immediate Coping Strategies\n1. **Deep Breathing**: Focus on slow, deep breaths to calm the body.\n2. **Muscle Relaxation**: Tense and then relax different muscle groups.\n3. **Grounding Techniques**: Use methods like the 5-4-3-2-1 technique to focus on the present.\n4. **Mindfulness**: Acknowledge the panic attack and remind yourself it is temporary.\n\n### Long-term Strategies\n- **Cognitive Behavioral Therapy (CBT)**: Helps change negative thought patterns.\n- **Exposure Therapy**: Gradually exposes individuals to feared situations.\n- **Medication**: Antidepressants (SSRIs, SNRIs) and anti-anxiety medications can be effective but should be used cautiously.\n\n### Lifestyle Modifications\n- Engage in regular exercise.\n- Maintain a healthy diet.\n- Avoid caffeine and alcohol.\n- Practice stress management techniques.\n\n### Supporting Others\nIf someone is experiencing a panic attack:\n- Stay calm and provide reassurance.\n- Encourage them to focus on their breathing.\n- Help them identify and describe their physical sensations.\n\n### When to Seek Help\nConsult a healthcare provider if panic attacks are frequent or interfere with daily life. Emergency care is necessary if symptoms resemble those of a heart attack.\n\n### Conclusion\nPanic attacks can be distressing, but with proper understanding and management strategies, individuals can learn to cope effectively. Seeking professional help is essential for those experiencing recurrent panic attacks or significant anxiety.\n\nFor more detailed information, you can refer to resources from mental health organizations or consult a healthcare professional."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"Tell me the best methods to keep my eyesight sharp\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "ka-Zt4BsA-5H",
        "outputId": "c561d27c-0cf2-4463-f4a8-f9e2ac450560"
      },
      "id": "ka-Zt4BsA-5H",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 2862\n",
            "Token count (response): 24\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- Summarizing Tool Results -------------------------\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 3703\n",
            "Token count (response): 461\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "To keep your eyesight sharp and maintain overall eye health, consider the following best methods:\n\n### 1. Follow the 20-20-20 Rule\n- Every 20 minutes, look at something 20 feet away for 20 seconds to reduce digital eye strain.\n\n### 2. Schedule Regular Eye Exams\n- Regular check-ups are essential for early detection of conditions like glaucoma and macular degeneration.\n\n### 3. Protect Your Eyes from UV Rays\n- Wear sunglasses that block 100% of UVA and UVB rays to prevent cataracts and macular degeneration.\n\n### 4. Fuel Your Vision with Nutrition\n- Consume foods rich in omega-3 fatty acids, lutein, and vitamins C and E. Leafy greens, fish, and nuts are excellent choices.\n\n### 5. Stay Hydrated\n- Drink enough water to prevent dry eyes and maintain overall health.\n\n### 6. Limit Blue Light Exposure\n- Use blue light-blocking glasses and take breaks from screens to reduce eye strain.\n\n### 7. Maintain Good Contact Lens Hygiene\n- Wash your hands before handling lenses and follow proper cleaning schedules to prevent infections.\n\n### 8. Stay Active for Better Circulation\n- Regular exercise promotes healthy blood flow to the eyes, which is vital for maintaining vision.\n\n### 9. Make Sleep a Priority\n- Aim for 7-8 hours of quality sleep each night to support eye health.\n\n### 10. Explore Modern Eye Care Solutions\n- Consider innovative treatments for common eye issues, and stay informed about advancements in eye care.\n\n### Eye Exercises to Improve Vision\n- **Palming**: Relax your eyes by covering them with warm palms.\n- **Blinking**: Regular blinking helps keep your eyes moist.\n- **Pencil Push-ups**: Focus on a pencil as it moves closer to train convergence.\n- **Near and Far Focus**: Alternate focus between near and distant objects.\n- **Figure Eight**: Trace an imaginary figure eight to improve tracking.\n\n### Conclusion\nBy incorporating these practices into your daily routine, you can take proactive steps to protect your vision and prevent potential eye problems. Regular check-ups with eye care professionals are essential for early detection and management of eye conditions. For more detailed information, consider consulting with an eye care specialist."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"Research on the latest methods of cancer treatment\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "CWIQSIncBEnB",
        "outputId": "71e202f5-a9e8-4af8-e0d0-da62cbd22c72"
      },
      "id": "CWIQSIncBEnB",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 4166\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- Summarizing Tool Results -------------------------\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 4223\n",
            "Token count (response): 568\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "The latest methods of cancer treatment in 2025 showcase significant advancements in technology, precision medicine, and innovative therapies. Here are the key highlights:\n\n### 1. Precision Medicine\n- **Genomic Technologies**: Advances in Next-Generation Sequencing (NGS) are enhancing personalized cancer treatment. Tools like DeepHRD, an AI tool for detecting homologous recombination deficiency in tumors, are improving diagnostic accuracy and treatment outcomes.\n\n### 2. Artificial Intelligence (AI)\n- **AI Integration**: AI is revolutionizing cancer care by improving diagnostics, treatment planning, and optimizing clinical trials. AI tools are being integrated into clinical workflows to enhance patient outcomes and streamline processes.\n\n### 3. Immunotherapy Advances\n- **New Treatments**: Significant progress includes new immune checkpoint inhibitors and bispecific antibodies, which are showing promise in treating various cancers. The FDA has approved several new immunotherapy drugs in 2025.\n\n### 4. Key Drug Discoveries\n- **AI Drug Discovery**: A novel approach using AI has shown a 60% life extension in mouse models for colorectal cancer.\n- **Combination Therapies**: New strategies combining precision drug therapy with antibodies and radiation have demonstrated effectiveness in eliminating tumors.\n- **In Vivo T Cell Reprogramming**: Clinical trials are testing therapies that reprogram T cells to target multiple myeloma.\n- **Quantum Computing**: Researchers are using quantum computing to identify molecules that interact with cancer-driving proteins.\n- **New Cancer Vaccine**: A combination of a new vaccine and checkpoint inhibitors is showing promise in treating head and neck cancers.\n\n### 5. Emerging Therapies\n- **Thyroid Cancer**: A combination of pembrolizumab, dabrafenib, and trametinib has shown improved surgical outcomes for patients with advanced thyroid cancer.\n- **Colorectal Cancer**: New combination therapies for BRAF-mutated metastatic colorectal cancer have demonstrated higher response rates and improved survival.\n- **mRNA-Encoded Antibody**: A first-in-class mRNA-encoded bispecific antibody is showing promise in early trials.\n- **KIF18A Inhibitor**: An oral KIF18A inhibitor is being tested for safety and efficacy in patients with chromosomal instability.\n- **BPDCN Treatment**: A new antibody-drug conjugate for treating blastic plasmacytoid dendritic cell neoplasm is showing promising efficacy and safety.\n\n### Conclusion\nThe advancements in oncology in 2025, particularly in precision medicine, AI integration, and immunotherapy, are set to improve patient outcomes and redefine cancer treatment paradigms. However, challenges such as access and cost remain critical issues that need to be addressed to ensure equitable cancer care for all patients.\n\nFor more detailed information, consider consulting oncology journals or healthcare professionals specializing in cancer treatment."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "query = \"Research on common symptoms of clinical depression\"\n",
        "output = call_conversational_agent(agent, query, uid, verbose=False)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 908
        },
        "id": "h5CbsVWqEtgK",
        "outputId": "8ad12efe-8581-4c32-9688-f12cc46c56f4"
      },
      "id": "h5CbsVWqEtgK",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Running Agent. Please wait...\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 4265\n",
            "Token count (response): 23\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "------------------------- Summarizing Tool Results -------------------------\n",
            "------------------------- Trimming overall context if needed -------------------------\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "Token count (input context): 4815\n",
            "Token count (response): 451\n",
            "------------------------- TOKEN USAGE -------------------------\n",
            "\n",
            "\n",
            "Agent Final Response:\n",
            "\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.Markdown object>"
            ],
            "text/markdown": "Clinical depression, also known as Major Depressive Disorder (MDD), is a serious mental health condition characterized by a persistently low mood and a loss of interest in activities that were once enjoyable. Here are the common symptoms associated with clinical depression:\n\n### Psychological Symptoms\n- **Persistent Low Mood**: A continuous feeling of sadness or emptiness.\n- **Feelings of Hopelessness and Helplessness**: A belief that things will not improve.\n- **Low Self-Esteem and Guilt**: Excessive self-blame or feelings of worthlessness.\n- **Irritability and Lack of Motivation**: Increased frustration and decreased interest in activities.\n- **Difficulty Making Decisions**: Trouble concentrating or focusing.\n- **Anxious or Worried Thoughts**: Persistent anxiety or worry.\n- **Suicidal Thoughts**: Thoughts of death or self-harm.\n\n### Physical Symptoms\n- **Changes in Appetite or Weight**: Significant weight loss or gain, or changes in eating habits.\n- **Fatigue and Low Energy**: Persistent tiredness that does not improve with rest.\n- **Sleep Disturbances**: Insomnia (difficulty sleeping) or hypersomnia (sleeping too much).\n- **Unexplained Aches and Pains**: Physical symptoms without a clear medical cause.\n\n### Social Symptoms\n- **Withdrawal from Social Activities**: Avoiding friends, family, and social engagements.\n- **Neglecting Hobbies and Interests**: Loss of interest in activities that were once enjoyable.\n- **Difficulties in Home, Work, or Family Life**: Struggles with responsibilities and relationships.\n\n### Diagnosis and Treatment\nDiagnosis is based on a thorough evaluation of symptoms, medical history, and mental health history. Treatment often involves a combination of medication (such as antidepressants) and psychotherapy (like Cognitive Behavioral Therapy).\n\n### Conclusion\nClinical depression is a common and serious mental health condition that can significantly impact daily life. However, effective treatments are available, and early intervention can lead to better outcomes. If you or someone you know is experiencing symptoms of depression, it is important to seek help from a healthcare provider.\n\nFor more detailed information, consider consulting mental health resources or professionals specializing in depression."
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can go on running this agent and the overall context window size maintained in the agent memory is reduced by **approximately 97%**"
      ],
      "metadata": {
        "id": "x6xjccbm4BHT"
      },
      "id": "x6xjccbm4BHT"
    },
    {
      "cell_type": "code",
      "source": [
        "((128000-4000) / 128000) * 100 # roughly 4K tokens are in memory after multiple turns"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "5CSZmMdW33l8",
        "outputId": "7070a015-6b04-4e74-a772-fc93a2bc4b28"
      },
      "id": "5CSZmMdW33l8",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "96.875"
            ]
          },
          "metadata": {},
          "execution_count": 28
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# total agent messages in the state memory at any point in time is around 16\n",
        "len(agent.get_state({\"configurable\": {\"thread_id\": uid}}).values['messages'])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "i3cL3VBdGxhW",
        "outputId": "2d9efec1-845d-4ed1-a06e-d4693c3428fa"
      },
      "id": "i3cL3VBdGxhW",
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "17"
            ]
          },
          "metadata": {},
          "execution_count": 34
        }
      ]
    }
  ],
  "metadata": {
    "colab": {
      "provenance": [],
      "include_colab_link": true
    },
    "language_info": {
      "name": "python"
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}